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Wild birds are the natural reservoirs of Influenza A viruses (IAVs) which cause occasional 
pandemics and seasonal epidemics. Avian IAVs can be transmitted from wild birds to domestic 
poultry, low mammals, and humans. It is well accepted that avian IAVs prefer to sialic acids 
(Sia) 2,3-linked galactose (SA2,3-Gal), whereas human IAVs to 2,6-linked galactose 
(SA2,6-Gal). However, SA2,3-Gal in wild bird tissues is widely distributed with little 
variation while some subtypes of avian IAVs have species preference.  The different isolation 
rates among wild bird species cannot be explained by avian IAVs binding to SA2,3-Gal alone. 
Specifically, this dissertation had the following aims: Firstly, to determine distribution of glycan 
receptors across respiratory and gastrointestinal tissues of wild birds and domestic poultry;  
Secondly, to determine the viral-receptor binding specificity of avian IAVs; Thirdly, to 
understand the role of glycan motifs in shaping virus evolution during the natural history of 
IAVs, especially  from wild bird to poultry transmission. We found that avian H7 and H10 
viruses acquired the binding ability to SA2,6-Gal without adaptation, furthermore, we 
evaluated one of these H10 virus that possess the ability of binding to SA2,6-Gal in ferret 
model and found it could cause aerosol and contact transmissions. On the other hand, H7 viruses 
 
 
have strong binding avidity to SLex which are present widely in epithelial cells of chicken 
trachea, which could facilitate the transmission of avian H7 viruses from waterfowl to poultry. 
Lastly, we found that H7 viruses from waterfowl bound both Neu5Ac and Neu5Gc while 
chicken isolates from China only prefer to Neu5Ac. Of interest, we found Neu5Gc was found in 
mallards but not in chickens, which indicated that viruses reduce or lost binding ability to 
Neu5Gc by adapting in chicken. In summary, this dissertation focused on certain subtypes of 
avian IAVs, which have caused threats to domestic poultry and public health, and primary avian 
species for influenza risk. The glycan substructures may play an important role in avian IAVs 
transmission and adaptation. The knowledge derived from this dissertation will help identify 
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Classification of influenza viruses 
Influenza viruses belong to Orthomyxoviridae family and are classified into four genera 
including type A, B, C and recent emerging type D (Hause et al. 2013) (Hause et al. 2014) based 
on their antigenic differences in nucleoprotein (NP) and matrix 1 (M1) proteins. Influenza 
viruses contain segmented, negative-sense, single-stranded RNA genomes. Influenza A viruses 
(IAVs) and influenza B viruses (IBVs) contain 8 viral RNA (vRNA) gene segments whereas 
influenza C viruses (ICVs) and influenza D viruses (IDVs) have 7 vRNA gene segments. The 
gene segments of influenza viruses are numbered in order of decreasing length. Segments 1 
(PB1), 2 (PB2), 3 (PA), 5 (NP), 7 (MP), and 8 (NS) of IAVs and IBVs encode polymerase basic 
protein 2 (PB2), polymerase basic protein 1 (PB1), polymerase acidic protein (PA), NP, matrix 
proteins (M1 and M2), and non-structural proteins (NS1 and NS2), respectively, which will be 
described in the subsequent sections.  
For ICV and IDV, segments 1, 2, 3, 5 encode proteins PB2, PB1, P3, and NP,  
respectively, and segment 4 encodes the only glycoprotein spiked on the viral envelope, 
hemagglutinin-esterase fusion (HEF) protein, which functions in receptor binding, receptor 
destruction, and membrane fusion (Rosenthal et al. 1998; Wang and Veit 2016; Hause et al. 
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2013). Segment 6 encodes two proteins M1 and CM2 by alternative splicing of mRNA precursor 
P42; however, the splicing mechanism is different between ICV and IDV: ICV introduces a 
termination codon in mRNA whereas IDV has a 4-amino acid peptide in the preceding exon (M 
Yamashita 1988) (Hause et al. 2014). Similar to segment 6, segment 7 encodes NS1 and NS2 
proteins by mRNA splicing. The un-spliced mRNA produces NS1 whereas the spliced mRNA 
produces shorter NS2 (nuclear export protein, NEP) (Nakada et al. 1985) (Nakada, Graves, and 
Palese 1986) (Paterson and Fodor 2012) (Hause et al. 2014).  
IAVs have been further categorized into different subtypes based on the antigenic 
diversity of glycoproteins HA and NA, including 18 HA (H1-18) and 11 NA (N1-N11) subtypes. 
There are 16 HA and 9 NA subtypes identified in the IAVs recovered from wild birds (Webster 
et al. 1992). Recently, H17N10 (Zhu, Yu, et al. 2013; Tong et al. 2012) and H18N11 (Tong et al. 
2013) were identified in influenza A-like viruses in bats (Ma, Garcia-Sastre, and Schwemmle 
2015). The HA subtypes can be grouped into two groups on the basis of the phylogeny of the HA 
genomic sequence: group 1 (which includes H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, 
IAV-like H17, and IAV-like H18) and group 2 (which includes H3, H4, H7, H10, H14, and H15) 
(Air 1981) (Nobusawa et al. 1991; Wu et al. 2014).  
Unlike IAVs, IBVs, ICVs, and IDVs do not have the HA and NA subgroup specific 
nomenclature. However, IBVs have diverged into two different lineages: B/Victoria/2/1987-like 
and B/Yamagata/16/1988-like, and the viruses are antigenically distinct (Rota et al. 1992) and 
have been co-circulating in humans since 1983 (Rota et al. 1990). IDVs are genetically grouped 
into D/OK-like, D/660-like viruses (Collin et al. 2015), and D/Japan-lineages (Murakami et al. 
2016) (Odagiri et al. 2018) (Murakami et al. 2020) , and the viruses in D/OK-like, D/660-like 
groups showed antigenic discrepancy but do have a high level of cross-reactivities in serological 
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analyses of all three groups (Collin et al. 2015) (Odagiri et al. 2018). Our recent study showed 
that 32 isolates recovered from the same facility between 2014 and 2016 have cross-reacted (HI 
titers ranging from 20 to 640) to sera generated by representative IDVs from different clades 
(Wan et al. 2020).These studies agree that IDVs have a certain levels of cross-reactivity between 
viruses. 
IAVs infect a wide range of animals including wild waterfowl, humans, pigs, horses, 
canine, and sea mammals (Webster 1992; Payungporn et al. 2008), which poses  significant risks 
of zoonotic infection, inter-hosts, intra-host transmission, and pandemics. IBVs  mainly infect 
humans (Cox and Subbarao 2000), although limited spillovers to seals (Osterhaus et al. 2000) 
(Bodewes et al. 2013) and pigs (Guo et al. 1983) have reported. Similar to IBVs, ICVs are 
mostly found in humans, and sporadically found in pigs (Guo et al. 1983). Unlike the other three 
types of influenza viruses, cattle have been considered the reservoir of IDVs (Hause et al. 2014; 
Hause et al. 2017), although several serological studies showed that IDV specific antibodies have 
been detected in other species including pigs (Hause et al. 2013; Chiapponi et al. 2016), small 
ruminants (goats, sheep) (Quast et al. 2015), camels (Elias et al. 2017), equine (Nedland et al. 
2018), and feral swine (Ferguson et al. 2018). However, IDVs have only been recovered from 
swine and cattle so far.  
Several studies have assessed infection risks of IDV in humans and serological evidence 
suggested that IDVs might infect humans. When the IDVs were first identified and recovered 
from swine in 2011, HI was performed against a set of 316 human serum samples. There were 4 
seropositive although HI titers were low (20 to 40), which made 1.3% seropositivity rate (Hause 
et al. 2013). Similarly another study identified 1% seroprevalence in a cohort of older people 
who lived in a community with possible exposure to cattle, and found the HI measure against 
 
4 
IDVs was not specific (Eckard 2016). However, a different study for IDVs in humans surveyed a 
total of 46 participants with 35 reported occupational exposure to cattle and 11 report no 
exposure to cattle, which found high seroprevalence with HI among cattle-exposed (91%) and 
non-cattle-exposed humans (75%) while the seroprevalence are 97% (cattle-exposed) and 18% 
(non-cattle-exposed) with micro neutralization assay (White et al. 2016). Although the high 
seroprevalence is from a limiting numbers of sampling study, these studies shown detectable 
antibodies against IDVs in human serum and suggested IDVs may infect humans. 
 
IAV structures 
IAV is a pleomorphic virus, which is known to display different morphological states, 
from filamentous to spherical (as shown by using electron microscopy), with the spherical forms 
on the order of 80 to 120 nm in diameter or the filamentous forms often in of up to 20 m in 
length [reviewed in (Bouvier and Palese 2008; Badham and Rossman 2016)]. IAVs are 
enveloped with a host cell derived lipid bilayer membrane, with glycoproteins HA and NA 
spiked on the envelop, and with matrix (M2) ion channels traversing the envelope. These three 
integral membrane proteins overlay a matrix of M1 proteins, which form the virion skeleton of 
IAVs.  
The HA is a trimer that is synthesized as the inactive precursor HA0, while the NA 
assembles as a tetramer of four identical polypeptides (Wilson, Skehel, and Wiley 1981) 
(Colman, Varghese, and Laver 1983). Inside the viral envelope, there are NEP (also known as 
NS2) and one of eight vRNA segments as viral ribonucleoprotein (vRNP) complexes. Each 
vRNP is comprised of one of eight vRNAs wrapped around with NP and bound with the 
heterotrimeric viral RNA-dependent RNA polymerase (RdRp) that consists of PB1, PB2 and PA 
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(Arranz et al. 2012; Moeller et al. 2012; Pflug et al. 2014). These vRNPs encode at least 10 
proteins needed for infectious virions, which are PB2, PB1, PA, HA, NP, NA, M1 and M2 
proteins, and non-structural (NS1) protein and NEP. Several strain-dependent accessory proteins 
such as PB1-N40, PB1-F2, PA-N155, PA-N182, PA-X have also been discovered via alternative 
machinery of mRNA splicing or transcription process (Chen et al. 2001; Briedis, Lamb, and 
Choppin 1982; Lamb et al. 1980; Muramoto et al. 2013; Jagger et al. 2012).  
vRNA contains noncoding regions at both 3’ and 5’ ends, at the end of which are highly 
conserved among all IAVs segments. These conserved and semi-complimentary vRNA from 
both ends form helical hairpin and bind to viral RdRp initiating replication (Fodor, Seong, and 
Brownlee 1993; Pflug et al. 2014).  
 
Biology of HA 
HA is a trimer with two regions: a stem, comprising a triple-stranded coiled-coil of alpha-
helices, and a globular head of antiparallel beta-sheet, positioned atop the stem (Wilson, Skehel, 
and Wiley 1981). HA binds to the receptors by receptor binding site (RBS) which located in the 
globular head. The RBS contains four structural elements : the 130-loop, 150-loop, 190-helix, 
and 220-loop, among which Tyr98, Trp153, His183, and Tyr195 (H3 numbering) are the highly 
conserved amino acids in HAs across different HA subtypes (Skehel and Wiley 2000). Mutations 
in RBS can switch the receptor binding specificity (Xiong, Coombs, et al. 2013; de Vries et al. 
2011; Chen et al. 2012; Stevens, Blixt, Tumpey, et al. 2006), which is one of the determinants of 
the virus host, tissue, and cell specificity. 
HA has played an important role in the IAV life cycle and primarily functions in viral 
attachment and fusion. IAVs initiate the infection process by using HA. Precursor glycoprotein 
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HA0 enters a metastable conformation at neutral pH after enzymatic cleavage, comprising two 
chains per subunit, HA1 and HA2, which comprise 328 and 221 residues, respectively (Wilson, 
Skehel, and Wiley 1981). The HA attaches the virus to the glycoconjugates of host glycoproteins 
that typically have terminal sialic acid (Sia) residues to trigger endocytosis of the virion (Rust et 
al. 2004a). Once the virion gets into the cell, the virion is trafficked into the endosome where the 
M2 ion channel can be activated by low pH (Rust et al. 2004b; Pinto and Lamb 2006; 
Lakadamyali et al. 2003) and cause the confirmation change of HA, which facilitate the 
membrane fusion and vRNA release. Fusion of the viral-endosomal membranes by HA occurs 
through multiple steps. After the cleavage of HA0, the fusion peptide on the N-terminus of the 
HA2 is exposed and inserts into the endosomal membrane, while the C-terminal transmembrane 
domain anchors HA2 in the viral membrane. The HA2 trimers then fold back on themselves to 
create a hairpin that brings the two membranes close to each other. The hairpin bundles further 
collapse into a six-helix bundle, which makes the two membranes come closer enabling the 
formation of the lipid stalk, and the subsequent fusion of the membranes.  
 
Receptors for IAVs 
HA of IAVs binds to glycoconjugates that typically contain terminal Sia residues. Sia is a 
family of derivatives of neuraminic acid, a sugar with a nine-carbon backbone. Sia family 
process a glycerol-like side chain from C-7 to C-9 but different in the substituent attached to C-5. 
Two common forms of the Sia family include the N-acetylneuraminic acid (Neu5Ac) and N-
glycolylneuraminic acid (Neu5Gc). The other forms of the family, such as 
ketodeoxynonulosonic acid (Kdn) that have a hydroxyl at the C-5 carbon appears less abundant 
(at least in mammals), or the neuraminic acid (Neu) with the free amine at the C-5 is rare present 
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in nature (Varki A 2017). Avian IAVs have been shown to preferentially bind to Sia that are 
linked to galactose by an α2,3 linkage (SAα2,3-Gal), whereas human IAVs show preference to 
Sia that are linked to galactose by an α2,6 linkage (SAα2,6-Gal) (Matrosovich et al. 2000; 
Gambaryan et al. 1997; Matrosovich et al. 2004). Although Neu5Gc is a common form of Sia, a 
few studies have been performed to analyze Neu5Gc as IAV receptors (Masuda et al. 1999; 
Higa, Rogers, and Paulson 1985b; Gambaryan et al. 2012; Wang, Tscherne, et al. 2012b; 
Broszeit et al. 2019), whereas most studies have been focused on the role of Neu5Ac as IAV 
receptors.   
The major difference between Neu5Ac and Neu5Gc is that the latter is generated by the 
hydroxylation of the N-acetyl moiety at C-5 of Neu5Ac. Researchers have been focusing on 
receptor specificity between α2,3- and α2,6-link Sias, in most cases with Neu5Ac. Since 1985, 
Higa, Rogers et al. had tested the HA binding to erythrocytes containing different forms of Sias 
included Neu5Gc, which suggested that recognition of the various Sia is an important factor in 
analysis of the receptor specificity of HA (Higa, Rogers, and Paulson 1985a).  Few studies have 
been followed up to explore the signiture residues for subtype H3, and H5 that affect the binding 
specificity to Neu5Gc (Masuda et al. 1999; Takahashi et al. 2009; Wang, Tscherne, et al. 2012a) 
. In 2012, Gambaryan et al. found an H7N7 isolated from equine bind exclusively to Nue5Gc 
while another H3N8 from equine prefer to Neu5Ac (Gambaryan et al. 2012). Not only the 
recognition of the Neu5Gc for IAVs, Broszeit, Tzarum et al. found that NA can cleave N-
glycolyl efficiently which supported Neu5Gc can serve as receptor biologically and revealed 
strict species specificity of binding to Neu5Gc(Broszeit et al. 2019). These studies have provided 
insights into the recognition of Neu5Gc-containing glycans, which could be functional receptors 
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and determinant of species specificity for IAVs. However, the limited numbers of studies are not 
enough to understand the role of Neu5Gc plays in IAVs evolution and others. 
 
IAVs reservoir 
As mentioned previously, in addition to humans, IAVs can infect and circulate in a wide 
range of animals, including avian, swine, equine, canine, and marine mammals (i.e. seals and 
whales). In addition, IAVs were reported to infect other animals such as feline (Fiorentini et al. 
2011; Hatta et al. 2018), minks (Klingeborn et al. 1985a).  Low pathogenetic avian influenza 
(LPAI) viruses have been isolated from at least 105 wild bird species belonging to 26 different 
families (Olsen et al. 2006). Among such a wide range of wild bird species, the aquatic wild 
birds and shorebirds such as Anseriformes (i.e. ducks, geese and swans) and Charadriiformes 
(i.e. gulls, terns and waders) are considered the major natural reservoir of IAVs (Webster et al. 
1992; Olsen et al. 2006). IAVs, except recently emerging Gs/Gd/96-like H5 HPAIV (Guo, Xu, 
and Wan 1998; Wan 2012; Pantin-Jackwood and Swayne 2009), have been circulating in aquatic 
wild birds asymptomatically, which offers the environment for reassortment and spreading of 
these IAVs by migration (Wille et al. 2011; Huang et al. 2014; Olsen et al. 2006). 
Several reports have indicated that the prevalence of IAVs in wild birds vary across 
different wild bird species, different seasons, and different geographic areas. Based on a 
surveillance study spanning from 1998 to 2006, the most abundant recovered subtypes are H6 
(seropositivity, 17.8%), H4 (16%), N2 (19.9%), and N6 (17.8%) of a total of 332 isolates, thus 
the most abundantly HA and NA combinations are H4N6 (13.6%), H7N7 (10.5%), and H6N2 
(9.9%), respectively (Munster et al. 2007). Another surveillance study of North America's wild 
ducks (26 years from 1976 to 2001) and shorebirds (16 years from 1985 to 2000) revealed 
 
9 
differences in the prevalence of IAVs among mallard, northern pintail, blue-winged teal, 
redhead, American green-winged teal, American wigeon, and other wild bird species (Krauss et 
al. 2004). Shorebirds had a high frequency of IAV isolation during their northern migration, 
whereas wild ducks had high virus isolation frequencies during their southern migration. HA 
subtypes H1 to H12 were detected in both wild birds and shorebirds but H13 only in shorebirds. 
H14 and H15 were detected neither in shorebirds nor in wild ducks (Krauss et al. 2004). Another 
study suggested that H13 and H16 were primarily identified in gulls (Munster et al. 2007; Olsen 
et al. 2006), which are genetically distinct from those of IAVs from ducks and geese (Fouchier et 
al. 2005b). A 12-year surveillance study of avian IAVs in eastern Germany from 1977 to 1989 
shown more than 40 combinations of HA/ NA were identified in a total of 124 isolates, of which 
H6N1 was most predominant (23.6% of all samples), followed by H4N6 (11%). As of individual 
species, the favorite recovered subtypes were H2N3 (20.8%) and H4N6 (20.3%) in wild ducks, 
H7N7 (22.3%), H4N6 (24.4%) and H2N3 (10.4%) in Pekin ducks, and H6N1 (34.8%) and H6N6 
(15.1%) in domestic ducks (Suss et al. 1994). Another European surveillance study sampling 
from wild waterfowl in Sweden (from 2002 to 2005) found the similar results as in the previous 
Germany study that the most prevalent subtype combinations H4N6, H7N7, and H6N2 
(Wallensten et al. 2007). By aligning the surveillance results from European and North America, 
subtypes H4N6 and H6N2 were the most common ones identified in wild.  The differences are 
the German study had higher numbers of H1 and H2 whereas the other two studies share a high 
number of H6 isolations, (Suss et al. 1994; Krauss et al. 2004; Wallensten et al. 2007). However, 
these differences maybe truly exited due to the nature of IAVs and environment and habitat of 
wild birds, or because of the limitation of surveillance samples bias in collection time, date, 




Distribution of glycan receptors in mammals and birds 
The most common ways to determine glycan receptors in the host is with the 
immunofluorescent or immunohistochemistry assays. No monoclonal antibodies have been 
developed that specifically bind α2-6-linked (SA2,6Gal) and α2-3-linked sialic acid (SA2,3Gal), 
and instead lectins have been used to differentiate α2-6-linked sialic acid and α2-3-linked sialic 
acid through binding specificity. For example, Sambucus nigra agglutinin [SNA] was shown 
with a preferred binding to Neu5Acα2-6Galβ1-4GlcNAc (Shibuya et al. 1987) and Maackia 
amurensis [MAA] with Neu5Acα2-3Galβ1 (Wang and Cummings 1988), respectively. MAA 
contains two isoforms termed MAL (MAA-II) or MAH (MAA-I). MAL binds Neu5Acα2-
3Galβ1-4GlcNAc whereas MAH does Neu5Acα2-3Galβ1-3GalNac (Konami et al. 1994; Geisler 
and Jarvis 2011).  
Distribution of SA2,3Gal and SA2,6Gal receptor in birds 
Separate studies have shown that birds are highly susceptible to avian IAVs because 
various species of birds, such as chickens, pekin ducks, and turkeys, express SA2,3Gal in both 
the respiratory and gastrointestinal tracts (Costa et al. 2012; Kuchipudi et al. 2009; Pillai and Lee 
2010b). SA2,6Gal are identified in respiratory tracts (nasal cavity, respiratory epithelium, trachea 
and lungs) of chickens, turkeys and mallards with different abundance but they are only detected 
in gastrointestinal tracts (duodenum, jejunum-ileum, cecum, colon) of chickens and turkeys (but 
not mallards) (Costa et al. 2012). However, another study indicated SA2,6Gal can be found in 
ileum/caeca of mallard (Franca, Stallknecht, and Howerth 2013). These contradicting results 
suggest that, due to its low sensitivity and lack of quantitative nature, lectin histochemistry 
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analyses may be inconsistent. Nevertheless, lectin histochemistry has provided a fast and 
convenient method to reveal the general distribution of these receptors in wild birds.  
To further evaluate the potential role of Sia receptors of wild birds in determining the 
susceptibility to AIVs, a study had been performed to analyze the distributions of SA2,6Gal and 
SA2,3Gal receptors in 37 species from 11 orders (Franca, Stallknecht, and Howerth 2013). They 
reported that birds of Anseriformes (mallard, blue-winged teal, cinnamon teal, northern pintail, 
red head, wood duck, black swan, bar-headed goose, cackling goose), Charadriiformes (dunlin, 
sanderling, ruddy turnstone, herring gull, laughing gull, ring-billed gull), Ciconiiformes (great 
blue heron), Gaviiformes (red-throated loon), Gruiformes (American coot, Stanley crane), and 
Pelecaniformes (American white Pelican) express abundant SA2,3Gal in nasal turbinate, trachea, 
lung (bronchi), duodenum/jejunum, ileum/caeca (Table 1), but there are large variations how 
SA2,6Gal express among species (Table 2). This study suggested SA2,6Gal and SA2,3Gal may 
not be species dependent but rather tissue dependent.  
On the other hand, the distribution of these receptors are not only host and tissue 
dependent but also cell type dependent. For instance, in quail, SA2,3Gal receptors are present 
primarily in non-ciliated cells, whereas SA2,6Gal linked receptors are localized predominantly 
on the surface of ciliated cells of trachea. In quail intestine, both types of receptors were found 
on epithelial cells as well as in crypts (Wan and Perez 2006). SA2,3Gal and SA2,6Gal  were 
broadly detected in duodenum, jejunum-ileum, cecum and colon of chicken; however, the cell 
types were found differently, for examples in chicken duodenum, SA2,6Gal were detected in 
GALT lymphocytes whereas SA2,3Gal in columnar epithelial and goblet cells (Costa et al. 
2012). Another example is that mallards have SA2,3Gal in trachea ciliated cells but in goblet 
 
12 
cells of duodenum/jejunum and enterocytes of ileum/caeca (Franca, Stallknecht, and Howerth 
2013).  
 






























+++ Cil +++ Cil +++ Cil +++ Ent +++ Ent 
Cinnamon teal +++ MuG +++ Cil +++ Cil +++ Ent +++ Ent 
Northern 
pintail 
+++ Cil +++ Cil +++ Cil -/+ Gc +++ Ent 
Red head +++ MuG +++ Cil +++ Gc + Ent +++ Ent 
Wood duck +++ MuG +++ Cil +++ Cil +++ Ent +++ Ent 
Black swan +++ MuG +++ Cil +++ Cil + Ent +++ Ent 
Mute swan +++ MuG +++ Cil +++ Cil +++ Gc +++ Ent 
Bar-headed 
goose 
+++ MuG +++ Cil +++ Cil +++ Gc +++ Ent 
Cackling goose +++ MuG +++ Cil +++ Cil +++ Gc +++ Ent 
Dunlin NA  +++ Gc +++ Gc +++ Ent +++ Ent 
Sanderling NA  +++ Cil +++ Gc +++ Gc NA NA 
Red knot +++ MuG +++ Gc +++ Gc - - - - 
Ruddy 
turnstone 
NA  NA  +++ Cil +++ Gc +++ Gc 
Herring gull -/+++ MuG +++ Gc ++ Cil + Gc ++ Gc 
Laughing gull +++ MuG +++ Cil +++ Cil +++ Ent +++ Ent 
Ring-billed 
gull 
+++ Cil +++ Gc +++ Gc +++ Gc +++ Gc 
Great blue 
heron 




Table 1 (continued) 
Red-throated 
loon 
NA  +++ Cil +++ Cil +++ Gc +++ Gc 
American coot +++ MuG +++ MuG +++ Gc +++ Ent +++ Ent 
Stanley crane +++ Cil +++ Cil +++ Cil +++ Gc +++ Gc 
American 
white pelican 
NA  NA  +++ Cil +++ Gc +++ Gc 
Chicken NA  +++ NS +++ NS ++ NS +++ NS 
(Pillai and Lee 
2010a) 
Duck NA  +++ NS +++ NS - NS +++ NS 
Turkey NA  +++ NS +++ NS +++ NS +++ NS 
Pigeon NA  +/- NS +/- NS +/- NS +++ NS (Liu, Han, et 
al. 2009) Chicken NA  +++ NS +++ NS +/- NS -  
Chicken +++ Cil ++ 
Cil, 
MuG 
+++ Bep +++ Cep, Gc + Cep, Gc 
(Costa et al. 
2012) 
Common quail +++ Cil + All + Bep ++ Cep, Gc ++ Cep 
Red-legged 
partridge 
++ Cil + All -  + Cep + Cep 
Turkey ++ Cil +++ 
Cil, 
MuG 
++ Bep + Cep, Gc + Cep 
Golden 
pheasant 
++ Cil + 
Gc, 
MuG 
+ Bep ++ Cep, Gc ++ Cep, Gc 
Ostrich +++ Cil + All + Bep ++ Cep, Gc ++ Cep, Gc 
Mallard ++ Cil ++ All + Bep +++ Cep +++ Cep 
a: The distribution of receptors was scored using lectin immunohistochemistry: ‘-’ no staining, 
‘+’ mild, ‘++’ moderate, ‘+++’ strong, NA not available, NS not specified. Cell types: Cil is 
ciliated cells, Gc is Goblet cells, MuG is mucous gland cells, Bep is bronchial epithelial cells, 









Table 2 Distribution of SA2,6Gal receptors in respiratory and intestine tracts in birds 
Species 
 










score cell types score cell types score cell types score cell types score cell types 







-  +++ Cil +++ Cil +++ Ent +++ Ent 
Cinnamon 
teal 
-  +++ Cil +++ Cil +++ Ent +++ Ent 
Northern 
pintail 
+++ Cil +++ Cil +++ Cil -  +++ Ent 
Red head +++ Cil +++ Cil +++ Cil -  +++ Ent 
Wood duck + Gc + Gc -  ++ Ent +++ Ent 
Black swan -  +++ Gc +++ Gc +++ Gc +++ Ent 
Mute swan -  +++ Gc +++ Gc -  +++ Gc 
Bar-headed 
goose 
+ MuG +++ Gc -  -  +++ Ent 
Cackling 
goose 
+++ MuG +++ Gc +++ Cil -  +++ Ent 
Dunlin NA  +++ Cil +++ Cil -  -  
Sanderling NA  -  -  +++ Ent NA  
Red knot -  -  ++ Cil -  -  
Ruddy 
turnstone 
NA  NA  +++ Gc -  -  
Herring gull +++ Cil +++ Cil +++ Gc -  -  
Laughing 
gull 
+++ Cil +++ Cil +++ Cil + Gc + Gc 
Ring-billed 
gull 
+++ Cil +++ Gc +++ Gc -  + Gc 
Great blue 
heron 
+++ MuG +++ Gc +++ Gc + Gc -  
Red-throated 
loon 
NA  +++ Cil +++ Cil -  -  
American 
coot 
-  +++ Gc -  -  -  
Stanley crane +++ MuG +++ Gc +++ Gc +++ Gc -  
American 
white pelican 
NA  NA  +++ Cil -  -  
Chicken NA  +++ NS +++ NS ++ NS +++ NS 
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Table 2 (continued) 
(Pillai and 
Lee 2010a) Duck NA  +++ NS +++ NS -  -  
Turkey NA  +++ NS ++ NS -  -  
Pigeon NA  +++ NS +++ NS -  -  (Liu, Han, et 
al. 2009) Chicken NA  +/- NS -  -  -  
Chicken ++ Cil + All +++ Bep + Cep ++ Cep 




+++ Cil +++ All +++ Bep + Cep, Gc ++ Cep, Gc 
Red-legged 
partridge 
++ Cil + MuG -  + Cep + Cep, Gc 
Turkey ++ Cil + Gc, MuG +++ Bep +  + Cep 
Golden 
pheasant 
++ Cil ++ All + Bep + Cep, Gc ++ Cep, Gc 
Ostrich -  -  -  + Cep, Gc +  
Mallard + Cil ++ Cil, Gc + Bep -  -  
a: The distribution of receptors was scored using lectin immunohistochemistry: ‘-’ no staining, 
‘+’ mild, ‘++’ moderate, ‘+++’ strong, NA not available, NS not specified. Cell types: Cil is 
ciliated cells, Gc is Goblet cells, MuG is mucous gland cells, Bep is bronchial epithelial cells, 
Cep is columnar epithelial cells, all indicated all cell types. The blank cells indicated not applied. 
 
Distribution of SAα2,3-Gal- and SAα2,6-Gal-linked receptors in humans and other 
mammals 
Although lectins isoforms MAAI, MAAII shown different binding patterns to cell types, 
SA2,3Gal receptors were detected in the upper and lower respiratory tract with MAAI and 
alveolar epithelial cells of the lung with MAA II of human. SNA binding was detected in 
bronchial and alveolar epithelial cells with variations between adults and children (Nicholls et al. 
2007).  
Compared with those in wild birds, the distributions of SA2,3Gal and SA2,6Gal were 
characterized primarily in those animal models used in influenza research, such as ferrets, swine, 
guinea pig. Because the high expression of SA2,6Gal  linked receptors in the conducting airways 
and the presence of SA2,3Gal  linked receptors in the lung parenchyma, ferrets represent the 
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respiratory system in humans (Leigh et al. 1995). Both SA2,3Gal and SA2,6Gal receptors were 
detected in pig trachea (Ito et al. 1998), and in the nasal and tracheal areas of the guinea pig (Sun 
et al. 2010). Comparative distribution of human and avian type sialic acid influenza receptors in 
the pig (Nelli et al. 2010). Taking together, SA2,6Gal receptors found in guinea pig are believed 
to be one of the reasons that it is susceptible to human influenza virus  (Sun et al. 2010) and the 
pig is the “mixing vessel” of the IAVs (Ito et al. 1998) (Nelli et al. 2010).  Some extended 
studies have been performed using mass spectrometry to analyze the glycan presented in 
respiratory tracts of human (Walther et al. 2013), swine (Byrd-Leotis et al. 2014) and ferrets (Jia 
et al. 2014), which were consistent with the staining results; in addition to the lineages of sialic 
acids, these studies suggested structural complexity of these glycans located on these tissues.   
In addition to SA2,3Gal and SA2,6 Gal, which were determined using lectins, 
monoclonal antibodies have been developed detected other glycan substructures as well (Table 
3) (Varki A 2017) , of which this study will focus on well-studied receptor of IAVs such as 
SA2,3Gal and SA2,6Gal as well as other receptors such as SLex and Neu5Gc. 
Table 3 Mammalian glycan antigens recognized by monoclonal antibodies 
Glycan antigen Glycan structure sequence 
Sialyl Lewis x Neu5Acα2,3Galβ1,4(Fucα1,3)GlcNAc 
Sialyl-Lewis a Neu5Acα2-3Galβ1-3(Fucα1-4)GlcNAc 
Lewis x Galβ1,4(Fucα1,3)GlcNAc 
Lewis a Galβ1-3(Fucα1-4)GlcNAc 
Lewis b Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc 
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Table 3 (continued) 
Lewis y Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc 
3’-Sulfo-Lewis x sulfo-3Galβ1–4(Fucα1–3)GlcNAc 
3’-Sulfo-Lewis a sulfo-3Galβ1–3(Fucα1–4)GlcNAc 
6-Sulfo-sialyl Lewis x Neu5Acα2-3Galβ1-4(Fucα1-3)-(6-HSO3)GlcNAc 
6-Sulfo-sialyl Lewis a Neu5Acα2-3Galβ1-3(Fucα1-4)-(6-HSO3)GlcNAc 
Sialyl T antigen Neu5Acα2-3Galβ1-3GalNAc-O-Ser/Thr 
Sialyl Tn antigen Neu5Acα2-6GalNAcα-O-Ser/Thr 
T antigen Galβ1-3GalNAc-O-Ser/Thr 
Tn antigen GalNAcα-O-Ser/Thr 
H antigen type 1 Fuc(a1-2)Gal(b1-3)GlcNAcβ 
H antigen type 2 Fuc(a1-2)Gal(b1-4)GlcNAcβ 
H antigen type 3 Fuc(a1-2)Gal(b1-3)GlcNAcα 
H antigen type 4 Fuc(a1-2)Gal(b1-4)GlcNAcβ 
A antigen type 1 Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)b-GlcNAc 
A antigen type 2 Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)b-GlcNAc 
A antigen type 3 Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)a-GalNAc 
A antigen type 4 Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)b-GalNAc 
B antigen type 1 Gal(α1-3) [Fuc(a1-2)]Gal(b1-3)GlcNAcβ 
B antigen type 2 Gal(α1-3) [Fuc(a1-2)]Gal(b1-4)GlcNAcβ 
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Table 3 (continued) 
B antigen type 3 Gal(α1-3) [Fuc(a1-2)]Gal(b1-3)GalNAcα 
B antigen type 4 Gal(α1-3) [Fuc(a1-2)]Gal(b1-4)GalNAcβ 
Galα 1-3Gal antigen Gal(a1-3)Gal 
HNK-1 GlcA3S(b1-3)Gal(b1-4)GlcNAc 
Sda antigen NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GlcNAc(b1-3)Gal 
Forssman antigen GalNAc(a1-3)GalNAc(b1-3)Gal (a1-4)Gal (b1-4)Glcβ 
Pk antigen Gal(a1-4)Gal 
P antigen GalNAc(b1-3)Gal(a1-4)Gal 
P1 antigen Gal(a1-4)Gal(b1-4)GlcNAc(b1-3) 
 
Distribution of Neu5Ac and Neu5Gc in avian, humans, and other mammals  
In addition to Neu5Ac, Neu5Gc is another common form of Sia and could serve as a 
receptor for IAVs (Higa, Rogers, and Paulson 1985b; Takahashi et al. 2014a).  Neu5Gc is 
created by the hydroxylation of the Neu5Ac moiety, which have been reported that hydroxylase 
generated by cytidine monophosphate (CMP)-N-acetyl neuraminic acid hydroxylase (CMAH) is 
required.  
Although Neu5Gc is common exist in mammals including bonobos and chimpanzees, in 
humans, Neu5Ac is the most common Sias because a loss-of-function deletion in CMAH 
prevented Neu5Gc expression (Irie et al. 1998 ; Kawano et al. 1995), though, humans could 
absorb Neu5Gc from exogenous sources (Tangvoranuntakul et al. 2003).  Some mammals 
include dogs, ferrets, seals lack the function of CMAH, which are expressing Neu5Ac instead of 
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Neu5Gc (Wen et al. 2018; Ng et al. 2014; Peri et al. 2018). Others include cows, horses and pigs 
have been reported to predominately express Neu5Gc (Pettersson et al. 1958; Naiki 1971; Wen 
et al. 2018; Song et al. 2010).  
Limited studies on Neu5Gc have been performed in respiratory and intestinal tracts of 
wild birds since they are commonly express Neu5Ac. The first report appeared to show Neu5Gc 
in duck intestine, mainly on the crypt epithelial cells of duck colon (Ito et al. 2000). Low 
incidence of Neu5Gc in birds and reptiles and its absence in the platypus in tested tissues (liver/ 
muscle/ ovomucin/ eggs) (Schauer, Srinivasan, Coddeville, Zanetta, and Guérardel 2009). High-
performance liquid chromatography, and mass spectrometry analysis of chicken tissues indicated 
that chickens did not synthesis Neu5Gc but limited amount of Neu5Gc detected in eggs may 
come from the diet (Schauer, Srinivasan, Coddeville, Zanetta, and Guerardel 2009). On the other 
hand, histological immunostaining could not detect Neu5Gc in chicken trachea (Suzuki et al. 
2000).  
Receptors as a determinant of host range 
Receptor binding specificity of IAVs beyond SAα2-3Gal-linked receptors 
Although AIVs were shown to bind preferentially to Neu5Acα2-3Gal receptors, the fine 
receptor specificity of the viruses varies depending on the avian species. Previous studies 
suggested sulfated and/or fucosylated Neu5Acα2-3Gal receptors have strong binding avidity to 
IAVs (e.g. subtype H5, H6, H7 and H9) in terrestrial poultry but not those in ducks (Gambaryan 
et al. 2008). Instead, IAVs in ducks displayed high avidity for Neu5Acα2-3Galβ1-3 (duck-type) 
receptors rather than Neu5Acα2-3Galβ1-4 (Gambaryan, Yamnikova, et al. 2005; Gambaryan et 
al. 2018). Viruses in gulls were shown to preferentially bind to receptors bearing fucose at N-
acetylglucosamine residue, whereas viruses in both chicken and mammalian show increased 
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binding avidity for glycans that have a sulfate group at C-6 of (β1–4)-linked GlcNAc. Unlike 
other IAVs of aquatic birds, H16 IAVs showed efficient binding to Neu5Acα2-6Gal receptors 
and bound poorly to duck-type receptors (Neu5Acα2-3Galβ1-3) (Gambaryan et al. 2018).  
A small change of amino acids in RBS could affect the binding specificity of IAVs with 
glycan receptors. For examples: a G225D mutation can switch binding specificity of an avian 
H6N1 virus from SAα2,3Gal to SAα2,6Gal (de Vries, Tzarum, et al. 2017); Q226L, G228S are 
believed to the reason of avian H2, H3 viruses switching from SAα2,3Gal to SAα2,6Gal (Xu et 
al. 2010; Liu, Stevens, et al. 2009; Ha et al. 2003). The pandemic A/New York/1/1918 possessed 
a mutation E190D different from convention avian H1N1, which enables the virus binding to 
both SAα2,3 Gal and SAα2,6Gal (Stevens, Blixt, Glaser, et al. 2006; Glaser et al. 2005); three-
amino-acid mutations (V186G/K-K193T-G228S or V186N-N224K-G228S) can switch the 
receptor specificity of the H7N9 HA from SAα2,3Gal to SAα2,6Gal (de Vries, Peng, et al. 
2017). A change in receptor-binding specificity may also result in pathogenic changes. A protein 
of a novel clade 2.3.4.4 H5 bind to SLex because of substitutions K222Q and S227R, which are 
unique for highly pathogenic influenza virus H5 proteins (Guo et al. 2017). Viral receptor 
binding specificity also affects transmission of IAVs. The mutation G222D of H1N1pdm 
(A/California/07/2009) results in a gain of binding avidity of long-chain SAα2,6 which is 
believed to confer its airborne transmission in ferrets and it is proposed that loss of SAα2,3 
binding is not necessary for airborne transmission (Lakdawala et al. 2015).   
Formation of Sia is a determinant factor of host range of IAVs 
Prior studies have found that equine H3N8 viruses prefer binding to Neu5Ac, whereas the 
equine H7N7 exclusively binds to Neu5Gc (Gambaryan et al. 2012). Yang et al (Yang et al. 
2013) reported that Neu5Gc was detected in the canine trachea but not in chicken trachea, which 
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indicated that the Neu5Gc may play an important role in the interspecies transmission of avian-
like H3N2 IAV from avian to canine species. An additional study found that mutation W222L at 
the RBS of equine HA significantly increase binding avidity of the virus to glycans with Neu5Gc 
and SLex motifs, combined with the results that these receptors are present in canine and horse, 
indicated that this could facilitate viral adaption from equine influenza A(H3N8) virus to dogs 
(Wen et al. 2018). An H5N1 A/Vietnam/1203/04 Y161A mutant has been shown to possess 
binding specificity to Neu5Gc from Neu5Ac (Wang, Tscherne, et al. 2012a; Broszeit et al. 
2019). The NA of IAVs are able to cleave Neu5Gc, and viral tissue-binding specificity to 
Neu5Ac or Neu5Gc indicated this is a species barrier of selection (Broszeit et al. 2019). These 
findings suggest that recognition of the Neu5Gcα2,3-Gal moiety plays an important role in the 
interspecies tropism of avian influenza viruses. However, Neu5Gc has been reported as a decoy 
receptor to prevent entry of  IAVs that possess Neu5Gc binding ability (Takahashi et al. 2014b). 
 
Knowledge Gaps 
Substructures of sialic acid receptors affect tissue and host tropism  
The substructures of Sia receptors have a huge diversity, such as the linkages between 
Neu5Acα2-3Gal-disaccharide and GlcNAc, the fucosylation, sulfation of GlcNAc, and Neu5Gc 
which affect virus binding specificity as well as tissue and host tropism. Additionally, the 
SAα2,3Gal binding preference of IAV was reported to require host fibronectin, suggesting that 
host proteins may also be involved in the receptor binding process of IAV, which remains largely 
unknown. There are still gaps and questions in the field: 1) The distribution and intensity of Sia 
receptors among tissues and hosts are not fully characterized.  2) The role of those substructures 
of Sia in the adaption from waterfowl to poultry and infection of IAVs is not clear. 3) Besides 
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Sia receptors, host factors that involved in the entry of IAV and how they regulated are not fully 
understood.  
Receptors in wild birds have been not systematically characterized 
Several studies have focused on Neu5Acα2-3Gal receptors for avian IAVs and wild 
birds, however, it is documented that viral binding specificity for other glycan substructures 
mentioned above could affect the viral adaptation, replication, transmission and even 
pathogenesis. However, there remains knowledge gaps in the field: 1) It is still not fully clear 
how Neu5Gc receptors play a role in the evolution of IAVs in wild birds; 2) The distribution of 
such glycan structures in wild birds is not systematically characterized; 3) The biological 
outcome of the binding preference of avian IAVs to these glycan substructures is still unknown. 
 
Objectives of this dissertation 
The HA of IAVs binding to host glycan receptors is one of the key determinants for viral 
host tropism. The receptor-binding pockets of the HA are known to affect the receptor binding 
avidity, specificity, transmission ability of IAV. However, most studies have been focusing on 
individual receptor binding sites (i.e. residues 226 and 228 (H3 numbering)) and their impacts on 
two types of Sia receptors (SAα2,3Gal and SAα2,6Gal). Although prior reports have 
demonstrated HA and NA of avian IAVs from chicken are different from those of wild birds, the 
knowledge of how they evolved is lacking. More studies have been focusing on the fine Sia 
receptor binding to different species of avian origin IAVs in order to understand this 
phenomenon, however, although the binding linkage preferences for some of the species were 
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discovered, the distribution of these Sia receptors in birds and biological meaning of these 
receptors are largely unknown.  
The objectives of this project are 1) to evaluate the spillover risks of emerging IAVs from 
wild birds to domestic poultry, mammals, and humans; 2) to determine distribution of glycan 
receptors across respiratory and gastrointestinal tissues of chickens and mallards and other wild 
birds and domestic poultry; 3) to determine the role of glycan motifs in affecting the intra and 
inter-species infectivity of avian IAVs; 4) to understand the role of glycan motifs in shaping 
virus evolution during the natural history of IAVs, especially intra- and inter- species 
transmission. Sialyl-Lewis X (SLex) and Neu5Gc, two common SA2,3Gal substructures were 
the focus in this study.  
The hypotheses of this project are 1) that glycan motifs SLex and Neu5Gc contribute to 
host and tissue tropism of IAVs and 2) that distribution of such glycan receptor motifs in 
different species play a role in the evolution of IAVs receptor binding specificity thus form 
species barrier and 3) that the binding specificity of avian IAVs are species dependent regarding 
glycans distribution of the host.  
Three specific aims of the project are: 1) to determine public health risk of an emerging 
gull-origin subtype H10N7 IAV;  2) to determine if the distribution of SLex receptors affects 
tissue/host tropisms of avian H7 IAVs in birds; 3) to determine the role of Neu5Gc receptors in 




AEROSOL TRANSMISSION OF GULL-ORIGIN ICELAND SUBTYPE H10N7 IAVS IN 
FERRETS
 
Subtype H10 IAVs have been recovered from domestic poultry and various aquatic bird 
species, and sporadic transmission of these IAVs from avian species to mammals (i.e., human, 
seal, and mink) are well documented. In 2015, we isolated four H10N7 viruses from gulls in 
Iceland. Genomic analyses showed four gene segments in the viruses were genetically associated 
with H10 IAVs that caused influenza outbreaks and deaths among European seals in 2014. 
Antigenic characterization suggested minimal antigenic variation among these H10N7 isolates 
and other archived H10 viruses recovered from human, seal, mink, and various avian species in 
Asia, Europe, and North America. Glycan binding preference analyses suggested that, similar to 
other avian-origin H10 IAVs, these gull-origin H10N7 IAVs bound to both avian-like and 
human-like receptors. However, when the gull-origin viruses were compared with another 
Eurasian avian–origin H10N8 IAV, which caused human infections, the gull-origin virus showed 
significantly higher binding avidity to human-like glycan receptors. Results from ferret 
experiment demonstrated that a gull-origin H10N7 IAV replicated well in turbinate, trachea, and 
lung, but replication was most efficient in turbinate and trachea. This gull-origin H10N7 virus 
can be transmitted between ferrets through the direct contact and aerosol routes, without prior 
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adaptation. Gulls share their habitat with other birds and mammals, and have frequent contact 
with humans; therefore, gull-origin H10N7 IAVs could pose a risk to public health. Surveillance 





IAVs belong to the family Orthomyxoviridae and are classified into different antigenic 
subtypes based on their surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). 
Sixteen HA and nine NA IAV subtypes have been recovered from wild birds (Webster et al. 
1992; Röhm et al. 1996; Fouchier et al. 2005a). In addition to infecting humans, IAVs infect a 
wide range of natural hosts (e.g., avian, swine, canines, and equines), among which migratory 
waterfowl, shorebirds, gulls, and terns serve as the major IAV reservoir and play important roles 
in virus movement, transmission, and genetic reassortment because of their seasonal movements 
(Huang et al. 2014; Wille et al. 2011). 
    Subtype H10 IAVs have been recovered from a range of avian and mammalian 
species. Sporadic cases of H10 avian IAV infection in humans have been reported, but human-
to-human transmission has not been established. In 2004, H10N7 virus caused fever and cough 
in two infants in Egypt (World Health Organization, Communicable Diseases, and Containment 
2004); in 2010, two abattoir workers in Australia were found to be H10 virus-positive during a 
low pathogenic avian influenza outbreak among chickens (Arzey et al. 2012); and in 2013, an 
H10N8 avian IAV infected three humans in China, resulting in two deaths (Xu et al. 2015). In 
addition to humans, H10 IAVs have also been reported in other mammals, including mink 
(Klingeborn et al. 1985b), seals (Zohari et al. 2014), and pigs (Wang, Zou, et al. 2012).  
In 2014, dead harbor seals (i.e., Phoca vitulina) in Germany, Sweden, and Denmark were 
found to be infected with a subtype H10N7 IAV (Krog et al. 2015; Zohari et al. 2014; Bodewes, 
Bestebroer, et al. 2015). The virus caused respiratory diseases and transmitted efficiently among 
harbor seals and gray seals (i.e., Halichoerus grypus), leading to multiple outbreaks across 
multiple regions throughout Europe (Bodewes, Rubio Garcia, et al. 2015; Bodewes et al. 2016); 
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from March through November 2014, the outbreaks led to 1,400 deaths among a population of 
approximately 12,000 seals in these regions (Bodewes, Bestebroer, et al. 2015). Serosurveillance 
suggested that up to 58% of adult harbor seals and 28% of adult gray seals were exposed to this 
H10N7 virus (Bodewes, Rubio Garcia, et al. 2015). Laboratory studies in a ferret model showed 
that this seal H10N7 virus caused respiratory tract inflammation extending from the nasal cavity 
to bronchi, but not lung (van den Brand et al. 2016). Similar to the genomic segments of an 
H3N8 virus isolated from dead North American harbor seals (Anthony et al. 2012), all eight 
genomic segments of this virus were of avian origin. Prior study suggested that this H3N8 virus 
could be transmitted among ferrets without adaptation through aerosol droplets (Karlsson et al. 
2014). Of note, most low pathogenic avian IAVs replicate strictly in the gastrointestinal tracts of 
avian hosts and replicate to only a limited extent in mammals.  
 In 2015, we isolated four H10N7 IAVs from gulls in Iceland; the risk these 
viruses posed to the sea mammal population and, potentially, to humans was unknown. To assess 
the risk to mammal populations in the North Atlantic, we characterized the four viruses in terms 
of their genetic associations with the 2014 European seal virus and their antigenicity, receptor 
binding preference, pathogenicity, and transmissibility.  
Materials and Methods 
Field sampling 
Gulls were live-captured at Sandgerdi, Iceland (64.041° N, -22.714° W), during 
November 10–18, 2015, using a cannon-propelled capture net (approximately 18 m long × 12 m 
wide) as previously described(Hall et al. 2014). Briefly; captured birds were marked with 
individual metal bands, identified to species, and ages were determined by plumage 
characteristics (Larsson 2004). Birds were sampled using a combined oral and cloacal swab 
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where the same swab was first used to swab the oral cavity and then the cloaca. Each swab 
sample was immediately placed in an individual 2.0-ml cryovial containing 1.25 ml of virus 
transport medium (Hall et al. 2014). Vials were held on ice for up to 5 hours prior to being stored 
in liquid nitrogen or liquid nitrogen vapor. Samples were shipped by private courier from Iceland 
to Madison, Wisconsin, USA, on dry ice in biosecure containers. Once received in the 
laboratory, samples were stored at -80°C until analyzed. 
Detection of IAV-positive samples and virus isolation 
Viral RNA was extracted using the MagMAX-96 AI/ND Viral RNA Isolation Kit 
(Applied Biosystems Foster City, CA, USA) following the manufacturer’s procedures. Real-time 
RT-PCR was performed using previously published procedures, primers, and probe designed to 
detect the IAV M gene (Spackman et al. 2002). All samples exhibiting a positive cycle threshold 
from RT-PCR analysis were subjected to virus isolation in 9- to 11-day-old embryonated chicken 
eggs (PR 2008). 
Cells and virus propagation 
MDCK cells, A549 cells, and DF-1 cells were obtained from American Type Culture 
Collection (Manassas, VA, USA). The cells were maintained until use at 37°C under 5% CO2 in 
Dulbecco’s Modified Eagle Medium (Gibco DMEM; Thermo Fisher Scientific, Waltham, MA, 
USA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, 
USA). 
Viral isolates were inoculated in 9-day-old SPF chicken embryonated eggs and incubated 
at 37°C for 72 hours. Viruses used to generate HI results for antigenic cartography (Figure 2) 
include Ck/34609, Seal/ 221, A/mallard/Northlands/1/2014 (H10N7), 
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A/duck/Bangladesh/24035/2014 (H10N1), A/laughing gull/DE/209/2013 (H10N8), 
A/duck/Hong Kong/562/1979 (H10N9), Mink/E12665, A/mallard/Netherlands/10240/2002 
(H10N7), A/duck/Bangladesh/821/2009 (H10N7), A/duck/Bangladesh/824/2009 (H10N7), 
A/chicken/Bangladesh/842/2009 (H10N7), A/duck/Bangladesh/8987/2010 (H10N2), 
A/duck/Bangladesh/8988/2010 (H10N9), A/chicken/Queensland/1/2012 (H10N7), rg-A/Jiangxi-
Donghu/346/2013[R] (6+1+1) inactivated (H10N8), A/ruddy turnstone/King 
Island/7104CP/2014 (H10N8), A/northern shoveler/CA/27943/2007 (H10N7), A/ruddy 
turnstone/DE/579/2008 (H10N7), A/shorebird/DE/327/2009 (H10N1), A/ruddy 
turnstone/DE/6200/2009 (H10N7), A/American coot/MS/09OS615/2009 (H10N3), A/American 
black duck/New Brunswick/00971/2010 (H10N6), A/northern shoveler/AR/12OS160/2012 
(H10N3), A/mallard/MS/12OS443/2012 (H10N1), A/mallard/OH/13OS1979/2013 (H10N7), 
A/red knot/DE/420/2013 (H10N7), A/spot-billed duck/Alberta/308/2016 (H10NX), and A/ruddy 
turnstone/DE/409/2016 (H10N5). Viruses used in growth kinetics analyses, glycan receptor 
binding analyses, and animal studies include Gg/4552, Ig/4402, Gg/4270, Ig/4266, Seal/221, 
Mink/E12665, A/American black duck/New Brunswick/00971/2010(H10N6), Ck/34609, 
A/California/01/2009(H1N1), and A/duck/Hunan/795/2002(HA, NA)A/Puerto Rico/8/34 
(H5N1).  
Ferret antisera 
Ferret antisera used in HI assays to generate results for antigenic cartography (Figure 2) 
include those raised against A/chicken/Jiangxi/34609/2013 (H10N8), A/laughing 
gull/DE/209/2013 (H10N8), A/glaucous gull/Iceland/4552/2015 (H10N7), 
A/seal/Netherlands/P14-221/2014 (H10N7), A/mallard/Netherlands/1/2014 (H10N7), 




RNA extraction and genomic sequencing 
Viral RNA was extracted by using the KingFisher Pure Viral NA Kit (Thermo Fisher 
Scientific, Asheville, NC, USA) according to the manufacturer’s instructions. Influenza 
amplicons were obtained from the 2-step RT-PCR amplification and sequenced using an in-
house influenza targeted sequencing procedure using influenza primers and PCR amplification 
conditions adapted from previous studies (Zhou et al. 2009; Hoffmann et al. 2001).  Nextera XT 
DNA Library Preparation Kit was utilized to prepare the next-generation sequencing (NGS) 
libraries prior to sequencing with the MiSeq Reagent v3 600 cycles kit with a MiSeq sequencing 
system (all from Illumina, San Diego, CA, USA) according to the manufacturer’s suggested (Xu, 
Bailey, Spackman, Li, Wang, Long, Baroch, Cunningham, Lin, and Jarman 2016). The quality of 
paired-end reads obtained from MiSeq sequencing was checked by FastQC (Babraham 
Bioinformatics, https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and trimmed by 
Trimmomatic version 0.36 (Usadel Lab, http://www.usadellab.org/cms/?page=trimmomatic) 
using a quality score threshold of 20. After quality trimming was performed, all paired-end reads 
were aligned to reference genome of a corresponding virus by using Bowtie 2 (Johns Hopkins 
University, http://bowtie-bio.sourceforge.net/bowtie2/index.shtml).  
In addition to the viruses obtained from viral isolation, the viruses propagated for 
phenotype analyses were also sequenced to ensure no additional mutations acquired during virus 
propagation before they are used in animal experiments and glycan binding. 
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Sequence alignment and phylogenetic analysis 
Multiple sequence alignments were generated using Muscle v3.8.31 (Edgar 2004). The 
phylogenetic tree for each gene segment was inferred by using a maximum-likelihood method by 
running RAxML v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized 
time–reversible substitution model (Stamatakis 2014). Phylogenetic trees were visualized by 
using FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/).  
Virus titration 
To quantify virus titer, TCID50 was determined on MDCK cells. Briefly, MDCK cells 
were maintained as stock cultures in DMEM and re-plated 1 days before infection in 96 well 
plates for TCID50 assays. Treated samples and their paired controls were thawed and 
immediately serially diluted. Cell cultures were then infected for 1 h after three times of 
phosphate buffered saline (PBS) (pH 7.4) washes. The media for dilution and infections was 
Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA, USA) 
supplemented with 100 U/ml Gibco penicillin-streptomycin (Thermo Fisher Scientific, Waltham, 
MA, USA). Post infection TCID50 cultures were washed and fed with Opti-MEM medium 
supplemented with 100 U/ml Gibco penicillin-streptomycin and 1 µg/ml TPCK treated Trypsin 
from bovine pancreas (Sigma-Aldrich, St. Louis, MO, USA). After 72 hours of incubation post-
infection, supernate from 96 well plates were determined by hemagglutination using 0.5% turkey 
erythrocytes. Results were recorded and TCID50 were calculated by the Spearman-Karber 
algorithm (Ramakrishnan 2016).  
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Hemagglutination and HI assays 
Hemagglutination and HI assays were performed using 0.5% turkey erythrocytes as 
previously described (Sun et al. 2013).   
Virus purification 
 The allantoic fluids were harvested and subjected to centrifugation at 1,200 × g for 30 
minutes at 4°C. The viruses were then purified by ultracentrifugation at 45,000 × g for 3 hours at 
4°C. The pellets were dissolved with 1 ml of phosphate buffered saline (PBS) (pH 7.4) and 
subjected to sucrose gradient (30%/60%) centrifugation at 103,000 × g for 1.5 hours at 4°C. The 
viruses in the intermediate phase were collected and subjected to centrifugation at 103,000 × g 
for 1 hour at 4°C. The pellets were dissolved in 0.5 ml of PBS and stored at −80°C until use.  
Quantification of viral concentration 
The purified viruses were quantified by using the solid-phase ELISA method as described 
elsewhere (Lin et al. 2012). In brief, ELISA was performed for each testing virus by mouse 
monoclonal anti-NP antibody (NR-43899; BEI Resources, National Institute of Allergy and 
Infectious Disease [NIAID], National Institutes of Health [NIH], Bethesda, MD, USA) against 
Goat Anti-mouse IgG HRP Conjugate (Sigma-Aldrich, St. Louis, MO, USA) and 1-Step Ultra 
TMB-ELISA Substrate Solution (Thermofisher, Rockford, IL).  
Biolayer interferometry receptor binding assay and data analyses 
Virus-receptor avidities were determined by biolayer interferometry receptor binding 
assay using an Octet RED instrument (Pall FortéBio, Fremont, CA, USA). To test the potential 
binding avidity to human- and avian-like receptors, we used two biotinylated glycan analogs, 
3ʹSLN and 6ʹSLN (Lectinity Holdings, Moscow, Russia). The glycans were preloaded onto 
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streptavidin-coated biosensors at up to 0.5 µg/ml for 3 minutes in 1 × kinetic buffer (Pall 
FortéBio, Menlo Park, CA, USA). Each test virus was diluted to a final concentration of 100 pM 
with 1 × kinetic buffer containing 10 µM oseltamivir carboxylate (American Radiolabeled 
Chemicals, St. Louis, MO, USA) and zanamivir (Sigma-Aldrich, St. Louis, MO, USA) to 
prevent cleavage of the receptor analogs by NA proteins from virus. Association was measured 
for 30-50 minutes at 25°C as described elsewhere (Lin et al. 2012; Xiong, Coombs, et al. 2013; 
Benton et al. 2015; Wen et al. 2017).  
Responses were normalized by the highest value obtained during the experiment, and 
binding curves were fitted by using the binding-saturation method in GraphPad Prism 7 
(https://www.graphpad.com/scientific-software/prism/). The normalized response curves report 
the fractional saturation (f) of the sensor surface as described in a previous study (Xiong, Martin, 
et al. 2013). RSL0.5 was used to quantitate the binding avidity of two selected viruses against two 
glycan analogs. The higher the RSL0.5, the weaker the binding avidity. 
Virus growth kinetics in vitro 
To determine the replication of the viruses in different cell lines, we infected A549, 
MDCK, and DF-1 cells with viruses at a multiplicity of infection of 0.01. After absorption for 1 
hour at 37°C, the cells were washed with PBS and incubated for 72 hours at 37°C in 5% CO2 
with Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA, USA) 
supplemented with 1 µg/ml TPCK treated Trypsin from bovine pancreas (Sigma-Aldrich, St. 
Louis, MO, USA) and with 100 U/ml Gibco penicillin-streptomycin (Thermo Fisher Scientific, 
Waltham, MA, USA).  Supernatants were collected at 8, 24, 48, and 72 hours after infection and 
titrated using the TCID50 in MDCK cells. 
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Pathogenicity of H10N7 IAV from Iceland in ferrets 
We studied the pathogenesis of Iceland H10N7 virus (Ig/4266) in ferrets. Fifteen 6-
month-old ferrets were purchased from Triple F Farms (Sayre, PA, USA). All ferrets were 
seronegative for IAV, as determined by HI assay. Three inoculation group ferrets were each 
intranasally administered 0.5 ml of 106 TCID50 of virus (0.25 ml/nose). At the same time, three 
control ferrets were administered 0.5 ml of PBS. At 5 days post inoculation (dpi), necropsies 
were performed on two infected and two control ferrets, and respiratory tissues were collected 
for virus titration in MDCK cells and for immunohistochemistry staining. Tissues were collected 
from the respiratory system (turbinate, soft palate; upper and distal trachea, left cranial and 
caudal lung, right cranial and caudal lung, right middle lung, and right accessory lobes).  
Transmission study in ferret model 
We used 12 ferrets to evaluate the potential for contact transmission or aerosol 
transmission of Iceland H10N7 IAV among humans. At 0 dpi, six of the 12 ferrets were each 
intranasally administered 0.5 ml of 106 TCID50 of Ig/4266 virus. At one dpi, each of these ferrets 
was randomly paired with an H10 IAV–seronegative ferret for study of aerosol transmission 
(group I) and direct contact transmission (group II). Paired group I ferrets (i.e., inoculated and 
aerosol transmission ferrets) were housed in the same cage but separated by a 1-cm-thick, 
double-layered steel partition with 5-mm perforations (Allentown, Inc., Allentown, NJ). Paired 
group II ferrets (i.e., inoculated and contact ferrets) were housed in the same cage without a 
partition. Nasal wash fluids were collected on 1, 3, 5, 7, 10 dpi/dpe, and virus titers were 
determined by TCID50 in MDCK cells. Blood samples were obtained on 0, 10, and 21 dpi/dpe to 




We performed immunohistochemical staining to confirm the presence of viral antigen in 
ferret tissues. Tissues were fixed in 10% neutral buffered formalin solution, paraffin embedded, 
and sectioned before being stained. The sections were deparaffinized by using 100% xylene, 
50% ethanol in xylene, 100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol, and distilled 
water. Antigen retrieval was performed by boiling in 1× antigen retrieval solution (Dako, 
Carpinteria, CA, USA) in a steamer for 20 minutes. Sections were washed with PBST (PBS with 
0.5% Tween 20) before endogenous peroxidase activity was quenched in 3% H2O2. Sections 
were then blocked with 10% normal goat serum (Invitrogen, Carlsbad, CA, USA) for 1 hour at 
room temperature before incubation with anti-NP monoclonal antibody (BEI Resources, NIAID, 
NIH) (Hirata et al. 2014) for 20 hours at 4°C. Sections were treated with a biotinylated goat anti-
mouse IgG polyclonal secondary antibody for 30 minutes before ABC reagent (Vectastain, 
Burlingame, CA, USA) was applied according to the manufacturer’s instructions. Sections were 
counterstained with hematoxylin, washed, dehydrated, and covered with cover slips. 
Histologic tissue inflammation analysis 
Tissues collected from ferrets at 5 dpi were sectioned as previously described and then 
stained with hematoxylin and eosin. The following tissue sections were analyzed: turbinate, soft 
palate; upper and distal trachea, left cranial and caudal lung, right cranial and caudal lung, right 
middle lung, and right accessory lobes. 
Statistical analysis 
Student t-test was used to determine statistical difference between viral titers from 
different tissues, and an alpha of 0.05 was used as the criteria for significance. 
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Biosafety and animal handling 
Laboratory and animal experiments were conducted under BSL-2 conditions in 
compliance with protocols approved by the Institutional Animal Care and Use Committee of 
Mississippi State University or the U.S. Geological Survey National Wildlife Health Center. 
Accession numbers 
Sequencing data has been deposited in the GenBank under accession number 




Results   
Genetic analyses of gull-origin H10N7 IAVs 
We isolated and genetically sequenced IAVs from four gulls, all of which were sampled 
on the western coast of Iceland during November 10-18, 2015. One of the four isolates 
[A/glaucous gull/Iceland/4552/2015(H10N7), abbreviated Gg/4552] was from an adult glaucous 
gull (Larus hyperboreus), and another [A/glaucous gull/Iceland/4270/2015(H10N7), abbreviated 
Gg/4270] was from a hatch-year glaucous gull. One of the other two isolates [A/Iceland 
gull/Iceland/4266/2015(H10N7), abbreviated Ig/4266] was from an adult Iceland gull (Larus 
glaucoides), and the other [A/Iceland gull/Iceland/4402/2015(H10N7), abbreviated Ig/4402] was 
from a hatch-year Iceland gull. Genetic sequencing showed that the isolates were >99.50% 
similar to each other across all eight genetic segments. Furthermore, phylogenetic analyses 
showed that all eight gene segments of these H10N7 IAVs from Iceland were of Eurasian lineage 
and that four genes (i.e. HA, NA, PB2, MP) of these Icelandic H10N7 IAVs were genetically 
similar to an H10N7 IAV isolate [A/harbor seal/Germany/1/2014(H10N7)] recovered from a 
sick seal on November 7, 2014 whereas four other genes (i.e. PB1, PA, NP, and NS) of these 
Icelandic H10N7 IAVs belong to at a genetic clade distinct from those of the seal origin isolates 
(Figure 1). Molecular characterization suggested that the PB1, PA, and NP genes of the Iceland 
gull-origin H10N7 IAVs (e.g. A/glaucous gull/Iceland/4270/2015) and those of seal origin 
isolates shared nucleotide sequence identities 93.51%, 93.78%, and 95.49%, respectively 
whereas those for all other 5 genes (HA, NA, PB2, MP, and NS) were > 96.00%. For example, 
the HA, NA genes of the Iceland gull–origin H10N7 IAVs shared 97.69% and 98.68% 
nucleotide sequence identity, respectively, with HA and NA genes of A/harbor 
seal/Germany/1/2014(H10N7). Phylogenetic analyses suggested that the NS genes from the seal 
 
38 
H10N7 and the gull viruses we recovered do not belong to the same genetic clade although they 
shared a nucleotide sequence identity of 96.15%. 
 
  
Figure 1 Phylogenetic and antigenic analyses of subtype H10 IAVs 
A) hemagglutinin gene, B) neuraminidase gene, and C) polymerase acidic protein. The 
phylogenetic tree for each gene segment was inferred by using a maximum-likelihood method by 
running RAxML v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized 
time–reversible substitution model (Stamatakis 2014). The bootstrap values were labeled for the 
selected representative branches with bootstrap values  70. Phylogenetic trees were visualized 
by using FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/).  Scale bars represent 
nucleotide substitutions per site. Red indicates the H10N7 IAV strain isolated from an Iceland 
gull in 2015; green indicates the subtype H10N7 avian IAVs isolated from European seals in 
2014; the virus marked in blue indicates the IAVs isolated from Iceland from other studies. 
 
Sequence analyses showed that most amino acids at the HA receptor binding sites were 
conserved among the Iceland gull-origin H10N7 isolates, the seal-origin H10N7 isolates, the 
H10 isolates from Eurasia, and the H10 isolates from North America (Table 4). The Iceland gull-





























































































































































































(corresponding to 226 at H3), which is identical to those at the HA sequences of two H10 
isolates from the 2014 outbreak among European seals (Table 4). However, the other four seal 
isolates from the 2014 outbreak among European seals have amino acid 222L instead (Dittrich et 
al. 2018) (Table 4). All H10 isolates had amino acid 224G (corresponding to 228 at H3) (Table 
4). 
Table 4 Molecular characterization of receptor binding sites at hemagglutinin proteins of 
H10 IAVs 
H10 numbering 128 129 185 186 187 188 214 215 216 217 218 219 220 221 
H3 numbering 137 138 192 193 194 195 221 222 223 224 225 226 227 228 
A/Iceland Gull/Iceland/4266/2015 K A N D L Y P Q V N G Q S G 
A/Iceland Gull/Iceland/4402/2015 . . . . . . . K . . . . . . 
A/Glaucous Gull/Iceland/4552/2015 . . . . . . . . . . . . . . 
A/Glaucous Gull/Iceland/4270/2015 . . . . . . . K . . . . . . 
A/black-headed gull/Iceland/1298/2011 . . . . . . . . . . . . . . 
A/emperor goose/Alaska/602/2012 . . . . . . . . . . . . . . 
A/Mallard/Netherlands/1/2014 . . . . . . . . . . . . . . 
A/mallard/New Brunswick/04394/2007 . . . . . . . . . . . . . . 
A/black scoter/Maine/276/2011 . . . . . . . . . . . . . . 
A/Duck/Bangladesh/24035/2014 . . . . . . . . . . . . . . 
A/American Black Duck/New 
Brunswick/00971/2010 . . . . . . . . . . . . . . 
A/Chicken/Jiangxi/34609/2013 R . . . . . . . . . . . . . 
A/Seal/Sweden/SVA1412040224-
SZ1847/H10N7/2014 . . . . . . . . . . . . . . 
A/Seal/Sweden/SVA1412040224-
SZ5634/H10N7/2014 . . . . . . . . . . . . . . 
A/harbor seal/NL/PV325-14 NS/NL/2014 . . . . . . . . . . . L . . 
A/harbor seal/NL/PV14-221 Ts/2015 . . . . . . . . . . . L . . 
A/harbor seal/NL/PV141113.07 L/NL/2014 . . . . . . . . . . . L . . 
A/harbor seal/NL/PV141113.05 NS/2014 . . . . . . . . . . . L . . 
A/harbor seal/NL/PV141113.04 L/NL/2014 . . . . . . . . . . . L . . 
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Antigenic analyses of gull-origin H10N7 IAVs 
Results from hemagglutination inhibition (HI) assays suggested homologous titers of 
seven prototype H10 IAVs from Eurasia, North America, and Australia, including 
A/chicken/Jiangxi/34609/2013 (H10N8), A/laughing gull/DE/209/2013 (H10N8), A/glaucous 
gull/Iceland/4552/2015 (H10N7), A/seal/Netherlands/P14-221/2014 (H10N7), 
A/mallard/Netherlands/1/2014 (H10N7), A/duck/Bangladesh/24035/2015 (H10N1), and 
A/chicken/Germany/N/49 (H10N7), ranged from 1:40 to 1:1280. The four Iceland gull-origin 
H10N7 IAVs cross-reacted with ferret sera against these seven H10 prototype viruses, and the HI 
titers varied from 1:40 to 1:320 (raw data not shown). 
Antigenic cartography analyses using AntigenMap (Cai, Zhang, and Wan 2010; Barnett 
et al. 2012) showed no clear antigenic clusters among 32 viruses: the 4 Iceland gull-origin 
H10N7 IAVs, 2 mammalian origin (seal and mink) H10N7 IAVs, 10 domestic poultry-origin 
(chicken and duck) IAVs, and 16 wild bird IAVs (Figure 2). The average antigenic distance 
between all 32 H10 isolates we tested was 1.3569 (0.8247) units, the antigenic distances 
between 16 wild bird-origin H10 isolates was 1.3228 (0.9137) units, and the antigenic distance 
between the four gull H10N7 isolates was 1.2259 (0.5692) units; each unit corresponds to a 
two-fold change in HI titer. The antigenic distance between A/seal/Netherlands/P14-221/2014 
(H10N7) and four gull H10N7 isolates was 2.1107 (0.9278) units and that between domestic 
poultry-origin isolates and four gull H10N7 isolates was 1.2700 (0.7246) units. Sequence 





Figure 2 Antigenic map of 32 subtype H10 influenza A viruses (IAVs) 
The map was constructed using hemagglutination inhibition (HI) data derived from ferret 
antisera. The open triangles indicate viruses isolated from humans or other mammals; the open 
cirlces indicate viruses isolated from domestic poultry; and the black circles indicate viruses 
isolated from wild birds. IAVs with identical HI titers may have overlapping positions on this 
antigenic map. The map was constructed using AntigenMap  (Cai, Zhang, and Wan 2010; 
Barnett et al. 2012). Each gridline (horizontal and vertical) in the map represents one antigenic 
unit distance corresponding to a 2-fold difference in HI titers. Ig/4266, A/Iceland 
gull/Iceland/4266/2015(H10N7); Gg/4552, A/glaucous gull/Iceland/4552/2015(H10N7); 
Gg/4270, A/glaucous gull/Iceland/4270/2015(H10N7); Ig/4402, A/Iceland 
gull/Iceland/4402/2015(H10N7); rg-A/Jiangxi-Donghu/346/2013[R] (6:2) (H10N8), a 
reassortant with HA and NA genes from A/Jiangxi-Donghu/346/2013 (H10N8) and six other 
genes from A/PR/8/1934(H1N1).  
In summary, the above analyses suggested that the four Icelandic gull H10N7 isolates 
(Gg/4552, Gg/4270, Ig/4266, and Ig/4402) are antigenically and genetically similar to each other 
and that these H10N7 isolates do not have significant antigenic diversities from but do have 
different levels of genetic diversity (e.g. internal gene segments) with the contemporary H10 
isolates from avian, mammals, and seals we studied. Based on these results, from these four 
Icelandic gull H10N7 isolates, Ig/4266 was randomly selected for detailed analyses on their 
replication, glycan receptor binding, and transmission properties as described in the next 
sections.    
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Gull-origin H10N7 IAV had competitive replication in vitro 
To determine the ability of gull-origin H10N7 IAV to replicate in different cells, we 
infected Madin-Darby canine kidney (MDCK), chicken embryo fibroblast (DF-1), and 
adenocarcinomic human alveolar basal epithelial (A549) cells with Ig/4266 virus and three other 
representative H10 isolates [A/seal/Netherlands/P14-221/2014(H10N7) (abbreviated as 
Seal/221); A/mink/Sweden/E12665/1984(H10N4) (Mink/E12665); and 
A/chicken/Jiangxi/34609/2013(H10N8) (Ck/34609)] at a multiplicity of infection of 0.01. All 
four testing viruses replicated efficiently in MDCK, A549, and DF-1 cells, reaching peak virus 
titers at 48 or 72 hours after inoculation (Figure 3). In general, these viruses grew better in 
MDCK cells than in the other cell lines but showed similar growth patterns in MDCK and DF-1 
cells. However, in A549 cells, the mink-origin H10N4 virus had a higher virus titer than the 
other three viruses. 
 
Figure 3 Replication kinetics of four subtype H10 IAVs in vitro 
Growth curves for influenza A/Iceland gull/Iceland/4266/2015(H10N7) virus 
(Ig/4266);A/chicken/Jiangxi/34609/2013(H10N8) (Ck/34609) virus; 
A/mink/Sweden/E12665/84(H10N4) virus (Mink/E12665); and A/seal/Netherlands/P14-
221/2014(H10N7) virus (Seal/221) in Madin-Darby canine kidney (MDCK), adenocarcinomic 
human alveolar basal epithelial (A549) and chicken embryo fibroblast (DF-1) cells. Cells were 
infected with viruses at a multiplicity of infection of 0.01; dashed lines indicate the limit of virus 
detection, 1.50 log10 [50% tissue culture infective dose/ml (TCID50/ml)]. Virus titers are 
expressed as mean ± standard deviation of log10 TCID50/ml. 
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Gull-origin H10 IAV had strong binding avidity to alpha 2,6-linked sialic acids and alpha 
2,3-linked sialic acids. 
To understand the receptor binding properties of these isolates, we tested their receptor 
binding avidities to two glycan analogs [i.e., Neu5Acα2-3Galβ1-4GlcNAcβ (3ʹSLN, an avian-
like receptor) and Neu5Acα2-6Galβ1-4GlcNAcβ (6ʹSLN, a human-like receptor)] for eight 
representative H10 viruses from various hosts: gull, seal, mink, duck, and chicken, and two 
prototype influenza viruses, A/California/01/2009(H1N1) and A/Duck/Hunan/795/2002 (HA, 
NA) × A/PR/8/34(H5N1)(Figure 4). All of the 8 tested H10 viruses had binding avidities to 
3ʹSLN at a sugar-loading concentration of 0.5 µg/ml; however, at the same sugar-loading 





Figure 4 Glycan binding screening of H10 IAVs to biotinylated glycan analogs 
 
To further determine the testing IAVs’ binding preference (i.e., to 3ʹSLN or 6ʹSLN), we 
quantified and compared the 50% relative sugar loading (RSL) concentration (RSL0.5) at half the 
fractional saturation (f = 0.5) of the tested virus against 3ʹSLN and 6ʹSLN. The higher the RSL0.5, 
the smaller the binding avidity. Quantitative analyses showed that Ig/4266 virus had an RSL0.5 of 
0.0835 (±0.0072 standard deviation [SD]) for 3ʹSLN and 0.2917 (±0.0019) for 6ʹSLN, whereas 
Ck/34609 virus had an RSL0.5 of 0.0996 (±0.0178) for 3ʹSLN and 0.3398 (±0.0004) for 6ʹSLN. 
As expected, our results showed that A/California/01/2009(H1N1) showed binding avidities only 
to 6ʹSLN (RSL0.5 = 0.1076 ± 0.0097) but not to 3ʹSLN whereas A/duck/Hunan/795/2002 (HA, 
































































Figure 5 Glycan binding specificity of subtype H10 IAVs 
A) biotinylated α2,3–linked sialic acid (3ʹSLN) and B) α2,6–linked sialic acid (6ʹSLN) glycan 
analogs as determined by biolayer interferometry using an Octet RED instrument (Pall FortéBio, 
Fremont, CA, USA). Streptavidin-coated biosensors were immobilized with biotinylated glycans 
at different levels. Sugar loading–dependent binding signals were captured in the association step 
and normalized to the same background. Binding curves were fitted by using the saturation 
binding method in GraphPad Prism 7 (https://www.graphpad.com/scientific-software/prism/). 
Horizontal dashed line indicates half of the fractional saturation (f = 0.5); vertical dashed line 
indicates relative sugar loading (RSL0.5) at f = 0.5; the higher the RSL0.5, the smaller the binding 
avidity. Virus abbreviations: A/Iceland gull/Iceland/4266/2015(H10N7), Ig/4266; 
A/chicken/Jiangxi/34609/2013 (H10N8), Ck/34609; A/California/04/2009(H1N1), H1N1; and 
A/duck/Hunan/795/2002(HA, NA) × A/PR/8/34 (H5N1), H5N1.  
Gull-origin H10 IAV caused infections in ferrets 
To determine the infectivity and pathogenesis of the gull-origin H10N7 IAV in 
mammals, we inoculated 6 seronegative ferrets (One group of 3 ferrets where each ferret was co-
housed with an uninoculated ferret [to examine contact transmission] and another group of 3 
ferrets where each ferret was co-housed with an uninoculated ferret but not in direct contact [to 
examine aerosol transmission]; Table 5) with Ig/4266 virus. Three additional ferrets were 
maintained in a separate room to serve as controls. Two ferrets inoculated with Ig/4266 (from the 
three contact-transmission groups) and two control ferrets were euthanized and necropsied at 5 















































days post inoculation (dpi) to determine viral pathogenesis and tissue tropism. Virus shedding 
levels and seroconversion was determined for the remaining four ferrets.  
 
Table 5 HI titers in serum samples from ferrets inoculated with or exposed to animals 
inoculated with A(H10N7) 
Group no., virus exposure 
route, ferret ID (cage no.) 
Titera,b  
0 dpi or dpe 10 dpi or dpe 21 dpi or dpe 
I    
 Inoculation    
  E4129 (4) <10 NA NA 
  E4130 (5) <10 NA NA 
  E4132 (6) <10 80 80 
 Direct contact     
 E4133 (4) <10 <10 40 
 E4136 (5) <10 <10 <10 
 E4137 (6) <10 160 160 
II    
 Inoculation    
  E4126 (1) <10 160 160 
  E4127 (2) <10 160 320 
  E4128 (3) <10 160 160 
 Aerosol     
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Table 5 (continued) 
  E4138 (1) <10 <10 <10 
  E4139 (2) <10 320 160 
  E4140 (3) <10 <10 <10 
III    
 Control    
 E4141 (7) <10 NA NA 
 E4142 (7) <10 NA NA 
 E4143 (8) <10 <10 <10 
Abbreviations: dpe, days post exposure; dpi, days post inoculation; ID, identification; NA, not 
available because ferrets were euthanized for pathogenicity study. 
aHemagglutination inhibition assays were performed using turkey erythrocytes.  
During the entire experimental period, influenza-like clinical signs (i.e. sneeze) were 
observed in neither the ferrets inoculated with Ig/4266 nor those exposed to Ig/4266 through 
direct contact or aerosol droplets.  Compared with ferrets in the control group, the results from 
body temperature monitoring through implant Transponder sensor (BioMedic Data Systems, 
Inc., Seaford DE) did not show significant consistent temperature elevation in the ferrets 
inoculated with Ig/4266 or in the ferrets exposed to Ig/4266 through both direct contacts and 
aerosol droplets (data not shown). The results from body weight monitoring did not show weight 
loss in all three control ferrets and five out of six ferrets inoculated with Ig/4266 (one ferret 
[#E4128] inoculated with Ig/4266 had a body weight loss [~5%] on 3 dpi recovered quickly on 5 
dpi) (data not shown). The body weight in the transmission ferrets were not monitored to avoid 
any potential contaminations.  
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All four remaining inoculated ferrets seroconverted by 10 dpi; at 21 dpi, HI titers ranged 
from 1:80 to 1:320 (Table 5). Virus titration in MDCK cells suggested that all six inoculated 
ferrets shed virus from 3 dpi to 5 dpi and had peak titers of up to 5.00 log10 50% tissue culture 
infective dose (TCID50)/ml at 3 dpi (Figure 6). To determine the tissue tropism of Ig/4266 virus, 
we quantified viral titers at 5 dpi in 10 tissue sections from each of the two ferrets’ respiratory 
tracts; tissues sections were from the turbinate; soft palate; upper and distal trachea; and lung 
(i.e., left cranial and caudal lungs and right cranial, caudal, middle lungs, and right accessory 
lobes). Except for the left cranial and left caudal lung sections, all tissue samples had H10 IAV-
positive titers ranging from 3.75 to 6.25 log10TCID50/g of tissue. Turbinate sections had an 
average titer of 5.87 log10 TCID50/g of tissue, whereas accessory sections had an average titer of 
3.88 log10 TCID50/g of tissue (Figure 7). Immunohistochemistry staining of the H10-positive 
tissue sections showed that IAV-specific antigen was multifocally presented within epithelium 
cells of the nasal turbinate, trachea, and lung (Figure 8), a finding consistent with virus titration 
results (Figure 7; Table 6). In summary, the average viral loads in turbinate were significantly 
higher than those in lungs (P < 0.05), and the turbinate has the highest viral loads among all the 
tested tissues: soft palates (4.63 ± 0.37 log10TCID50/ml), turbinate (5.88 ± 0.38 log10TCID50/ml), 
trachea (upper and distal trachea) (4.69 ± 0.31 log10TCID50/ml), and lung (left cranial and caudal 







Table 6 Viral titers (log10 TCID50/ml) in tissue sections from ferrets inoculated with 
A(H10N7) 
 
Tissue E4129 E4130 
Turbinate 5.50 6.25 
SP 4.25 5.00 
TR-U 5.50 4.50 
TR-D 4.75 4.00 
RA 4.00 3.75 
LCR aND ND 
LCD ND ND 
RCR 5.00 4.25 
RMD 3.75 4.00 
RCD 4.25 4.00 
 
Note: aND, Not detected. The results shown are log10 TCID50/gram. The tissue abbreviation is 
listed below: soft palate (SP), upper trachea (TR-U), distal trachea (TR-D), left cranial lung 
(LCR), left caudal lung (LCD), right cranial lung (RCR), right caudal (RCD), right middle lung 




Figure 6 Mean titers of IAV recovered from nasal wash fluids of virus-inoculated and contact 
ferrets in transmission experiments 
Ferrets (n=3 per group/experiment) were inoculated with 106 tissue culture infectious doses/ml 
(TCID50/ml) of influenza A/Iceland gull/Iceland/4266/2015(H10N7) virus. Twenty-four hours 
later, naïve ferrets (n=3) were each randomly paired with an inoculated ferret and either housed 
in same cages but on a different side of a 1 cm–thick, double-layered, steel partition with 5-mm 
perforations (aerosol transmission group. Panels A, B, and C represent each direct contact 
transmission group (white bars = inoculated ferrets; grey bars = naïve ferrets), and Panels D, E, 
and F represent each aerosol transmission group (white bars = inoculated ferrets; black bars = 
naïve ferrets). Nasal wash fluids were collected on the indicated days after inoculation or 
exposure for virus quantification using endpoint titration in Madin-Darby canine kidney cells; 
ending titers were expressed as log10TCID50/ml. Each panel represents a set of paired ferrets. 
Dashed lines indicate the limit of detection, log1010
1.5 TCID50/ml. Ferrets represented by the 
individual panels correspond to those listed in Table 5: A) ferrets in cage 4, B) ferrets in cage 5, 
C) ferrets in cage 6, D) ferrets in cage 1, E) ferrets in cage 2, and F) ferrets in cage 3.  



















































































































































Figure 7 Mean titers of influenza virus recovered from respiratory tract tissues of ferrets 
nasally inoculated with 106 50% tissue culture infectious doses (TCID50) of 
A(H10N7) virus 
Two ferrets were euthanized 5 days post inoculation (dpi), and virus titers in the respiratory 
tissues of each ferret were determined by using end-point titration in Madin-Darby canine kidney 
cells. The results shown are log10 TCID50/gram. The tissue abbreviation is listed below: soft 
palate (SP), upper trachea (TR-U), distal trachea (TR-D), left cranial lung (LCR), left caudal 
lung (LCD), right cranial lung (RCR), right caudal (RCD), right middle lung (RMD), and right 
accessory lobes (RA). Dashed line indicates the limit of detection, 1.50 log10TCID50/ml. 
Results for tissues from the control group were negative (data not shown). 
To further demonstrate the pathogenesis of Ig/4266 in ferrets, we performed hematoxylin 
and eosin staining on tissue sections from all locations. Ferrets inoculated with Ig/4266 virus 


















































clusters of neutrophils within the epithelium and luminal aggregates of degenerate neutrophils, 
macrophages, cellular debris and occasional hemorrhage (Figure 8B, D). One inoculated ferret 
(E4130) had rare areas of luminal neutrophils and cellular debris within terminal bronchioles 




Figure 8 Pathogenic changes in respiratory tract tissues of ferrets inoculated with A(H10N7) 
at 5 dpi 
Immunohistochemistry staining showed the presence of H10 antigen in respiratory epithelium 
cells within nasal turbinate (A, brown staining), ciliated epithelial cells within the trachea (B, 
brown staining), and scattered ciliated epithelial cells in bronchioles tissue were immunoreactive 
(C, arrows). D–G) Hematoxylin and eosin–stained ethmoid turbinate sections at 5 dpi in control 
(D, F) and infected (E, G) ferrets. Ethmoid turbinates from virus-inoculated ferrets had 
intraluminal aggregates of degenerate neutrophils, macrophages and, cellular debris. In addition, 




Gull-origin H10 IAV is transmitted by direct contact and by exposure to infectious aerosol 
droplets. 
To determine the transmission ability of Ig/4266 virus through direct contact, we used 
three sets of ferrets, each comprising a subtype H10 IAV-seronegative contact ferret and an 
Ig/4266 virus-inoculated ferret (6 ferrets total) (Table 5, group I). The three sets of ferrets were 
separately housed in partition-free cages. At 21 days post exposure (dpe), two of the three 
contact ferrets had seroconverted (HI titers of 1:160 and 1:40, respectively) (Table 5). At 5 and 7 
dpe, one of the seropositive contacts had a peak virus titer of 3.50 log10 TCID50/ml in nasal wash 
fluids (Figure 6C); virus was not detected in nasal wash fluids from the other two contact ferrets 
(Figure 6A, B). All three virus-inoculated ferrets had detectable virus titers in their nasal wash 
fluids (range, 3.00–5.00 log10
 TCID50/ml). By integrating data from both virological and 
serological analyses, two out of three direct contact-exposed-ferrets became infected with 
Ig/4266.   
We also used three sets of ferrets to determine the transmission ability of Ig/4266 virus 
through aerosol droplets; each set comprised a subtype H10 IAV-seronegative ferret and an 
Ig/4266 virus-inoculated ferret (6 ferrets total) (Table 5, group II). The two ferrets in each set 
were housed in the same cage but separated by a 1-cm-thick, double-layered steel partition with 
5-mm perforations. Nonrecirculating air in the cages flowed from the side housing the inoculated 
ferret through the partition to the side housing the exposure ferret and exhausted to room air 
through HEPA filtration. All three virus-inoculated ferrets had detectable virus titers in their 
nasal wash fluids (range, 3.00-5.00 log10 TCID50/ml). By 10 dpe, one of the three aerosol-
exposed ferrets had seroconverted (HI titer of 1:160) (Table 5), and the same ferret shed virus 
from 3 to 7 dpe; peak titers (5.50 log10 TCID50/ml) were detected at 5 dpe (Figure 6E). No virus 
was detected in nasal wash fluids from the other two aerosol-exposed ferrets (Figure 6D, F). By 
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integrating data from virological and serological analyses, one out of three aerosol-exposed 
ferrets became infected with Ig/4266.  
A total of three control ferrets (Table 5, group III) were housed in two cages in a separate 
room from the experimental ferrets. Virus titration of collected tissues, nasal wash fluids, 
immunohistochemical staining, and serologic assays remained negative for the control ferrets.  
 
Discussion 
In this study, we isolated four H10 IAVs from two gull species in Iceland, Iceland gulls 
and glaucous gulls. Genomic sequence analyses suggested that these isolates were genetically 
related to Eurasia lineage H10 IAVs, including those that caused the 2014 outbreak among 
European seals (Dusek et al. 2014; Hall et al. 2014; van den Brand et al. 2016). Although genetic 
connections have been reported among avian IAVs isolated from North America and Iceland 
(Dusek et al. 2014), none of the gene segments among the four H10 IAVs we isolated for this 
study were associated with those from North America. However, in previous studies both 
Eurasian and American lineages of AIV have been reported in Iceland including an H10 subtype 
of mixed Eurasian and American lineage (Dusek et al. 2014; Hall et al. 2014).   
Human IAVs preferentially bind to α2,6-linked sialic acids (SAα2,6GA), whereas avian 
IAVs prefer α2,3-linked sialic acids (SAα2,3GA) (Connor et al. 1994; Rogers et al. 1983; Rogers 
and D'Souza 1989). In this study, biolayer interferometry analyses on the gull-origin H10N7 
isolate we recovered (Ig/4266 virus) showed that the isolate bound to both SAα2,3GA and 
SAα2,6GA, as also shown with three other H10 isolates from chicken, seal, and mink (Figure 4). 
These results are consistent with other studies that also used biolayer interferometry analyses to 
determine binding avidity for avian-origin H10 viruses (Vachieri et al. 2014), and they are 
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consistent with results for a study, using turkey erythrocytes expressing both SAα2,3GA and 
SAα2,6GA or only SAα2,6GA receptors, of seal-origin H10 IAVs that showed significant 
binding ability to SAα2,3GA and SAα2,6GA (Dittrich et al. 2018). However, our results showed 
that the binding avidities to SAα2,6GA could vary to some extent, depending on the virus strain, 
but sequence analyses for the reported HA receptor binding sites were mostly conserved among 
the isolates (Table 4). Of note, a mutation, Q220L (corresponding to 226 in H3 numbering), 
which was reported to have been acquired in the 220 loop of the HA receptor binding site during 
the subtype H10N7 IAV outbreaks among European seals, increased replication ability in 
mammalian cells (A549 cells) and retained replication efficiency in the avian cells (chicken 
embryo kidney primary cells)(Dittrich et al. 2018). This mutation seems to increase the binding 
avidity of avian-origin H10N7 IAV to SAα2,6GA (Dittrich et al. 2018). Mutations Q226L and 
G228S (in position H3) can increase the ability of avian IAV to infect humans (Ha et al. 2003; 
Liu, Stevens, et al. 2009; Bateman et al. 2008; Connor et al. 1994; Nobusawa and Nakajima 
1988; Vines et al. 1998; Wan and Perez 2007). Our results suggest that replication of mink-
origin H10N4 virus in mammalian cell line A549 and MDCK cells (but not in avian DF-1 cells) 
was more efficient than that of gull-origin H10 IAVs, although receptor binding properties of 
these H10 viruses were similar. It is unclear whether the NA or internal genes of mink virus 
could also contribute to such phenotypic differences in growth analyses (Figure 3). Nevertheless, 
the binding ability of the gull-origin H10 IAVs to SAα2,6GA could facilitate viral infection of 
mammal hosts (e.g., ferrets and humans) expressing SAα2,6GA and facilitate the generation of a 
more transmissible virus.  
Antigenic analyses showed a lack of significant antigenic diversity among 32 H10 IAVs 
that we tested (Figure 2); this finding is similar to that from a prior study, in which the antigenic 
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properties of 20 IAVs were compared (Sutton et al. 2017). Sequence analyses showed that the 
amino acids across the HA antibody binding sites were conserved (data not shown). The limited 
antigenic diversity for H10 avian IAVs is consistent with the concept of evolutionary stasis in 
natural reservoirs of IAVs (i.e., aquatic birds, such as migratory waterfowl and shorebirds) 
(Sturm-Ramirez et al. 2005). These results are consistent with those from other studies of other 
subtypes of waterfowl-origin IAVs, such as subtype H3 (Bailey et al. 2016) and H7 viruses (Xu, 
Bailey, Spackman, Li, Wang, Long, Baroch, Cunningham, Lin, Jarman, et al. 2016; Munster et 
al. 2005; Campitelli et al. 2008). 
As one of the key natural reservoirs of IAVs, gulls play an important role in transmission 
and dissemination of various subtypes of IAVs, including subtypes H5 and H7 (Benkaroun 
2016). Prior studies suggested that gull species seem to be involved in transportation of avian 
IAVs in the North Atlantic and in the reassortment of these viruses into new genetic 
combinations (Wille et al. 2011; Hall et al. 2013). The habitat variety of gulls certainly create the 
possibility of acquiring a variety of IAVs from multiple sources because they are consummate 
generalists and can be found in practically any habitat, including coastal, marine, brackish, 
freshwater, agricultural, and even human urban and suburban environments. Glycan receptor 
characterization showed that gulls (herring gull, laughing gull, ring-billed gull) had abundant 
expression of α2,3-linked sialic acid in the respiratory tract (nasal turbinate, trachea, bronchi, 
lung) and intestinal tract (duodenum/jejunum, ileum/caeca). In addition, α2,6-linked sialic acid 
was abundantly expressed in gulls’ respiratory tracts; however, little or no expression of α2,6-
linked sialic acid was detected in the gulls’ intestinal tracts (Franca, Stallknecht, and Howerth 
2013). Previous reports indicated that gulls, when infected with highly pathogenic avian IAV, 
exhibited a variety of clinical and pathologic phenotypes: some IAV strains caused severe 
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disease and even death, whereas other strains caused mild lesions and no deaths  (Wood, 
Webster, and Nettles 1985; Ramis et al. 2014; Brown et al. 2006; Perkins and Swayne 2002; 
Brown, Stallknecht, and Swayne 2008). Gulls experimentally infected with low pathogenic avian 
IAVs showed no signs of disease, and none died (Bahl and Pomeroy 1977; Brown et al. 2012; 
Curran et al. 2013). Most of these infected gulls shed virus from the oropharynx and cloaca 
(Perkins and Swayne 2002; Brown et al. 2006; Brown, Stallknecht, and Swayne 2008; Ramis et 
al. 2014; Bahl and Pomeroy 1977; Brown et al. 2012; Curran et al. 2013). Of note, a gull-origin 
H16N3 IAV was shown to attach to the human respiratory tract, cornea, and conjunctiva, and a 
human virus was shown to bind to the trachea of gull species tested (Lindskog et al. 2013). In 
summary, prior studies suggest that gulls could be infected with avian or human IAVs and serve 
as asymptomatic carriers facilitating virus transmission. In this study, the Eurasian lineage H10 
viruses, which were associated with outbreaks among seals (Figure 1) and have been identified 
in at least two gull species in Iceland. Thus, gulls could facilitate spillover of viruses to other 
hosts within the IAV ecologic environment and to other geographic regions, including North 
America.  
Ferrets have been used as a model of human infection in this study as their physiology 
and immune system and the influenza-associated glycan receptor distribution in their respiratory 
tracts are similar to those in humans (Maher and DeStefano 2004; van Riel et al. 2007); thus, 
ferrets have been used widely as a model of influenza infection in humans for influenza  risk 
assessment (e.g., pathogenesis and virus transmission) and to evaluate influenza vaccines 
(Houser et al. 2013; Vela et al. 2012; Govorkova et al. 2006; Belser, Katz, and Tumpey 2011). 
Human seasonal influenza virus infections in ferrets primarily occur in the upper respiratory tract 
(Renegar 1992; Smith and Sweet 1988). Instead, avian IAVs (e.g. subtype H5N1) can cause 
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upper respiratory tract and lower respiratory tract manifestations in humans (Beigel et al. 2005). 
In laboratory conditions, many avian IAVs, including subtype H5N1 and H7N9, can cause 
infections in both upper and lower respiratory tracts in ferrets (Zhu, Wang, et al. 2013) (Lipatov 
et al. 2009).  However, most of these laboratory studies in ferrets involve in a high dose (e.g. 105 
to 107 plaque-forming units, TCID50, or 50% egg infectious doses) usually, through intranasal or 
intratracheal inoculation. Recent studies suggest that the method of virus administration and 
dosage in the challenges affects the pathogenesis and the tissues where the challenging virus can 
be recovered (Bodewes et al. 2011; Lipatov et al. 2009; Belser et al. 2016; Moore et al. 2014). 
Human seasonal and pandemic influenza viruses typically can be transmitted efficiently between 
ferrets through direct contact or aerosol droplets. In our study, gull-origin subtype H10N7 IAV 
replicated primarily in the upper respiratory tract of ferrets, although some virus was also 
identified in the lower respiratory tracts of ferrets inoculated with H10N7 virus (Figure 7; Table 
6). In addition, H10N7 virus infection caused moderate histologic changes in ferrets (Figure 8). 
In a prior study, pathogenesis was evaluated in ferrets that had been infected with one of 20 
subtype H10 IAVs from different host species in Eurasia and North America: domestic poultry 
(chicken, turkey, duck, quail), wild birds (mallards, ruddy turnstone, northern pintail, American 
black duck, Eurasian wigeon, unidentified shorebird species), and mammals (mink, seal, human) 
(Sutton et al. 2017). Results showed that the 20 H10 IAVs had robust viral replication in the 
nasal turbinate and various degrees of replication in the lungs (Sutton et al. 2017); those findings 
are consistent with our findings for gull-origin H10N7 virus. Furthermore, gull H10N7 virus can 
be transmitted between ferrets through both direct contact and aerosol droplets, although aerosol 
transmission is less efficient than direct contact transmission (Table 5). Our findings suggest that 
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the gull-origin H10 IAVs have the potential to infect mammals, including humans, and possibly 
even result in human-to-human transmission.  
Evaluation of the replication and transmission ability of avian-origin IAVs in mammals is 
a key component of influenza pandemic preparedness. This study supported that preparedness 
component, showing that, similar to subtype H1, H3, H5, H6, H7, and H9 avian IAVs, subtype 
H10 avian IAVs can infect mammals, including humans (World Health Organization, 
Communicable Diseases, and Containment 2004; Arzey et al. 2012; Xu et al. 2015), minks 
(Klingeborn et al. 1985b), seals (Zohari et al. 2014), and pigs (Wang, Zou, et al. 2012). In 
addition, our findings suggest that avian H10 IAVs could potentially be transmitted among 
mammals through direct contact, aerosol droplets, or both, as was confirmed by the outbreaks 
among European seals (Dusek et al. 2014; Hall et al. 2014; van den Brand et al. 2016). Thus, 
monitoring the enzootic dynamics and evolutionary patterns of H10 IAVs among wildlife, 
including gulls, would facilitate influenza pandemic preparedness, and continuing surveillance of 




UNDERSTAND THE CORRELATION BETWEEN DISTRIBUTION OF SLEX RECEPTOR 
WITH HOST/TISSUE TROPISMS OF AVIAN H7 IAVS IN CHICKENS AND MALLARDS
 
Avian IAVs are enzootic in wild birds and cause sporadic spillovers into domestic 
poultry and humans. Prior studies suggested that certain avian IAVs prefer to fucosylated 
sulfated α2,3 sialoglycan. The goal of this study is to determine receptor binding specificity of 
H7 IAVs and the host/tissue tropisms of H7 viruses in chickens and mallards, and we will focus 
on fucosylated α2,3 sialoglycan in this study. We hypothesize that H7 IAVs would bind to 
fucosylated α2,3 sialoglycan and that fucosylated α2,3 sialoglycan would be expressed distinctly 
among the respiratory and gastrointestinal tracts of wild bird species. Results from bio-layer 
interferometry of 10 wild bird origin H7 isolates from North America, one human and one turkey 
H7 isolates from Eurasia showed binding to the glycans that terminated with either 
Neu5Aca2,3Gal or Neu5Aca2,6Gal, but with the binding preference to the ones with a Sialyl 
Lewis X (SLex) motif, a fucosylated Neu5Aca2,3Gal glycan. Of interest, Glycan receptor 
distribution analyses suggested that SLex is widely distributed in the trachea, cloaca, and colon 
of chickens as well as in the trachea and cloaca but not colon of mallards. SA2,3Gal is abundant 
in all tissues while SA2,6Gal is less expressed in chickens and mallards. More specifically, 
SA2,6Gal were detected in all tested tissues except in trachea-middle, trachea-distal, cloaca of 
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chickens; but only in duodenum and caecum of mallards were expressed SA2,6Gal. The animal 
challenge experiment using A/mallard/New Jersey/A00926089/2010 (H7N3) showed that viruses 
are detected in the tissues with or without SLex expression. Mallards had much higher shedding 
loads (p<0.001) and a longer shedding span than chickens. In addition, we found SLex were 
found in the trachea of H7 susceptible wild bird species but not in sea ducks and wood ducks in 
which rare H7 infections occurs. In summary, this study suggested that SLex may contribute to 
host tropism of avian H7 IAVs. Further studies are needed to reveal the relations between 





Subtype H7 avian IAVs are enzootic in wild birds and have been reported to spread 
sporadically into domestic poultry, lower mammals (e.g. harbor seals (Webster et al. 1981; Lang, 
Gagnon, and Geraci 1981; Kwon et al. 2011), swine (Kwon et al. 2011)), and humans (Banks, 
Speidel, and Alexander 1998; Campbell, Webster, and Breese 1970; DeLay, Casey, and Tubiash 
1967; Kurtz, Manvell, and Banks 1996; Taylor and Turner 1977; Webster et al. 1981; Koopmans 
et al. 2004; Fouchier et al. 2004b; Tweed et al. 2004; Dudley 2008). To date, all H7 avian IAVs 
identified from wild birds are low pathogenic (LP) but can mutate to high pathogenic (HP) after 
being transmitted to domestic poultry. The HP H7 IAVs has caused a number of outbreaks 
(Selleck et al. 2003; Hirst et al. 2004; Fouchier et al. 2004b; Berhane et al. 2009; Lopez-Martinez 
et al. 2013; Lee et al. 2017)  with devastating economic loss to the poultry industry (Lee et al. 
2017; Mannelli, Ferrè, and Marangon 2006; Mulatti et al. 2007) . Prior studies showed that, 
although interactions with wild birds exposed H7 IAVs to wild mammals (e.g. seals (Lang, 
Gagnon, and Geraci 1981) and feral swine (Martin et al. 2017) and humans (Koopmans et al. 
2004), the majority of H7 spillover cases were associated with direct contact with infected 
domestic poultry (Dudley and Mackay 2013; Kurtz, Manvell, and Banks 1996; Fouchier et al. 
2004b; Koopmans et al. 2004; Tweed et al. 2004; Lopez-Martinez et al. 2013). Typically, after 
being introduced and becoming enzootic in domestic poultry, these H7 avian IAVs can increase 
the opportunities to interact with domestic mammals, such as swine, and humans. Thus, it is 
important to perform spillover risk assessment of H7 avian IAVs to understand how avian H7 
IAVs can spillover from wild birds to domestic poultry.  
Surveillance studies suggested that the prevalence of subtype H7 IAVs in wild birds are 
not universally distributed across wild bird species (Krauss et al. 2004; Munster et al. 2007; 
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Olsen et al. 2006; Krauss et al. 2015). For example, a long-term surveillance of IAVs in 
migratory ducks in Alberta, Canada, from 1976 to 2012 and in shorebirds and gulls at Delaware 
Bay, United States, from 1985 to 2012 showed that H7 IAVs were more likely to be isolated in 
shorebirds and gulls (6.18%) rather than in ducks (1.11%) (Krauss et al. 2015). The limitation of 
these studies is that number of samples across various bird species are not evenly distributed and 
thus it is difficult to conclude H7 IAVs are host dependent across wild bird species. On the other 
hand, under laboratory conditions, H7 IAVs can infect a large number of wild and domestic 
avian species, including chicken, Pekin ducks, turkeys (Spackman et al. 2010; Yu et al. 2019), 
mallards (Pantin-Jackwood et al. 2016), Japanese quail, rock pigeons, and Embden geese 
(Pantin-Jackwood et al. 2014). Clinical signs, pathogenesis and shedding patterns varied greatly 
among these tested species. For example, an avian origin isolate A/Anhui/1/2013 (H7N9) 
infected chickens, Japanese quail, pigeons, Pekin ducks, Mallard ducks, Muscovy ducks, and 
Embden geese; while with no apparent clinical signs, chickens and Japanese quail shed more 
viruses and have a longer period than the other five species. Of interest, the viral shedding was 
higher in oropharyngeal swabs than in cloacal swabs from all these tested species (Pantin-
Jackwood et al. 2014). These data suggested that there were species barriers when H7 IAVs 
transmitted from one wild bird species to another and from wild birds to domestic poultry. There 
is a need to understand the molecular mechanism affecting how H7 avian IAVs host tropisms 
across various avian species, especially from wild birds to domestic poultry. 
 Receptor binding has been shown to be one of key factors determining the host tropisms 
of IAVs.  The surface glycoprotein hemagglutinin (HA) of IAVs enter the cells by attaching the 
sialic acids (Sias) on the cell surface. It has been well accepted that avian IAVs bind to receptors 
containing terminal sialyl-galactosyl residues linked by an α2-3 linkage (Neu5Acα2-3Gal, avian-
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like receptor), whereas human viruses bind to receptors which contain terminal α2-6-linked 
sialyl-galactosyl moieties (Neu5Acα2-6Gal, human-like receptor) and swine viruses to both 
Neu5Acα2-3Gal and Neu5Acα2-6Gal (Connor et al. 1994; Gambaryan, Karasin, et al. 2005; 
Matrosovich et al. 2000; Matrosovich et al. 1997).  Switching the binding specificity to receptors 
with different lineages can help change the host tropism of influenza viruses. For example, a 
change of the binding specificity from avian-like to human-like receptor for an IAV is one of key 
factors for the emergence of an endemic virus in humans (Baigent and McCauley 2003; 
Matrosovich, Gambaryan, and Klenk ; Malik Peiris 2009). Glycan distribution analyses  
demonstated that presence of Neu5Acα2-3Gal among various wild birds (e.g. mallards, mute 
swans) and domestic poultry species (e.g. chickens, turkeys) (Franca, Stallknecht, and Howerth 
2013; Guo et al. 2007; Liu, Han, et al. 2009). Thus, the linkage to the terminal sialyl-galactosyl 
residues in the glycan alone cannot be the cause of variations in the susceptibility of H7 IAVs 
across avian species.  
A number of studies investigated whether IAVs can bind differently to certain glycan 
substructures, so called glycan motifs, in addition to the well-known linkage to the terminal 
sialyl-galactosyl residues. In one study, all tested avian IAVs bound to Neu5Acα2-3Galβ1-
4GlcNAcβ (3’SLN),  but the duck origin viruses preferred Neu5Acα2-3Galβ1-3GalNAcα 
(SiaTF), the gull origin viruses preferred SLex, and the chicken origin viruses preferred 
Neu5Acα2-3Galβ1-4-(6-O-Su)GlcNAcβ (6-O-Su-3’SLN) (Gambaryan, Yamnikova, et al. 2005; 
Gambaryan et al. 2018). Another study showed that viruses originated from chicken, turkey, 
goose bind to Neu5Acα2-3Galβ1-4(Fucα1-3)-(6-HSO3)GlcNAcβ (Su-SLex) (Gambaryan et al. 
2008). Chicken, turkey, ostrich, mallard, green-winged teal, ruddy turnstone origin H7 IAVs had 
preferential binding to SLex and to both 6-O-Su-3’SLN and Su-SLex, two sulfated 
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oligosaccharides (Gambaryan et al. 2012). In summary, these studies suggested avian IAVs had 
variations in binding preferences among glycan substructures in addition to the linkage to the 
terminal sialyl-galactosyl residues. However, most of these studies are limited to glycan binding 
but without functional analyses. A recent study suggested that a chicken origin H5N2 virus had a 
higher binding preference to SLex than SA2,3Gal whereas a duck origin H5N2 virus to SA2,3 
than SLex. The chicken virus replicated more efficiently in the SLex expressed MDCK cells than 
in the SLex deficient MDCK cells. In addition, SLex is highly expressed in the upper respiratory 
tracks of chicken but not in colon of ducks, suggesting that SLex could a potential glycan 
receptor for avian H5 (Hiono et al. 2014). However, it is unclear whether SLex could play a role 
in affecting tissue and host tropism of avian IAVs, especially in how virus is transmitted from 
wild birds to domestic poultry.  
 In this study, we hypothesize that SLex would be distributed differently across the tissues 
of avian species and that such a distribution would cause different viral and shedding patterns 
between birds. We focused on subtype H7 avian IAVs in this study. To test these hypotheses, we 
analyzed the distribution of SLex across both respiratory and gastrointestinal tracts of a set of 
wild bird and domestic poultry species, which are commonly related to H7 infections during 
influenza surveillance, and then performed glycan binding analyses of a set of H7 avian IAVs 
from these birds. Through animal experiments using susceptible bird species, we correlated the 
glycan binding data with the viral abundance across tissues and in viral shedding, in mallard (a 
wild bird species) and chicken (a domestic poultry species).  
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Materials and methods 
Viruses, virus propagation, and purification 
Viruses used in this study include two reassortant viruses [A/Shanghai/2/2013 (H7N9) 
(HA,NA)×PR8 (H7N9) (IDCDC-RG32A; SH2) (BEI resources, https://www.beiresources.org), 
A/turkey/Virginia/4529/2002 (H7N2)×PR8 (H7N2) (IBCDC-5; Turkey/2002) (International 
Reagent Resource, https://www.internationalreagentresource.org)] and 11 avian IAV isolates 
listed in Table 7.  
All viruses were propagated for a single passage in specific pathogen free (SPF) 9-day 
old embryonated chicken eggs (Charles River, Norwich, CT) at 37 °C for 72 hours, and the 
allantoic fluids were harvested and stored at -80°C until use. The viruses used in biolayer 
interferometry receptor binding analyses were purified through sucrose density gradient 
ultracentrifugation and then quantified by solid-phase ELISA method as described elsewhere 
(Wen et al. 2018). 
Table 7 Viruses used in the study 
Viruses Abbreviation 
A/Shanghai/2/2013 (H7N9) (HA,NA)×PR8 (H7N9) (IDCDC-RG32A SH2 
A/turkey/Virginia/4529/2002 (H7N2)×PR8 (H7N2) (IBCDC-5) Turkey/2002 
A/American black duck/Delaware/A00870108/2010 (H7N3) Duck/2010 
A/mallard/New Jersey/A00926089/2010 (H7N3) Mallard/2010 
A/blue-winged teal/Taxes/A00463679/2010(H7N3) Teal/2010 
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Table 7 (continued) 
A/bufflehead/Virginia/A00120022/2008 (H7N2) Buff/2008 
A/domestic duck/West Virginia/A00140913/2008 (H7N3) Duck/2008 
A/American green-winged teal/Utah/A00654391/2009 (H7N3) Teal/2009 
A/mute swan/Rhode Island/A00325125/2008 (H7N3) Swan/2008 
A/northern pintail/Texas/A00466052/2009 (H7N3) Pintail/2009 
A/northern shoveler/Utah/A00468766/2009 (H7N3) Shoveler/2009 
A/ring-necked duck/Texas/A00766403/2009 (H7N1) Ring/2009 
 
Hemagglutination and hemagglutination inhibition (HI) assays 
Hemagglutination and HI assays were performed by using 0.5% turkey erythrocytes as 
described in the Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza 
by the World Health Organization (WHO) Global Influenza Surveillance Network (WHO 2011). 
The serum was first treated with washed-pack turkey erythrocytes with final concentration of 
10%, after which the serum-erythrocytes were mixed and incubate for 30 minutes at room 
temperature. Briefly, 2-fold serial dilutions of 25 μL of serum after turkey erythrocytes 
absorption with were made in 25 μl of phosphate buffered saline (PBS). Diluted sera were 
incubated with 8 hemagglutination units of viruses (in a volume of 25 μl) for 15 minutes at room 
temperature, and then 50 μL per well of 0.5% turkey erythrocytes were added. The results were 
recorded after 30 minutes of incubation at room temperature. HI titers were calculated as the 
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reciprocal of the last HI-positive serum dilution, and samples with a HI titer lower than 1: 10 
were considered negative. 
 
Virus titration 
The 50% tissue culture infectious dose (TCID50) was determined on MDCK cells. 
Briefly, MDCK cells were maintained as stock cultures in DMEM and re-plated 1 day before 
infection in 96-well plates for the TCID50 assays. Cell cultures were then infected for 1 hour after 
three times of PBS (pH 7.4) washes. The media used for dilution and infections was Opti-MEM I 
Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 100 
U/mL Gibco penicillin-streptomycin (Thermo Fisher Scientific, Waltham, MA). Post infection 
TCID50 cultures were washed and fed with Opti-MEM medium supplemented with 100 U/mL 
Gibco penicillin-streptomycin and 1 µg/mL TPCK treated Trypsin from bovine pancreas (Sigma-
Aldrich, St. Louis, MO). At 72 hours post inoculation, supernatant from 96 well plates were 
determined by hemagglutination using 0.5% turkey erythrocytes. Results were recorded and 
TCID50 were calculated by the Reed and Muench algorithm (Ramakrishnan 2016).  
 
H7 sequence data and molecular characterization 
The HA protein sequences of the tested virus isolates used in binding experiments were 
downloaded from GenBank, National Center for Biotechnology Information database. Multiple 
sequence alignments were generated using Muscle v3.8.31 (Edgar 2004). The amino acid 




Biolayer interferometry receptor binding assay 
The virus receptor binding avidities with three receptors were determined by biolayer 
interferometry assay with an Octet RED instrument (Pall ForteBio, Menlo Park, CA). Three 
biotinylated glycan analogs, Neu5Acα2-3Galβ1-4GlcNacβ-PAA-biotin (3’SLN), Neu5Ac α2-
6Galβ1-4GlcNacβ-PAA-biotin (6’SLN) (Lectinity Holdings, Moscow, Russia) and and Neu5Ac 
α2-3Galβ1-4GlcNacβ (β1-3Fuc)-PAA-biotin (SLex) were synthesized and kindly provided by 
Dr. Lei Li from Georgia State University. The glycans were preloaded onto streptavidin-coated 
biosensors at up to 0.3 µg/ml for 5 minutes in 1 × kinetic buffer (Pall FortéBio, Menlo Park, CA, 
USA). Each test virus was diluted to a final concentration of 100 pM with 1 × kinetic buffer 
containing 10 µM oseltamivir carboxylate (American Radiolabeled Chemicals, St. Louis, MO) 
and zanamivir (Sigma-Aldrich, St. Louis, MO) to prevent cleavage of the receptor analogs by 
NA proteins of virus. Association was measured for 30 minutes at 25°C as described elsewhere 
(Guan, Hall et al. 2019). Responses were normalized by the highest value obtained during the 
experiment, and binding curves were fitted by using the binding-saturation method in GraphPad 
Prism 8 (https://www.graphpad.com/scientific-software/prism/). The normalized response curves 
report the fractional saturation (f) of the sensor surface as described in elsewhere (Xiong, 
Tuzikov, et al. 2013). The RSL0.5 and SD were calculated by the software as mentioned above. 
RSL0.5 was used to quantitate the binding avidity of two selected viruses against two glycan 
analogs. The higher the RSL0.5, the weaker the binding avidity.  
 
RNA extraction, sequencing, and quantitative RT-PCR 
Before the tested virus isolates were used in the phenotypic analyses, their HA sequences 
were sequenced and confirmed that no mutations were developed during virus propagation.  To 
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sequence HA, viral RNAs were extracted from the allantoic fluid of SPF embryonated chicken 
eggs with GeneJET Viral DNA/RNA purification kit (Thermo Fisher Scientific, Waltham, MA) 
following the manufacturer’s instruction. The RNAs were subjected to cDNA synthesis by using 
the SuperScriptTM III Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA) according 
to the manufacturer’s instruction. PCR products of the full length HA were generated with IAV 
specific primers (Hoffmann et al. 2001). The parameters of the PCR were set as follows: one 
cycle at 98°C for 30 seconds, followed by 40 cycles at 98°C for 10 seconds, 55°C for 30 seconds 
and 72°C for 2 minutes, then one cycle at 72°C for 10 minutes. The PCR products were sent for 
Sanger sequencing by Eurofins Genomics LLC (Louisville, KY).  
To quantify the viruses shed by each bird and those in each tissue section, RNA was 
extracted from a swab or tissue sample by using Applied Biosystems 5×MagMAXTM Pathogen 
RNA/DNA Kit (Thermo Fisher Scientific, Waltham, MA). One-step qRT-PCR was performed to 
determine the viral RNA copy numbers by TaqMan Fast Virus 1-Step Master Mix (Thermo 
Fisher Scientific, Waltham, MA). The IAV matrix gene-based primers, including forward primer 
(5’- GACCRATCCTGTCACCTCTGAC -3’), reverse primer (5’- AGGGCATTY 
TGGACAAAKCGTCTA -3’), and TaqMan® Probe (5’- 
TGCAGTCCTCGCTCACTGGGCACG), were used in the qRT-PCR reaction. TaqMan® probes 
are labeled at the 5'-end with the reporter molecule 6-carboxyfluorescein (FAM) and with the 
quencher, Blackhole Quencher 1 (BHQ1) (Biosearch Technologies, Inc., Novato, CA) at the 3'-
end. The parameters of the qRT-PCR were set as follows: one cycle at 50°C for 5 minutes, 1 





Determine the number of viral copies using standard curve   
To quantify our RNA copy numbers in our samples, M-gene based standard curve were 
included in each one-step qRT-PCR plate with a detection limit of 10 viral RNA copies/l. The 
standard curves were generated based on M-gene plasmids, which are subjected to 10-fold serial 
dilutions ranging from 10 to 107 copies/L. Average of threshold cycle (Ct) values were 
recorded and plotted against plasmid concentration by linear regression. The average Ct were 
recorded and viral concentrations in samples were calculated based on the standard curve 
constructed as above. To better understand the viral concentrations, the units of liquid samples 
(swabs) were converted into copies/mL and solid samples (tissues) were converted into copies/g 
tissues and shown as log10 copies/mL for swabs or log10 copies/g for tissues. After the 
conversion, the limit of detection is 4.17 log10 copies/g and 3.65 log10 copies/mL for tissues and 
swabs, respectively.  
 
Glycan receptor distribution in respiratory tracts and intestines of chicken and mallard 
Tissues were prepared for histopathology and immunofluorescence staining. Briefly, a 
tissue was fixed by submersion in 10% neutral buffered formalin and embedded in paraffin. 
Sections were made at 5 μm. The sections were deparaffinized by dipping into the following 
solutions: 2 times of 10 minutes in xylene, 3 minutes of 1:1 xylene:100% ethanol, 100% ethanol, 
100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol and rinse in ddH2O. Antigen was then 
heat-induced target retrieved with diluted Target Retrieval Solution, Citrate pH 6.1 (10x) 
following the manufacturer’s manual (Dako, Carpinteria, CA). The sections were blocked by 
3.5% Bovine Serum Albumin for 2 hours at room temperature and then blocked with 
streptavidin/biotin blocking kit (Vector laboratories, Burlingame, CA) by following the user 
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guide. The sections were rinsed with PBS and incubated with the Alexa Fluor 488 anti-human 
Sialyl Lewis X (dimeric) antibody (1:100; BioLegend, San Diego, CA) overnight at 4°C. The 
tissue sections were incubated with the biotinylated Maackia Amurensis Lectin II (MAA II) 
(10g/mL; Vector laboratories, Burlingame, CA), followed by incubation with cy3-streptavidin 
(1:50 in 10% goat serum) for 30 minutes at room temperature. The sections were subjected to 
incubation with Cy5-conjugated Sambucus Nigra Lectin (SNA, EBL) (10g/mL; Vector 
laboratories, Burlingame, CA) for 2 hours at room temperature then counterstained with DAPI 
(4′,6′-diamidino-2-phenylindole; Thermo Scientific, Rockford, IL). The sections were washed 
three times of 5 minutes with PBST (PBS with 0.05% TWEEN 20) after every steps of antibody 
incubation. The slides were air dried and covered with coverslips by using Prolong antifade 
reagent. Pictures were captured with the Leica SP8 LCS diode confocal microscope (Leica 




To examine the variations in virus shedding and tissue tropism of subtype H7 avian IAVs 
in chicken and mallard, 56 3-week old chicken and 56 3-week old mallards were included in this 
study. The 1-day-old chicken and 1-day-old mallards were purchased from Murray McMurray 
Hatchery (Webster City, IA) and housed before the experiments. Before the experiment, all birds 
were confirmed to be seronegative using HI assays against the epidemic human seasonal IAVs 
[A/California/04/2009 (H1N1), A/Switzerland/9715293/2013 (H3N2), and A/Hong 
Kong/4801/2014 (H3N2)] and the testing avian IAV [Mallard/2010 (H7N3)]. 
 
74 
The chicken or mallard experiments, 32 birds were used in the treatment group and 24 in 
the negative control group. Each bird in the treatment groups was inoculated with an inoculum 
containing 106 TCID50 (in a volume of 0.1 mL) of Mallard/2010 (H7N3) by administrating the 
drops into eyes and nostrils of the birds. Each negative control bird was inoculated with PBS. 
The clinical signs for the birds were monitoring twice a day until the end of this experiment. 
Oropharyngeal and cloacal swab specimens were collected at 0, 1, 3, 5, 7, 9, 11, 14 and 21 dpi, 
and blood at 0, 14, 21 dpi. At 1, 3, 5, 7, 9, 11, 14, 21-day post inoculation, four birds in each 
treatment group and three in each control group were euthanized, and the tissues cross both 
respiratory tracts and gastrointestinal tracts were collected, including trachea-upper, trachea-
middle, trachea-distal, duodenum, jejunum, ileum, colon, caeca, cloaca. One set of the tissues 
were collected for virological analyses, and the other set was fixed in 10% formalin for 
histological analyses.  
 
Distribution of SLex in wild bird population 
To understand the distribution of SLex across wild bird species, tissue sections from 
trachea (trachea-upper, trachea-middle, trachea-distal) and gastrointestinal tracts (duodenum, 
jejunum, ileum, colon, caeca, cloaca) from six bird species, including sea duck (n=1), gadwall 
(GADW) (n=1), green-wing teal (GWTE) (n=1), wood duck (WODU) (n=2) and northern 
shoveler (NOSH) (n=1) were kindly offered by our collaborate from U.S. department of 
agriculture. The tissues were fixed and prepared for immunofluorescent staining as mentioned 
above. Deparaffinization and heat-induced target retrieved with diluted Target Retrieval 
Solution, Citrate pH 6.1 (10x) following the manufacturer’s manual (Dako, Carpinteria, CA) 
have been performed before incubation with the Alexa Fluor 488 anti-human Sialyl Lewis X 
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(dimeric) antibody (1:100; BioLegend, San Diego, CA) overnight at 4°C. As control, we also 
applied SAα2,3Gal staining at sea ducks and wood ducks as describe above. At the end, the 
sections were counterstained with DAPI, air dried and covered with coverslips by using Prolong 
antifade reagent. Pictures were captured with the Leica SP8 LCS diode confocal microscope 
(Leica Microsystems Inc, Buffalo Grove, IL). Results presented in the study are based on three 
independent experimental repeats with similar results.  
 
Biosafety and animal handling 
Laboratory and animal experiments were conducted under BSL-2 conditions in 
compliance with protocols approved by the Institutional Animal Care and Use Committee of 
Mississippi State University (IACUC 17-719). 
 
Statistical analyses  
The influence of species and days post inoculation on oral and cloacal shedding were 
analyzed using generalized linear mixed models (GLIMMIX). Results of shedding were log 
transformed and fitted to a GLIMMIX using a gaussian distribution. Denominator degrees of 
freedom were calculated using the Kenward-Roger option, and day post inoculation was a 
repeated measure and modeled with an autoregressive covariance structure. The 
GROUP=species option was used to account for different covariance in the shedding between 
species. Residual plots demonstrated an approximately normal distribution, least square means 
(LSM) were calculated and back transformed for comparison. A priori comparisons were 
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planned between species at each timepoint and between contiguous timepoints within each 
specie. No adjustment was made for LSM multiple comparisons.  
The same approach was used to model effects of species, days post inoculation, and 
tissue location on log transformed viral loads in tissues obtained at necropsy.  Subject within 
species was considered a random effect to account for within subject clustering. A priori 
comparisons were planned between species for each of the 9 tissues. No adjustment was made 
for the 9 LSM multiple comparisons. Residual plots demonstrated an approximately normal 
distribution, LSM were calculated and back transformed for comparison. 
HI titer measures obtained at days 0, 14, and 21 were log transformed and modelled as a 
function of time and species using Proc Mixed. Because measurement intervals differed in 
length, a spatial power covariance structure for the longitudinal time effect was chosen, and the 
GROUP option was used to allow for different variance between species in the random effect. 
LSM were calculated and compared. 
To investigate the relationship of viral load and presence of glycan type (SLex or 
SA2,6Gal) in different tissues, a GLIMMIX was employed, using log transformed viral load as 
the outcome. Tissues were aggregated into 4 anatomic regions (Upper Respiratory Tract, Lower 
respiratory tract, upper GI tract and lower GI tract). Denominator degrees of freedom were 
calculated using the Kenward-Roger option. Day post inoculation, specie, region, glycan SLex, 
glycan SA2,6Gal and 2- way interactions were tested. Tissue samples within subject were 
clustered and accounted for through a random statement with compound symmetry. Residual 




P-values of 0.05 were considered significant, and 95% confidence limits were calculated 
in all analyses.  
 
Results 
Subtype H7 avian IAVs bound to both avian-like and human-like receptors but prefer to 
fucosylated avian-like receptor 
To determine the binding avidities of H7 IAVs to SLex, we performed bio-layer 
interferometry glycan binding analyses for a total of 11 avian H7 IAVs, including one isolate 
from human and each other from domestic duck, mallard, American black duck (ABDU), ring-
necked duck (RNDK), BWTE, American green-winged teal (AGWT), NOSH, Bufflehead 
(BUFF), mute swan (MUSW), and NOPI. As a comparison, two glycan analogs, 3’SLN and 
6’SLN, were also included. Results showed that all virus isolates showed varying binding 
avidities to SLex, 3’SLN, and 6’SLN (Figure 9).  
To further differentiate the binding avidities of H7 IAVs among three glycan analogs, we 
quantified and compared the 50% relative sugar loading concentration (RSL0.5) at half the 
fractional saturation (f = 0.5) for three representative H7 viruses against each glycan analog. The 
higher value of the RSL0.5 indicates the weaker of the binding avidity. Results showed that 
Turkey/2002 has an RSL0.5 of 0.238 (± 0.005 standard deviation [SD]) for 3ʹSLN, 0.612 (± 
0.046) for 6’SLN, 0.117 (± 0.004) for SLex; Mallard/2010 has a RSL0.5 of 0.070 (± 0.003) for 
3’SLN, 0.429 (± 0.008) for 6’SLN, 0.0177 (± 0.0002) for SLex; and SH2 has an RSL0.5 of 0.218 
(± 0.004) for 3’SLN, 0.236 (± 0.009) for 6’SLN, and 0.080 (± 0.002) for SLex. The negative 
control, Ca/04, a 2009 H1N1 virus, shown binding signals to only 6’SLN but to neither SLex nor 
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3’SLN (data not showed). Overall, quantitative analyses showed the H7 IAVs had the lowest 
RSL0.5 to SLex compared to 3’SLN, and the highest RSL0.5 to 6’SLN (Figure 10). 
In summary, bio-layer interferometry glycan binding analyses showed that avian H7 






Figure 9 Glycan binding specificity of H7 influenza A viruses  
Glycan binding specificity of H7 influenza A viruses to biotinylated α2,6–linked sialic acid 
(6’SLN, white bars), α2,3–linked sialic acid (3’SLN, black bars) and SLex glycan (white bars 
filled with dots) analogs as determined by Bio-Layer Interferometry (Pall ForteBio LLC, 
Fremont, CA). Streptavidin-coated biosensors were immobilized with biotinylated glycans at a 
concentration of 0.3-0.5 µg/mL, and a virus load of 100 pM was used in binding analyses. x axis 
showed different viruses in the test, the y axis is the endpoint binding values (response) to the 
glycan analogs, which represents the higher binding signals detected. Virus abbreviations: 
Duck/2010: A/American black duck/Delaware/A00870108/2010 (H7N3), Mallard/2010: 
A/mallard/New Jersey/A00926089/2010 (H7N3), Teal/2010: A/blue-winged 
teal/Taxes/A00463679/2010(H7N3), Duck/2008: A/domestic duck/West 
Virginia/A00140913/2008 (H7N3), Teal/2009: A/American green-winged 
teal/Utah/A00654391/2009 (H7N3), Shoveler/2009: A/northern shoveler/Utah/A00468766/2009 
(H7N3), Buff/2008: A/bufflehead/Virginia/A00120022/2008 (H7N2), Swan/2008: A/mute 
swan/Rhode Island/A00325125/2008 (H7N3), Pintail/2009: A/northern 
pintail/Texas/A00466052/2009 (H7N3), SH2: A/Shanghai/2/2013 (H7N9) (HA,NA)×PR8 






Figure 10 Characteristic of receptor binding property of H7 viruses 
Glycan binding specificity of three subtype H7 IAVs A) Turkey/2002 (H7N2), B) Mallard/2010 
(H7N3), C) SH2 (H7N9) to biotinylated α2,3-linked sialic acid (3’SLN, square) , α2,6-linked 
sialic acid (6’SLN, triangle) , and SLex (circle) glycan analogs as determined by biolayer 
interferometry using an Octet RED instrument (Pall FortéBio, Fremont, CA). Streptavidin-coated 
biosensors were immobilized with biotinylated glycans at different levels. Sugar loading-
dependent binding signals were captured in the association step and normalized to the same 
background. Binding curves were fitted by using the saturation binding method in GraphPad 
Prism 8 (https://www.graphpad.com/scientific-software/prism/). Horizontal dashed line indicates 
half of the fractional saturation (f = 0.5); vertical dashed line indicates relative sugar loading 
(RSL0.5) at f = 0.5; the higher the RSL0.5 indicated the lower binding avidity. The RSL0.5 and SD 
were calculated by the fitting model in the software. The name of virus tested is listed on top of 
each figure. The structures of glycan analogs tested are shown at the right bottom. The 
A/California/04/09 (H1N1) (Ca/04) was used as negative controls for SLex and 3’SLN (data not 
showed). 
Distribution of SLex glycan in the respiratory and gastrointestinal tract tissues in wild 
birds and domestic poultry 
To evaluate whether the SLex glycan could be present differently across different tissues 
and different bird species, by using SLex specific monoclonal antibody, we performed 
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immunofluorescence staining on three sections of respiratory tracts (i.e. trachea-upper, trachea-
middle and trachea-distal and six sections of intestines tracts (i.e. duodenum, jejunum, ileum, 
colon, caeca and cloaca). We categorized the glycan receptor abundance by three groups:  none 
or limited staining (-), moderate and sporadic staining (+), and strong staining (++) (Table 8, 9). 
In this study, we focused on chicken (n=3) and six wild bird species, including mallard (n=3), 
sea duck (n=1), GADW (n=1), GWTE (n=1), WODU (n=2) and NOSH (n=1). The glycan score 
listed  among the six testing wild bird species, mallard, GADW, GWTE, and NOSH are common 
species detected with H7 infections (Munster et al. 2007; Krauss et al. 2015) whereas H7 IAVs 
were rarely recovered from sea duck and WODU (Table 10).  
Results showed that distinct patterns of SLex among the testing avian species and even 
among the tissue sections from the same avian species (Table 9). Specifically, in mallard, SLex 
was mainly expressed on the ciliated epithelial cells of trachea-middle (Figure 11), trachea-distal 
but with limited signals in trachea-upper. In GI tract of mallard, SLex was strongly showed on 
the epithelium of cloaca (Figure 13) and no detectable signals in the other five gastrointestinal 
tissues [i.e. duodenum, jejunum, ileum, colon (Figure 12), and caeca. In chicken, SLex was 
detected also on the ciliated epithelial cells across three sections of trachea (Figure 11), colon 
(Figure 12) and cloaca (Figure 13) but not in four other sections of GI tissues (i.e. duodenum, 
jejunum, ileum, and caeca). The cell types expressed SLex are also different among GI tract. 
SLex primary is expressed in muscularis layer in colon while cloaca express SLex in crypts cells.  
In sea ducks and wood duck, there is no detectable signals of SLex whereas strong expressions 
were found in trachea (upper, middle, distal) of gadwall, green-wing teal and northern shoveler. 
We can also find SLex in caeca of northern shoveler (Table 9). As controls, we also found strong 








SA2,3Gal SA2,6Gal SLex 
Chicken Mallard Chicken Mallard Chicken Mallard 
Trachea-
upper 
+ + + - ++ - 
Trachea-
middle 
++ ++ - - ++ ++ 
Trachea-distal ++ ++ - - ++ ++ 
Duodenum ++ ++ + + - - 
Jejunum ++ ++ + - - - 
Ileum ++ ++ ++ - - - 
Caecum ++ ++ + + - - 
Colon ++ ++ ++ - + - 
Cloaca ++ ++ - - + + 
a, the staining score was graded as mild (+), strong (++) and negative (-). The results are 




Table 9 Summary of SLex distribution among tissues in wild bird populationsb 
 Mallard NOSH GADW GWTE WODU Sea duck 
Trachea-
upper 
- ++ ++ + - - 
Trachea-
middle 
++ ++ ++ + - - 
Trachea-
distal 
++ ++ ++ + - - 
Duodenum - - - - - - 
Jejunum - - - - - - 
Ileum - - - - - - 
Colon - - - - - - 
Caeca - - - - - - 
Cloaca + - - - - - 




Table 10 H7 distributed in bird species 




Species Isolate numbers Percentage 
Mallard 458 19.32% 
Chicken 1352 57.05% 
Quail 31 1.31 % 
Turkey 324 13.67 % 
Wood duck 0 0 % 
Sea duck 9 0.38% 
Green-winged teal 71 3.00 % 
Blue-winged teal 125 5.27 % 




Figure 11 Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in trachea of chicken and 
mallard 
 
Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal 
(magenta), SAα2,6Gal (green) in trachea-middle of chicken (upper panel) and mallard (bottom 
panel).  Nuclei were stained with DAPI (blue). The scale bars are located at the right bottom of 








Figure 12 Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in colon of chicken and 
mallard 
Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal 
(magenta), SAα2,6Gal (green) in colon of chicken (upper panel) and mallard (bottom panel).  






Figure 13 Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in cloaca of chicken and 
mallard 
 
Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal 
(magenta), SAα2,6Gal (green) in cloaca of chicken (upper panel) and mallard (bottom panel).  
Nuclei were stained with DAPI (blue). The scale bars are located at the right bottom of each 
picture.  
On the other hand, our results demonstrated that SA2,3Gal are widely distributed in 
chickens and mallards (Figures 11, 12 and 13). For both species, SA2,3Gal is found in lamina 
propria and submucosa layer of the trachea, as well as in crypts and submucosa layers of GI 
tract. In the cloaca of mallard, SA2,3Gal is also found in the epithelium where express SLex as 
well. In contrast, although SA2,6Gal were also detected in all nine tissue sections for both 
mallard and chicken, only the signals of SA2,6Gal in duodenum were strong in the two species, 
as similar to SA2,3Gal, and those of SA2,6Gal in other eight tissue sections are much weaker 
than those for SA2,3Gal.  Similar to SA2,3Gal, SA2,6Gal is found in lamina propria and 
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submucosa layer of the trachea as well as in epithelial cells, and in crypts and submucosa layers 
of GI tract. 
In summary, distribution of SLex was distinctly distributed across the same tissue section 
from different avian species and from different tissue sections from the same avian species 
whereas such patterns were less apparent for SA2,3Gal and SA2,6Gal. Of particular interest, 
SLex was detected neither in trachea nor in gastrointestinal tissues of wood duck and sea duck, 
both of which were rarely detected with H7 infection.  
 
A mallard origin H7 IAV infected both mallard and chicken but shed more viruses in 
mallards than in chickens 
To determine the impacts of glycan distribution on the tissue and host tropisms of H7 
avian IAVs, we infected chicken and mallard with Mallard/2010 (H7N3) to determine the viral 
shedding patterns and the viral loads across different tissues. Results showed that mallards had a 
peak titer of 5.87 log10 copies/ml with higher titers than chicken with a peak titer of 4.48 log10 
copies/ml of oral shedding at 1 dpi. As for cloacal shedding, mallards had a peak titer of 6.47 
log10 copies/ml at 3 dpi higher than chicken with a peak titer of 4.81 log10 copies/ml at 7 dpi. 
Chickens and mallards have the same time span of oral shedding from 1 to 7 dpi, whereas 
mallards (1-9 dpi) have longer shedding time than chicken (3-9 dpi) did. 
To compare the shedding patterns of Mallard/2010 (H7N3) chicken and mallard, we 
fitted the oral and cloacal shedding data into a GLIMMIX (P=0.0145) with repeated measure, 
respectively. Type 3 tests of fixed effects indicated species (P<0.0001) and time (P<0.0001) 
affect the oral shedding significantly. Comparing oral swabs (Figure 14A), mallards have 
significantly higher oral shedding viral titers than chicken at 1 dpi [(4.48: 5.86; P<0.001); 
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expressed as (log10 (viral copy numbers) of chicken swabs: log10 (viral copy numbers) of 
mallard swabs; P values)], 3 dpi (4.50: 5.87; P<0.0001), 5 dpi (4.15: 4.71; P=0.0019), 
respectively, and have no significant difference at 7 dpi (3.79: 4.00; P=0.2757), 9 dpi (all 
collected samples are under the detect of limit). As for the cloacal swabs (Figure 14B), type 3 
tests of fixed effects indicated species (P< 0.0014) and time (P<0.0001) affect the cloacal 
shedding significantly. Mallards have significant higher cloacal shedding than chicken at 1 dpi 
(3.65: 4.18; P=0.0196), 3 dpi (4.47: 6.47; P<0.0001), 5 dpi (4.60: 6.00; P<0.0001), respectively, 
and they have no significant difference at 7 dpi (4.81: 4.51; P= 0.5244), 9 dpi (4.30: 4.16; P= 
0.5876), 11 dpi (all collected samples are lower the limit of detection), respectively. Besides, we 
found that mallards have a longer shedding time through cloacal (1 to 9 dpi) than through oral 
shedding (1 to 7 dpi) (Figure 14D), whereas chicken have oral shedding (1 to 7 dpi) and cloacal 
shedding (3 to 9 dpi) (Figure 14C). In summary, the viral shedding in mallards is higher than 
chicken in both oral and cloacal swabs. 
    In addition, we compared viral loads in the oral swabs and those in the cloacal swabs 
for chicken (Figure 14C) or mallards (Figure 14D) by using student’s t test. In chicken, cloacal 
shedding is significantly higher than oral shedding at 7 (P=0.0003), 9 dpi (P=0.0124), 
respectively. In mallard, whereas cloacal shedding is significantly higher than oral shedding at 3 
(P=0.0031), 5 (P<0.0001),7 (P=0.0196), and 9 dpi (P=0.0068), oral shedding is significantly 
higher than cloacal shedding at 1 dpi (P<0.0001).   
Serological data (HI) showed that both mallards and chickens seroconverted after 
infection. At 21 dpi, infected mallards had HI titers ranging from 20 to 80 whereas infected 
chickens had a range from 20 to 640 (Table 11). The HI results were fitted in a mixed model 
(P=0.0002) for repeated measure. Type 3 tests of fixed effects indicated species (P=0.0192) and 
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time (P=0.0001) significantly affect seroconversion of the infection. The geometric mean titer 
(GMT) for mallards was 33.64 at 21 dpi whereas GMT for chickens were 160 at 21 dpi.  
 
 
Figure 14 Viral shedding of chicken and mallards of H7 IAV infection. 
Mean titers of IAVs were detected by qRT-PCR from oral (in pink) and cloacal swabs (in blue) 
of infected chicken (shown as circles) and mallards (shown as triangles) in the challenge study. 
Birds were inoculated with 106 TCID50/mL of Mallard/2010 (H7N3). Swabs were collected 
every other day during the infection course. Mean titers of IAVs from oral of infected birds (A) 
and cloacal swabs of infected birds (B) are to compare the shedding patterns between chicken 
(left side within each dash line group in A, B; as in color circles) and mallards (right side within 
each dash line group in A, B; as in color triangles). Mean titers of IAVs from swabs of infected 
chicken (C) and mallards (D) are to compare the shedding patterns between oral and cloacal 
swabs within the same species. Statistical results comparison within each dash line group shown 
as: no * as not significant different (P>0.05); P<0.05 as *; P<0.01 as **; P<0.001 as *** and 
P<0.0001 as ****. 
 







































































Table 11 HI titer of infected birdsb. 
Species ID 
Days post-inoculation 





49 <10 <10 20 
50 <10 40 160 
170 <10 40 640 
171 <10 160 320 
78 <10 320 NA 
47 <10 1280 NA 
163 <10 40 NA 





128 <10 40 40 
129 <10 80 80 
130 <10 40 20 
131 <10 20 20 
110 <10 40 NA 
117 <10 20 NA 
119 <10 80 NA 
127 <10 40 NA 
b NA, not available due to sacrifice for pathogenicity study. 
 
The viral loads in mallard respiratory and gastrointestinal tissues are tissue and host 
dependent 
To compare the viral loads across tissues in the same host and between mallard and 
chicken, we quantified the viral copy numbers in tissues using one-step qRT-PCR. Results 
showed that, in mallard, with a peak titer on 3 dpi of 7.06 (±1.31) log10 copies/g, as well as in 
chicken, with a peak titer on 5 dpi of 6.05 (±1.30) log10 copies/g, decreased in trachea as the 
viral loads increased in intestinal tracts during the course of viral infection.  
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To determine the factors affecting viral loads across tissues of chicken and mallard, the 
results were fitted into a GLIMMIX (P<0.0001). Type 3 tests of fixed effects indicated that 
species (P=0.0009), tissues (P<0.0001) and dpi (P<0.0001) have significant impacts in viral 
loads from tissues.  By comparing the average viral loads of all collected samples on each day, a 
peak viral load at 3 dpi of 7.06 ±1.31 log10 copies/g for mallards, while a peak of 6.05 ±1.30 
log10 copies/g for chicken at 5 dpi. For mallard at 3 dpi which had the highest average viral 
loads, we found the highest viral loads in ileum and colon with the average titers of 8.88 ±1.19 
log10 copies/g and 8.74 ±0.37 log10 copies/g, respectively. The lowest viral loads were found in 
duodenum (5.74 ± 0.67 log10 copies/g) and jejunum (5.88 ± 1.01 log10 copies/g), which were 
significantly different from ileum and colon viral loads, respectively (P<0.0001). Although the 
highest viral loads presented in different tissues during infection, we found that the duodenum 
and jejunum always had the low viral loads compared to other tissues, which are 4.19 ± 0.13 
log10 copies/g and 5.13 ± 2.14 log10 copies/g on 5 dpi, respectively, and under the limit of 
detection on 7 dpi. There are limited or no viral loads detected on 1 and 11 dpi tissues for both 
chickens and mallards. 
However, infections in chicken showed a different story. At 5 dpi which had the highest 
average viral loads for chickens, we found comparative viral loads in the last sections of the 
intestinal tracts including ileum (7.44 ± 0.99 log10 copies/g), caeca (6.49 ± 1.01 log10 copies/g), 
colon (6.72 ± 1.30 log10 copies/g), cloaca (6.97 ± 1.45 log10 copies/g). As similar found in 
mallard, the duodenum and jejunum had low replication efficiency in chicken, which showed 
titers of 4.53 ± 0.49 log10 copies/g and 4.70 ± 0.69 log10 copies/g at 3dpi, 5.32 ± 1.49 log10 
copies/g and 5.93 ± 1.26 log10 copies/g on 5dpi, respectively (Figure 15). 
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To further determine the viral load patterns in chickens or mallards, the least-square 
means were obtained and systematically compared. Overall, mallard have significantly higher 
viral loads than chicken in caeca (P=0.0010), cloacal (P=0.0005), colon (P<0.0001), upper 
trachea (P=0.0175) but no significant differences for duodenum (P=0.7096), jejunum 
(P=0.8911), lower trachea (P=0.1284), middle trachea (P=0.1639) comparing the LSM. For 
chicken, the significant differences were found at 5 and 9 dpi. As of for mallards, the significant 
differences were found on 3, 5, 7, 9 dpi. For both species, we found that the H7 virus favors 
growing in the lower gas gastrointestinal tract (LGI, e.g. ileum, caeca, colon, cloaca) than trachea 
and upper GI tracts (UGI, e.g. duodenum, jejunum) of both species (Tables 12, 13, 14).  
 
Figure 15 Viral loads in tissues of H7 infection 
Viral loads of 3 dpi (A), 5 dpi (B) in tissues of infected chicken (black bars) and mallard (white 
bars) was showed. The y axis is the log10 (viral copies number)/ gram of tissues, the x axis is the 















































































































Duodenum Jejunum Ileum Caeca Colon Cloaca 
P=0.0175 NS NS NS NS NS P=0.0010 P<0.0001 P=0.0005 
NS indicated the statistical differences are not significant. 
 
Table 13  Viral load differences among the tissues from chickens 
dpi         Higher 
titer 
Ileum Caeca Colon Cloaca 
5 
Trachea-upper 0.0012 NS NS NS 
Trachea-middle 0.0002 NS NS 0.022 
Trachea-distal <0.0001 NS 0.0429 0.0046 
Duodenum 0.0008 NS NS NS 
9 
Trachea-upper NS <0.0001 NS NS 
Trachea-middle NS 0.002 NS NS 
Trachea-distal NS 0.0007 NS NS 
Duodenum NS 0.0110 NS NS 
The values in table indicated the P values calculated by the statistical analysis used in the method 





Table 14 Viral load differences among the tissues from mallards 
dpi 
          Higher titer 
Ileum Caeca Colon Cloaca 
3 
Trachea-upper 0.0006 NS 0.0023 NS 
Trachea-middle 0.0003 NS 0.0010 NS 
Trachea-distal 0.0001 NS 0.0004 NS 
Duodenum <0.0001 NS <0.0001 0.0309 
Jejunum <0.0001 NS <0.0001 NS 
5 
Trachea-upper <0.0001 0.0002 0.0002 NS 
Trachea-middle <0.0001 <0.0001 <0.0001 0.0002 
Trachea-distal <0.0001 <0.0001 <0.0001 <0.0001 
Duodenum NS <0.0001 <0.0001 <0.0001 
Jejunum <0.0001 <0.0001 <0.0001 0.0005 
7 
Duodenum NS NS NS 0.0124 
Jejunum NS NS NS 0.0124 
9 
Trachea-upper 0.0001 NS NS NS 
Trachea-middle 0.0001 NS NS NS 
Trachea-distal 0.0001 NS NS NS 
Duodenum 0.0001 NS NS NS 
Jejunum 0.0017 NS NS NS 
The values in table indicated the P values calculated by the statistical analysis used in the method 





The viral loads in respiratory and gastrointestinal tissues are associated with the 
distribution of SLex in chicken and mallards 
To correlate the distribution of receptors and viral loads in the counterpart tissues, we 
fitted the viral loads of tissues into a mixed model with species as random effect, and the least 
squares means were obtained for each glycan level and compared. To fit the glycan levels into 
the model, we graded glycan levels by 0 (absent) or 1 (present).  The results indicated that 
SA2,6Gal did not contribute effects on viral loads [LSM (1): LSM (0)= 4.93: 5.11; P=0.1352) 
while the distribution of SLex showed decreasing association with tissue viral loads [(LSM (1): 
LSM (0)= 4.87: 5.16;P=0.0084).  
Discussion 
In this study, to understand how H7 avian IAVs transmit from wild birds to domestic 
poultry and how avian IAVs infect differently among wild birds, we investigated the role of 
SLex in tissue and host tropisms of H7 IAVs across both domestic and wild bird species. Our 
results showed that H7 IAVs have stronger binding avidities to SLex than both SA2,3Gal and 
SA2,6Gal, and that, among the birds we analyzed, SLex was detected only in those bird species 
commonly reported with H7 infection. 
In our study, the tested H7 IAVs bind much stronger to SLex than 3’SLN, which is to 
some extent agree with prior study that H7 IAVs have comparable binding avidity to SLex and 
3’SLN (Gambaryan et al. 2012). Molecular model of H7 HA-glycan complex showed that there 
is no steric clashes from amino acid 222 for the fucosylated receptors or their nonfucosylated 
counterparts (Gambaryan et al. 2012). Unlike H7, majority subtypes of avian IAVs, such as H1, 
H2, H3, H4, H5, H9, H11, H12 and H14, showed varying binding avidity to SLex with 
consistent 5-20 times weaker binding avidities to SLex than to 3’SLN, which is explained by the 
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molecular model of the HA-glycan complex that fucose moiety located relatively close to the 
amino acid 222, changes in the HA structure in this region could lead to steric interference 
(Gambaryan, Yamnikova, et al. 2005). For example, subtype H5 which has also caused HP 
outbreaks in poultry and fatal human infections especially the HP H5 of novel clade 2.3.4.4 
(Shen et al. 2016; Saito et al. 2015; Ip et al. 2015), which has acquired the binding avidity to 
SLex compare to its ancestral clade 2.3.4 H5 proteins (Guo et al. 2017). The ability of LP IAVs 
binding to SLex has been speculated a poultry-specific adaptation although extensive studies on 
sufficient numbers of isolates across different HA subtypes are lacking (Gambaryan, 
Yamnikova, et al. 2005; Gambaryan et al. 2006; Hiono et al. 2014; Hiono et al. 2016). These 
findings implied that H7 IAVs have higher risks in poultry compare to many other HA subtypes 
of IAVs.  
Molecular epidemiological analyses showed that chickens and mallards are important 
avian species for avian IAVs (Krauss et al. 2004; Olsen et al. 2006; Verhagen et al. 2017) (Table 
10). We found that SLex was present in trachea and cloaca of both chickens and mallards as well 
as colon of chicken. Others found a similar distribution of SLex (Wen et al. 2018; Hiono et al. 
2014). In addition to the chicken and mallard, we also found that the SLex expressed lining in 
the epithelial cells of trachea of H7 susceptible wild bird species [i.e. GADW (trachea), GWTE 
(trachea), NOSH (trachea, caeca)] whereas sea duck and WODU, which have rare H7 isolations 
(Table 10), has no SLex detected but widely expressed SA2,3Gal in their trachea and GI tract, 
which are consistent with prior findings (Franca, Stallknecht, and Howerth 2013). Others had 
identified the expression of SLex in other poultry such as turkey, pheasant, guinea fowl and 
pigeon (Guo et al. 2017). Prior study showed that chicken and ducks could infect IAVs by both 
respiratory or alimentary routes of exposure (Pantin-Jackwood et al. 2013), however, they were 
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more susceptible to the infection by low infectious viral doses when exposed by intranasal as 
compared to alimentary routes of inoculation (Kwon and Swayne 2010). These findings 
suggested that SLex expressed in these bird species especially in trachea facilitates the H7 IAVs 
attachment for initial infection. Further, we performed a challenge study by inoculating a 
mallard-origin virus, which prefer binding to SLex over SAα2,3Gal, in chickens and mallards. 
Previous studies showed that chickens were rarely infected directly with viruses isolated from 
ducks, even though most influenza viruses isolated from chickens recognize SAα2,3Gal, 
similarly to the viruses of duck origin (Kishida et al. 2004; Matrosovich et al. 1997). One study 
found similar results that when inoculated in chickens with a duck H5 IAV that prefers 
SAα2,3Gal than SLex, no virus could be recovered from tissues or swabs (Hiono et al. 2014). In 
our study, evidences of HI, viral shedding and viral titers of tissues confirmed that chicken is 
susceptible to and successfully infected by the mallard origin H7 IAV. These evidences 
supported that virus with high binding avidity to SLex and the presence of SLex in trachea 
facilitate the H7 infections from duck to chicken.  
Although chicken is susceptible to the mallard origin H7 IAV, the virus replicated better 
in mallards than in chickens for both shedding and tissue viral loads. Similar shedding results 
have been reported that when wild bird origin-IAV infected mallards and chickens, mallards had 
higher shedding titer, longer shedding time span and higher percentage of shedding animal 
numbers than in chicken (Spackman et al. 2007; Spackman et al. 2010). The facts that mallards 
shed high virus in cloacal swabs during infection confirmed that its importance as IAVs 
reservoir. Plus, we found the virus prefer cloacal shedding in both species during the late 
infection period. Similar results were showed that the LP avian IAVs from wild birds are 
typically shed primarily through cloaca (Webster et al. 1978; Costa et al. 2011). However, when 
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these viruses adapted into gallinaceous poultry, they changed to shed a much higher level in the 
respiratory tract (Spackman et al. 2010; Pantin-Jackwood et al. 2014; Pantin-Jackwood et al. 
2016; Claes et al. 2013; Marche et al. 2012). Prior study showed that intranasal or intracloacal 
infection of IAVs have similar oral shedding patterns (Pantin-Jackwood et al. 2013). Of interest, 
we found that chickens have higher average oral shedding at 1 and 3 dpi as well as mallards at 1 
dpi compare to cloacal shedding. These may correlate to the strong expression of SLex in the 
epithelial cells in all sections of trachea (upper, middle and distal) of chickens whereas SLex 
expressed in epithelial cells of the middle- and distal- trachea but not in the upper-trachea of 
mallards. However, the overall shedding patterns of higher in mallards suggested that host 
factors were involved. 
One study showed that LP IAVs had low viral titers present in duodenum compare to the 
lower tract in ducks (small intestines close to the caecal end or rectum) (Webster et al. 1978). 
Previous study showed that in the LP IAV infected mallard tissues, there is no antigen-positive 
staining in duodenum/jejunum, but in ileum, ceca and colon (Franca et al. 2012), which indicated 
duodenum/jejunum have lower replication than others. Prior studies showed that the tropism and 
pathogenicity of IAVs infecting human are associated with the distribution of SA2,3Gal and 
SA2,6Gal in human airways (Zeng et al. 2013; Kumlin et al. 2008), however, whether the virus 
receptor binding properties affect avian IAVs tissue tropism in wild birds and poultry are still not 
clear. In this study, our results showed viral loads in tissues reveals that the virus prefers 
replicating in lower GI tract (i.e. ileum, caecum, colon and cloaca) for both chickens and 
mallards and much less viral load in upper GI tract (i.e. duodenum and jejunum).  On the other 
hand, although with abundance of SA2,3Gal and SLex in respiratory tract, the viral loads in 
trachea are relatively less by comparing to those in lower GI tract tissues in both species, and our 
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statistical analysis showed that the viral loads in tissues are not significantly related to neither the 
distribution of SA2,3Gal nor SA2,6Gal, but showed a negative association with SLex expression 
of chickens and mallards. However, the viral roads we determined in this study may not reflect 
the virus in a specific tissue, and thus interpretation of tissue tropism by directly correlating total 
viral loads with glycan concentration needs to be careful, and quantitative analyses of tissue 
specific viral replication would be needed. Nerveless, in order to confirm virus replication was 
present in tissues, we performed immunochemistry staining for nuclear protein of influenza with 
one pair of infected birds from 3 dpi. We did identify positive staining in distal-trachea, caeca, 
colon of chicken as well as jejunum and ileum of mallards although data are only qualitative 
rather than quantitative (Appendix A). Of note, in addition to glycan receptor, other tissue 
specific host factors could also contribute to variations in virus replication in various tissues.  
This study suggested there are variations in SLex expression across the tested wild bird 
species, supporting a large extent of variations of IAVs associated glycan receptor distributions 
in avian species, which have been reported in various domestic poultry (Guo et al. 2017). Prior 
studies showed that the subtype of H7 distributions in wild birds varied by time and by 
epidemiological factors of wild bird species (e.g. avian species, age, and pre-existing immunity) 
(Kaleta, Hergarten, and Yilmaz 2005; Olsen et al. 2006; Krauss et al. 2015; Latorre-Margalef et 
al. 2017). Understanding host factors such as glycan receptor distribution could help identify 
specific species for avian influenza surveillance and increase the effectiveness of avian IAVs 
surveillance, especially for establishment of avian IAVs alert program targeting risky subtypes 
such as H7.  
In conclusion, we have identified subtype H7 avian IAVs favor SLex than 3’SLN, in 
addition, the presence of SLex in susceptible poultry of H7 indicated that SLex plays a role in 
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determining host tropism. The systematic characterization of SLex expression in wild bird 
species is needed and surveillance tactics of avian H7 should be optimized to collect both oral 




THE ROLE OF NEU5GC AS RECEPTOR FOR AVAIN IAVS 
 
It is well accepted that a species barrier from avian to human for influenza A viruses 
(IAVs) is the terminal sialic acids linkage to galactose, which either is α2,3-linkage for avian or 
α2,6-linkage for human viruses. Another potential factor that determines host specificity is the 
modification of sialic acid. The hosts of IAVs can express the species-dependent sialic acids, one 
important of which is modified with N-glycolyl (Neu5Gc) instead of the dominant modification 
of N-acetyl (Neu5Ac) at C-5. Prior studies have demonstrated that Neu5Gc can serve as a 
receptor for IAVs and shown strict species-specificity in mammals. However, the role Neu5Gc 
plays in avian IAVs remains unknown. We have performed the hemagglutination assay, glycan 
array, biolayer interference assay to evaluate H7 avian IAVs in binding specificity to Neu5Gc 
and Neu5Ac, which suggested that isolates from North America wild birds could bind both 
Neu5Gc and Neu5Ac with variations while the H7 IAVs from chickens in China exclusively 
bind Neu5Ac. Further, we detected the NeuGc expression in the tissues of chickens and mallards 
by immunofluorescent staining assay, and known that mallards express Neu5Gc in intestinal 
tracts but not in chicken. These results suggested that H7 avian IAVs have a binding diversity to 





In addition to humans, influenza A viruses (IAVs) have been isolated from variety of 
animal species, such as avian, swine, equine, canine, marine mammals (e.g. seals and whale), 
mink, and feline. Low-pathogenic (LP) IAVs have been isolated from at least 105 wild bird 
species across 26 different families, of which waterfowl and shorebirds are thought to be the 
natural reservoir, especially Anseriformes (e.g. ducks, geese, and swans) and Charadriiformes 
(e.g. gulls, terns, and waders) (Webster 1992). In influenza surveillance of migratory waterfowl, 
IAVs were more frequently recovered from dabbling ducks [e.g. as mallards (Anas 
platyrhynchos)] than from others (Olsen et al. 2006).  
The genome of IAVs consists of eight gene segments of negative-stranded RNA which 
encode for at least 11 proteins. IAVs are classified based of two of these proteins budding on the 
surface of virions; the hemagglutinin (HA) and neuraminidase (NA) glycoproteins (Webster 
1992). To date, in wildfowl and poultry, there are 16 HA and 9 NA antigenic subtypes that have 
been detected (Röhm et al. 1996; Fouchier et al. 2005a), which can be found in numerous 
combinations. 
Among all subtypes of avian IAVs, subtype H7 virus has one of the primary subtypes 
causing disease burdens in domestic poultry and threats to public health. LP H7 avian IAVs can 
mutate to high pathogenic (HP) after being introduced into domestic poultry, such as chickens or 
turkeys (Richard et al. 2017), and HP H7 avian IAV typically emerged after a precursor LP H7 
virus was detected first in domestic poultry. In the past decades,  HP H7 viruses have caused a 
number of outbreaks in domestic poultry (Selleck et al. 2003; Hirst et al. 2004; Fouchier et al. 
2004b; Berhane et al. 2009; Lopez-Martinez et al. 2013; Lee et al. 2017)  and resulted in 
devastating large economic losses to poultry industry (Lee et al. 2017; Mannelli, Ferrè, and 
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Marangon 2006; Mulatti et al. 2007). Most of these H7 viruses were eliminated after being 
introduced into domestic poultry by depopulating the infected birds followed by biosafety 
management. However, H7 viruses introduced into domestic poultry can remain enzootic, such 
as those reported in Italy (H7N7) (Bonfanti et al. 2014) (Mulatti et al. 2017) , Mexico (H7N3) 
(FAO 2012) , and China (H7N9) (Fan et al. 2014).  
The LP H7N9 avian IAVs emerging in China since 2013 have been detected primarily in 
chickens and less frequently in domestic ducks, pigeons and quails (Chen et al. 2013; Wang et al. 
2013; Pantin-Jackwood et al. 2014; Millman et al. 2015). This LP H7N9 virus was mutated to 
HP during the fifth epidemic wave (October 2016 to September 2017) when an insertion 
occurred introducing the multi-basic amino acids at the LP HA cleavage site (LP form, 
PEIPKG/GLF; HP form, PEVPKRKRTAR/GLF) (Zhang et al. 2017) (Ke et al. 2017) (Chen et 
al. 2017). HP H7N9 IAVs caused number of outbreaks in poultry (FAO 2019) 
(http://www.fao.org).  
In addition to those in domestic poultry, these H7 avian IAVs caused a number of 
reported human infections, including H7N2 (Ostrowsky et al. 2012), H7N3 (Tweed et al. 2004), 
H7N7 (Koopmans et al. 2004; Fouchier et al. 2004a; Belser et al. 2009), most recently, H7N9 
(Gao et al. 2013). Of these H7 IAVs, H7N9 caused 1,568 confirmed human cases, 616 of which 
were fatal (as of Dec 4th, 2019), and H7N9 has become one of the targets in the influenza 
pandemic preparedness by the World Health Organization (WHO 2017). Majority of H7 
spillover cases were associated with the direct contacts with the domestic poultry infected with 
H7 avian IAVs (Dudley and Mackay 2013; Kurtz, Manvell, and Banks 1996; Fouchier et al. 
2004b; Koopmans et al. 2004; Tweed et al. 2004; Lopez-Martinez et al. 2013). Thus, 
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understanding how subtype H7 avian IAVs are transmitted from wild birds to domestic poultry 
will be a key to influenza risk assessment and pandemic preparedness.  
Surveillance studies suggested that the prevalence of subtype H7 IAVs in wild birds are 
not universally distributed across wild bird species (Krauss et al. 2004; Munster et al. 2007; 
Olsen et al. 2006; Krauss et al. 2015). For instance, one long-term surveillance of IAVs in 
migratory ducks in Alberta, Canada, from 1976 to 2012 and in shorebirds and gulls at Delaware 
Bay, United States, from 1985 to 2012 showed that H7 IAVs were more likely to be isolated in 
shorebirds and gulls (6.18%) rather than in ducks (1.11%) (Krauss et al. 2015). A 12-year 
surveillance study of avian IAVs in eastern Germany from 1977 to 1989 showed as of individual 
species, H7N7 seems to be one of the primary subtypes detected in various duck species: H2N3 
(20.8%, recovery rate) and H4N6 (20.3%) in wild ducks, H7N7 (22.3%), H4N6 (24.4%) and 
H2N3 (10.4%) in Pekin ducks, and H6N1 (34.8%) and H6N6 (15.1%) in domestic ducks (Suss et 
al. 1994). These data suggested that there would be species barriers when H7 avian species 
transmitted from one wild bird species to another and from wild birds to domestic poultry. It is 
important to understand the molecular mechanism affecting how H7 avian IAVs cross over to 
various avian species, especially from wild birds to domestic poultry.  
Neu5Ac and Neu5Gc are the two common forms of sialic acids (Sias).  Neu5Gc is 
created by the hydroxylation of the Neu5Ac moiety, and it has been reported that the 
hydroxylase generated by cytidine monophosphate (CMP)-N-acetyl neuraminic acid hydroxylase 
(CMAH) is required. In some mammals, such as dogs, ferrets, seals, lack the function of CMAH, 
thus express Neu5Ac instead of Neu5Gc (Wen et al. 2018; Ng et al. 2014; Peri et al. 2018); 
Others, such as cows, horses and pigs, have been reported to predominately express Neu5Gc 
(Pettersson et al. 1958; Naiki 1971; Wen et al. 2018; Song et al. 2010). There is a low incidence 
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of Neu5Gc in birds and reptiles and it is absent in the platypus in tested tissues (liver/ muscle/ 
ovomucin/ eggs) (Schauer, Srinivasan, Coddeville, Zanetta, and Guérardel 2009). In avian 
species, Neu5Gc was reported in duck intestine, mainly on the crypt epithelial cells of duck 
colon (Ito et al. 2000); in the chicken, histological immunostaining could not detect Neu5Gc in 
the trachea (Suzuki et al. 2000), and such results were supported by the analyses by high-
performance liquid chromatography, and mass spectrometry analysis of chicken tissues that 
indicated that chickens did not synthesize Neu5Gc and that limited amount of Neu5Gc detected 
in eggs may come from the diet (Schauer, Srinivasan, Coddeville, Zanetta, and Guerardel 2009). 
However, there is a lack of systematic analyses of Neu5Gc and Neu5Ac in respiratory and 
gastrointestinal tracts of avian species, especially those in wild birds. 
Prior studies suggested that both Neu5Ac and Neu5Gc could serve as receptors for IAVs 
infection (Higa, Rogers, and Paulson 1985b; Takahashi et al. 2014a), though little knowledge 
about Neu5Gc receptor has been reported. Broszeit, Tzarum et al. reported that Neu5Gc is 
suggested to be a functional receptor for IAVs infection because the NA from 
A/Vietnam/1203/04 (H5N1), A/CA/04/09 (H1N1),  A/Shanghai/2/13 (H7N9) was able to cleave 
Neu5Gc, albeit with lower enzymatic activity compare to Neu5Ac. Besides, equine H7 and H5 
HA mutant Y161A showed binding exclusively to Neu5Gc and only bound to the Neu5Gc-rich 
horse trachea  but not the Neu5Ac-rich canine trachea and revealed strict species specificity by 
Neu5Gc (Broszeit et al. 2019). We previously found that A(H3N8) canine IAV increased 
binding to GLex (Neu5Gcα2-3Galβ1-4[Fucα1-3]GlcNAcβ), which could have facilitated the 
adaptation of the equine-origin A(H3N8) virus to dogs (Wen et al. 2018). Knowledge of Neu5Gc 
in avian IAVs is lacking. In birds, six duck origin IAVs were shown to bind to the α2,3-linked 
Neu5Gc whereas the human viruses [e.g. A/Udorn/307/72 (H3N2)] bound only to α2,3-linked 
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Neu5Ac; in addition, a reassortant virus with HA from A/Udorn/307/72 (H3N2) but NA and 
other six genes from A/mallard/New York/ 6750/78 (H2N2) did not replicate in the duck 
intestine where Neu5Gc is expressed (Ito et al. 2000). These results suggested that Neu5Gc could 
serve an important role in the species barrier of IAVs. Avian IAVs had a large variation in 
binding avidities to Neu5Gc and Neu5Ac (Ito 2000), however, the role of Neu5Gc and Neu5Ac 
in avian host tropisms, especially in influenza transmission at the interface of wild birds and 
domestic poultry is unclear. 
In this study, we hypothesized that avian H7 IAVs in wild birds can bind to both Neu5Gc 
and Neu5Ac, and that those viruses with binding avidities to Neu5Ac are more likely to infect 
domestic poultry.  To test these hypotheses, we characterized Neu5Gc and Neu5Ac binding 
avidities using hemagglutination assays, glycan microarray, and biolayer interferometry assays. 
The HA variation determining binding specificity to Neu5Gc were identified and validated. In 
addition, the distribution of Neu5Gc in chicken, a common species of domestic poultry, and 
mallard, a common species of wild birds, was determined with immunofluorescent staining.  
 
Materials and methods 
Data, molecular and phylogenetic analyses 
A total of 3,387 unique H7 sequences of IAVs were obtained on July 22nd 2020 from the 
Influenza Research Database (www.fludb.org) and GISAID EPIFLU™ database 
(https://www.gisaid.org). Multiple sequence alignments were generated using Muscle v3.8.31 
(Edgar 2004). The phylogenetic tree for each gene segment was inferred by using a maximum-
likelihood method by running RAxML v8.2.9 and by using a Gamma model of rate 
heterogeneity and a generalized time–reversible substitution model (Stamatakis 2014) with 1,000 
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bootstraps. Phylogenetic trees were visualized by using FigTree v1.4.3 
(http://tree.bio.ed.ac.uk/software/figtree/).  
 
Viruses, virus propagation and purification 
The influenza viruses were propagated in 9-day-old specific pathogen free embryonated eggs 
at 37 °C for 72 hours, and the allantoic fluids were collected and stored at -80°C until use.  
Viruses used in the study were listed in Table 15. The viruses included 1) 5 H7N9 from 1-5 
waves in human outbreaks in China and 2) contemporary H7 viruses circulating in wild birds and 






Figure 16 Phylogenetic analyses of subtype H7 IAVs of hemagglutinin (HA) protein. 
The phylogenetic tree was inferred by using a maximum-likelihood method by running RAxML 
v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized time–reversible 
substitution model (Stamatakis 2014). The bootstrap values were labeled for the two selected 
representative branches with bootstrap values. Phylogenetic trees were visualized by using 
FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/).  Scale bars represent amino acids 
substitutions per site. The green dots (the five at top of the tree are H7N9 from China) indicated 
viruses selected for glycan array analysis. Clades in red indicated isolates from Asia, clades in 
brown are equine H7N7, clades in blue are from North America.  
 
 
Viruses were purified by sucrose gradient ultracentrifuge for BLI and glycan array purpose. 
In brief, allantoic fluids were centrifuge by 4,000 × g for 30 minutes to remove cell debris after 
harvesting from eggs. The remaining cellular debris were removed by ultracentrifugation at 4 °C 
for 30 minutes at 18,000 × g, then the virions were pelleted by ultracentrifugation at 4 °C for 90 
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minutes at 112,000 × g.  The virus was pelleted after sucrose gradient ultracentrifugation with 
four layers (30%, 40%, 50% and 60%) and stored at -80°C until use. 
Table 15 Viruses used in this study. 
Virus* Abbreviation Type# 
Experiments$ 
Array BLI HA 
A/chicken/Wuxi/0405005/2013 (H7N9) (HA) PR8 (H7N1) rg-CK/WX RG Y Y Y 
A/chicken/Dongguan/3418/2013(H7N9) (HA)  PR8 (H7N1) rg-CK/3418 RG Y  Y 
A/chicken/Wenzhou/RAQL01/2015(H7N9) (HA)  PR8 (H7N1) rg-CK/QL01 RG Y  Y 
A/chicken/Wenzhou/HATSLG01/2015(H7N9) (HA)  PR8 (H7N1) rg-CK/2015 RG Y  Y 
A/chicken/Heinan/ZZ01/2017(H7N9)(HA mutated to low path)  PR8 (H7N1) rg-CK/2017 RG Y  Y 
A/mallard/Netherlands/12/2000(H7N7) (HA)  PR8-IBCDC-1 (H7N1) rg-Md/12 RG Y   
A/mallard/New Jersey/A00926089/2010 (H7N3) Md/2010 WT Y   
A/domestic duck/West Virginia/A00140913/2008 (H7N3) Dk/2008 WT Y   
A/mute swan/Rhode Island/A00325125/2008 (H7N3) MS/5125 WT Y   
A/mute swan/Rhode Island/A00325125/2008 (HA)  PR8 (H7N1) rg-MS/5125 RG  Y  
A/Chicken/CA/1002/2000(H6N2)     Y 
A/Chicken/CA/B18/2005(H6N2)     Y 
A/mute swan/Rhode Island/A00325117/2008 (H7N3)     Y 
A/mute swan/Rhode Island/A00325114/2008 (H7N3)     Y 
A/mute swan/Rhode Island/A00325125/2008 (H7N3)     Y 
A/mute swan/Rhode Island/A00325105/2008 (H7N3)     Y 
A/mallard/Iowa/A00558620/2008 (H7N3)     Y 
A/mallard/Wisconsin/A00465618/2008 (H7N3)     Y 
A/mallard/Kansas/A00523306/2008 (H7N3)     Y 
A/mallard/South Dakota/A00649542/2008 (H7N3)     Y 
 
111 
Table 15 (continued) 
A/mallard/Oklahoma/A00749161/2009 (H7N3)     Y 
A/mallard/Nebraska/A00709657/2009 (H7N3)     Y 
A/mallard/Oklahoma/A00744383/2009 (H7N3)     Y 
A/mallard/New York/A00723400/2009 (H7N4)     Y 
A/mallard/Michigan/A00869519/2009 (H7N3)     Y 
*, PR8: A/Puerto Rico/8/1934 (H1N1). #, RG: reverse genetic virus, WT: wild type virus. $, Y: 
used in experiments. 
Hemagglutination assays  
Hemagglutination were performed by using 0.5% turkey RBC or 1% horse RBC as 
described in the Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza 
by the WHO Global Influenza Surveillance Network (WHO 2011). 
 
RNA extraction, PCR, qRT-PCR, and sequencing 
Viral RNA was extracted from the allantoic fluid of SPF embryonated chicken eggs with 
GeneJET Viral DNA/RNA purification kit (Thermo Fisher Scientific, Waltham, MA). The RNA 
was subjected to cDNA synthesis by using the SuperScriptTM III Reverse Transcriptase (Thermo 
Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. PCR products of 
full length HA were generated with IAVs specific primers (Hoffmann et al. 2001). The PCR 
products were confirmed without additional mutations by using Sanger sequencing. 
 
Gene synthesis, molecular cloning and virus rescue 




A/chicken/Wenzhou/HATSLG01/2015(H7N9), A/chicken/Heinan/ZZ01/2017(H7N9) (in which 
the PEVPKRKRTAR/GLFGA cleavage sites were mutated to PEIPKGR/GLFGA to remove 
multiple basic cleavage sites), were synthesized, and cloned into the pHW2000 vector by Gene 
Universal Inc.( Newark, DE). HA of A/mallard/New Jersey/A00926089/2010 (H7N3), 
A/domestic duck/West Virginia/A00140913/2008 (H7N3), A/mute swan/Rhode 
Island/A00325125/2008 (H7N3) were cloned into pHW2000 vector by using a universal primer 
described elsewhere (Hoffmann et al. 2001).  
7+1 reassortants viruses were rescued by including a HA gene from above H7 viruses and 
seven other gene segments from A/Puerto Rico/8/1934 (H1N1) (PR8) by using reverse genetics 
(Hoffmann et al. 2000)  (Table 15). The nucleotide sequences of the HA gene in each rescued 
virus was confirmed with unexpected mutations by using Sanger sequencing.  
 
Glycan microarray and data analyses 
The 83 N-glycans (41) were printed on N-hydroxysuccinimide (NHS)-derivatized slides 
as described previously (42). All glycans were printed in replicates of six in a subarray, and 
sixteen subarrays were printed on each slide. All glycans were prepared at a concentration of 100 
pM in phosphate buffer (100 mM sodium phosphate buffer [pH 8.5]). The slides were fitted with 
a sixteen-chamber adapter to separate the subarray into individual wells for assay. Before the 
assay, slides were rehydrated for 5 minutes in TSMW buffer (20 mM Tris-HCl, 150 mM NaCl, 2 
mM CaCl2, and 2 mM MgCl2, 0.05% Tween, pH 7.4). A 15 μl aliquot of 1.0 M sodium 
bicarbonate (pH 9.0) was added to 150 μl of purified virus, and the virus was incubated with 25 
μg of Alexa Fluor 488 NHS Ester (succinimidyl ester; Invitrogen) for 1 hour at 25°C. After 
overnight dialysis to remove excess Alexa 488, the virus HA titer was checked and then bound to 
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the glycan array. Labeled viruses were incubated on the slide at 4°C for 1 hour, washed, and 
centrifuged briefly before being scanned with an InnoScan 1100 AL fluorescence imager 
(Innopsys, Carbonne, France). Mean relative fluorescent units (RFU) and standard deviation 
were calculated for six replicates per virus. A threshold of 500 RFU was set to determine as 
background.  
BLI receptor binding assay 
The receptor binding avidity of viruses was determined by the BLI assay with an Octet 
RED instrument (Pall ForteBio, Menlo Park, CA). Biotinylated glycan analogs (listed in Table 
16) of 6’SLN was obtained from Lectinity Holdings (Moscow, Russia), and 3’GLN, 3’SLN, 
GLex, and SLex were synthesized and kindly provided by Dr. Lei Li from Georgia State 
University. The glycans were preloaded onto streptavidin-coated biosensors at up to 0.3 µg/ml 
for 5 minutes in 1 × kinetic buffer (Pall FortéBio, Menlo Park, CA, USA). Each test virus was 
diluted to a final concentration of 100 pM with 1 × kinetic buffer containing 10 µM oseltamivir 
carboxylate (American Radiolabeled Chemicals, St. Louis, MO) and zanamivir (Sigma-Aldrich, 
St. Louis, MO) to prevent cleavage of the receptor analogs by NA proteins of virus. Association 
was measured for 30 minutes at 25°C as described elsewhere (Guan et al. 2019). Responses were 
normalized by the highest value obtained during the experiment, and binding curves were fitted 
by using the binding-saturation method in GraphPad Prism 8 
(https://www.graphpad.com/scientific-software/prism/). The normalized response curves report 
the fractional saturation (f) of the sensor surface as described in a elsewhere (Xiong, Martin, et 
al. 2013). The RSL0.5 and SD were calculated by the software as mentioned above. RSL0.5 was 
used to quantitate the binding avidity of two selected viruses against two glycan analogs. The 
higher the RSL0.5, the weaker the binding avidity.  
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Table 16 Biotinylated glycan analogs used in BLI assay and their structure sequences. 







Distribution of the Neu5Gc receptor in respiratory tracts and intestines of chicken and 
mallard  
Tissues were prepared for histopathology and immunofluorescence staining. Briefly, 
collected tissues were fixed by submersion in 10% neutral buffered formalin and embedded in 
paraffin. Sections were made at 5 μm. The sections were deparaffinized by dipping into the 
following solutions: 2 times of 10 minutes xylene, 3 minutes of the following solutions: 1:1 
xylene:100% ethanol, 2 times of 100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol, rinse in 
ddH2O. Heat-induced target retrieved with diluted Target Retrieval Solution, Citrate pH 6.1 
(10x) following the manufacturer’s manual (Dako, Carpinteria, CA) was performed. The sections 
were blocked by 3% BSA for 1 hour at room temperature then washed three times with PBST 
(PBS with 0.05% Tween 20). Diluted purified anti-Neu5Gc antibody was incubated with slides 
for 2 hours at room temperature. All sections were washed three times each with PBST and PBS; 
the slides were then counterstained with DAPI (4′,6′-diamidino-2-phenylindole; Thermo 
Scientific, Rockford, IL) for 5 minutes. The slides were air dried and covered with coverslips by 
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using Prolong antifade reagent. Pictures were captured with the Leica SP8 LCS diode confocal 
microscope (Leica Microsystems Inc, Buffalo Grove, IL).  
 
Site-directed mutagenesis  
To validate the mutations being responsible for glycan binding, we generated H7 mutants 
to validate receptor binding by using site-directed mutagenesis and reverse genetics. Specifically, 
Phusion™ Site-Directed Mutagenesis Kit (Thermo Scientific, Rockford, IL) was used to create 
specific mutations in the plasmid of HA from A/chicken/Wuxi/0405005/2013(H7N9) in 
pHW2000 vector by using primers listed in Table 17. In brief, primers were treated with T4 
Polynucleotide Kinase (Thermo Scientific, Rockford, IL) for 5' phosphorylation following the 
manufacturer’s manual before PCR amplification.  The site-directed mutagenesis PCR 
amplification mixture contains: 23.5μl of water, 10μl of 5× Phusion HF buffer, 1μl of dNTPs 
(10mM), 5μl of each T4 Polynucleotide Kinase treated primer (5μM),  0.5μl of Phusion hot start 
DNA polymerase (2U/μl), 5μl of HA plasmid of A/chicken/Wuxi/0405005/2013 (1ng/μl). The 
parameters of the site-directed mutagenesis PCR were as follows: one cycle at 98°C for 30 
seconds, followed by 24 cycles at 98°C for 10 seconds, 69°C for 30 seconds, and 72°C for 2 
minutes then incubate at 72°C for 5 minutes. The PCR products were digested with 1μl of 
FastDigest DpnI at 37 °C for 15 minutes. The ligation reaction was performed at room 
temperature for 5 minutes after the digestion. Ligation mixture contained 2μl of PCR products, 
2μl of 5×rapid ligation buffer, 5.5μl of water, 0.5μl of T4 DNA ligase. The ligation products 
(5μl) were transformed into DH10B Competent Cells (Thermo Scientific, Rockford, IL) 
following the manufacturer’s protocol. The plasmids were then extracted with GeneJET Plasmid 
Miniprep Kit (Thermo Scientific, Rockford, IL), and the mutant viruses were rescued by 
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plasmid-based reverse genetics methods, as described above. The HA gene of each rescued virus 




Table 17 Primers for site-directed mutagenesis. 
A122N-F 5'-cagagaatcaggcggaattgacaaggaaaatatgggattcacatacagtg-3' 

























H7 viruses showed variations in hemagglutination activities to horse RBCs 
To examine variations of avian IAVs in binding Neu5Gc, we performed 
hemagglutination assays for a total of 42 viruses including 8 from northern shoveler, 4 from 
mute swan, 9 from mallard, 4 from blue winged teal, 9 from American green winged teal and 8 
from chicken by using horse RBCs which express primarily Neu5Gc, and turkey RBCs which 
express primarily Neu5Ac (Gentsch and Pacitti 1987; Ustinov et al. 2017; Jankowski et al. 
2019). Results showed that all viruses showed different binding avidities to turkey RBCs, and 
that 40 of 42 testing viruses showed high binding avidities to horse RBCs whereas two H6N2 
chicken IAVs did not bind to horse RBCs.  
To understand the variations of IAV binding avidities between horse and turkey RBCs, 
we compared the hemagglutination activities for each tested strain with the same amount of 
virus. HA titers dropped from turkey RBCs to horse RBCs indicated the reduced binding 
avidities to Neu5Gc. Of particular interest, chicken origin IAVs had the highest differences, with 
an average 8.72-fold loss, in hemagglutination activities by using horse RBCs. The losses vary 
greatly among the avian IAVs of wild bird origin, e.g. mallard (2.51-folds), mute swan (2-folds), 
blue winged teal (2.83-folds), American green winged teal (3.43-folds), and northern shoveler 





Figure 17 Hemagglutination with different RBCs. 
Hemagglutination with chicken (left), mute swan (middle), and mallard isolates (right) using 




Table 18 HA using different species IAVs 
Species of viruses Numbers of viruses Mean fold changes (Turkey/horse) 
Chicken 8 8.72 
American green winged teal 9 3.43 
Blue winged teal 4 2.83 
Mallard 9 2.51 
Mute swan 4 2.00 
Northern shoveler 8 3.08 
 
H7 avian IAVs in wild birds showed large variations in receptor binding avidities to 
Neu5Gc but those detected in domestic poultry exclusively bind to Neu5Ac  
To characterize the receptor binding diversity of H7 avian IAVs to Neu5Ac/Neu5Gc, we 
performed glycan arrays for four H7 IAVs from waterfowl and five from chicken. Results 
showed that all of the nine avian IAVs bind to α2,3 linked-Sias (glycan 1-28) with diverse mean 
binding signals ranging as low as 524.5 to a highest mean RFU of 29,255.25. The binding signal 
can vary from 0 to 65,536, and a binding signal of 500 was treated as negative in this study. On 
the other hand, the H7 IAVs did not bind (mean RFU<500) to non-Sias glycans (glycan 52-75, 
black rectangle of Figure 18) or glycans with the α2,6 linked-Neu5Gc (glycan 36-41) but can 
bind 5 glycans with the α2,6 linked-Neu5Ac (glycan 31-35).  
Further, we found that Sias types affect the binding pattern of these viruses even with the 
same inner structures, which is that chicken viruses bind exclusively to Neu5Ac but not to 
Neu5Gc. More specifically, rg-CK/WX binds to α2,3 linked-Neu5Ac with mean RFU from 
524.75 to 9723.25 (glycan 1-17, purple rectangle in Figure 18, e.g. glycan 1) but not to α2,3 
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linked-Neu5Gc (RFU<500, blue rectangle of Figure 18, e.g. glycan 18) (Figure 18A). Similar 
findings were identified with the other four chicken viruses. Rg-CK/3418 has the mean RFU 
from 617.5 to 14421.25 to α2,3 linked-Neu5Ac but not to α2,3 linked-Neu5Gc [except very low 
binding signals to two glycans: glycan 19 (RFU= 574.5) and glycan 21 (RFU= 614.75)] (Figure 
18B). Rg-CK/QL01 has the mean RFU from 558 to 16732.75 to α2,3 linked-Neu5Ac but no 
binding to α2,3 linked-Neu5Gc (RFU < 500) (Figure 18C). Rg-CK/2015 has the mean RFU from 
700.25 to 4310.75 to α2,3 linked-Neu5Ac and no binding to α2,3 linked-Neu5Gc (RFU<500) 
(Figure 18D). Rg-CK/2017 has a mean RFU from 1365 to 12807.5 with α2,3 linked-Neu5Ac and 
no binding to α2,3 linked-Neu5Gc (RFU<500) [except a low RFU of 524.5 to glycan 19] (Figure 
18E).    
Of interest, we found that waterfowl origin viruses can bind to both Neu5Gc and 
Neu5Ac. The rg-Md/12 has both binding signals to α2,3 linked-Neu5Ac (RFU from 784.5 to 
7739.5) and α2,3 linked-Neu5Gc (RFU from 784.5 to 7539.5) (Figure 18F). Similarly, the other 
three wild bird viruses: Md/2010 (Figure 18G), Dk/2008 (Figure 18H), and MS/5125 (Figure 
18I) bind to both α2,3 linked-Neu5Ac (RFU from 852 to 8942.5 for Md/2010, 610.75 to 7658.75 
for Dk/2008, 584 to 8210.5 for MS/5125, respectively) and α2,3 linked-Neu5Gc glycans (RFU 
from 639.5 to 18930.75 for Md/2010, 971.25 to 24643 for Dk/2008, 864 to 29255.25 for 
MS/5125, respectively). In addition, the binding avidities to Neu5Gc glycans vary among the 
wild bird origin viruses. For instance, the mallard virus (rg-Md/12, Md/2010) had a lower 
average RFU (2315.11) compared to Dk/2008 (4859.39) and MS/5125 (5372.39).  
Further, we looked into the substructures of the glycans in the array and picked four pairs 
of similar glycans as an example to show the pattern described above and detailed in the analysis 
(Table 19). The difference of these four pairs of glycans (pairs of glycan No. 1 vs No. 2, No. 8 vs 
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No. 9, No. 18 vs No. 19, No. 25 vs No. 26) are different Sias types (i.e. Neu5Ac, Neu5Gc). First 
of all, we found that all the tested viruses bound strongly to SLex (glycan 2, 8) whereas only 
waterfowl origin viruses bound both GLex (glycan 19, 25) and SLex.  
In summary, we found that chicken origin H7 viruses did not have or largely reduced the 
binding ability to Neu5Gc) and that some viruses from waterfowl origin viruses can bind both 






Figure 18 N-glycan microarray binding profiles of H7 IAVs. 
A) rg-CK/WX, B) rg-CK/3418, C) rg-CK/QL01, D) rg-CK/2015, E) rg-CK/2017, F) rg-Md/12, 
G) Md/2010, H) Dk/2008, I) MS/5125. The data (y axis) is the mean relative fluorescent units ± 
the standard deviations (vertical bars). The x axis represents the glycan number corresponding to 
the array. Glycans include in purple rectangle contain the terminal structure of Neu5Ac(2-3)Gal 
(glycan 1 to 17); glycans include in blue rectangle contain the terminal structure of Neu5Gc(2-
3)Gal (glycan 18 to 28); glycans include in orange rectangle contain the terminal structure of 
Neu5Ac(2-8)Neu5Ac (glycan 29, 30, 48, 49), 2,6-linked sialic acid (glycan 31 to 47), glycans 
contain other modification of sialic acid (glycan 50, 51), glycans include in black rectangle are 










waterfowl IAVs chicken IAVs 












1 6066 2946.5 2647.75 2989 8465 14421.25 5226.25 2046.75 5913.75 




2 7539.5 4282.75 7658.75 4416.25 9723.25 3329.25 2260.25 1430.75 4582 
8 6663 8942.5 1001.75 8210.5 2864.75 5324.25 12241.25 1201.75 14561 
3GLN 
(Neu5Gc, SLex-) 
18 2987.75 639.5 5446.5 3564.5 <500 <500 <500 <500 <500 




19 3039.5 7173.25 2633 9973.5 <500 574.5 <500 <500 524.5 
25 1859.5 18930.75 24643 29255.25 <500 <500 <500 <500 <500 
 
Avian H7 receptor binding specificity analysis to Neu5Gc by the BLI assay confirmed 
isolates from chicken, unlike wild bird stains, only bind to Neu5Ac but not Neu5Gc  
To confirm the variations of H7 avian IAVs in binding to Neu5Ac and Neu5Gc as 
observed in glycan array analyses, we used BLI assays to perform quantitative analyses on a set 
of glycan analogs (Table 16). Rg-CK/WX,  which exclusively bind to NeuAc (Figure 18A), and 
rg-MS/5125, which binds both Neu5Ac and Neu5Gc (Figure 18I) were selected for the analyses; 
to eliminate the potential effects of NA, both testing strains had HA from wild type virus, NA 
and other six genes from PR8.  Specifically, 100pM of the viruses were tested against seven 
concentrations of glycan loads (0-0.5μg/ml) for 30 minutes at 25°C. We quantified and 
compared the 50% relative sugar loading (RSL) concentration (RSL0.5) at half the fractional 
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saturation (f = 0.5) of virus against glycan analogs. The higher the RSL0.5, the smaller the 
binding avidity.  
Results showed that rg-CK/WX binds strongly to Neu5Ac glycans [i.e., SLex (RSL0.5= 
0.2230), 3’SLN (RSL0.5=0.2440), and 6’SLN (RSL0.5=0.2643)] but not to Neu5Gc glycans (i.e., 
3’GLN and GLex). In contract, rg-MS/5125 binds to all of the tested glycan analogs with a slight 
decrease in the binding avidities to Neu5Gc: the RSL0.5 was 0.02126 for SLex, 0.07831 for 
GLex, 0.0499 for 3’GLN, 0.02152 for 3’SLN, and 0.3530 for 6’SLN (Figure 19).   
In summary, these results confirmed that chicken origin rg-CK/WX has a high binding 
avidity to Neu5Ac but not to Neu5Gc whereas mute swan origin rg-MS/5125 showed a strong 
binding avidity to both Neu5Ac and Neu5Gc. Also, both rg-CK/WX and rg-MS/5125 bound to 
SLex stronger than 3’SLN. 
 
 
Figure 19 Glycan binding specificity of two subtype H7 IAVs. 
Glycan binding specificity of (A) rg-MS5125 and (B) rg-CK/WX to glycan analogs (Table 16) as 
determined by BLI using an Octet RED instrument (Pall FortéBio, Fremont, CA, USA). 
Streptavidin-coated biosensors were immobilized with biotinylated glycans at different levels. 
Sugar loading–dependent binding signals were captured in the association step and normalized to 
the same background. Binding curves were fitted by using the saturation binding method in 
GraphPad Prism 8 (https://www.graphpad.com/scientific-software/prism/).  





















































Distribution of N-Glycolylneuraminic acid in chicken and mallard 
We performed the immunofluorescent staining for respiratory tract (trachea-upper, 
trachea-middle and trachea-distal) and intestinal tract (duodenum, jejunum, ileum, colon, caeca 
and cloaca) from chicken and mallard for expression of the Neu5Gc glycan. In tissues from 
chicken, we detected no fluorescent signals but found slight to fine signals in mallard intestinal 
tracts. We found fine Neu5Gc expression in colon and cloacal, and less signals in ileum and 
caeca of mallards (Table 20, Figure 20).   






Trachea-upper - - 
Trachea-middle - - 
Trachea-distal - - 
Duodenum - - 
Jejunum - + 
Ileum - + 
Caecum - + 
Colon - ++ 
Cloaca - ++ 




Figure 20 Neu5Gc expression in chicken and mallard. 
Immunofluorescence staining of Neu5Gc was performed to test the distribution of Neu5Gc 
(magenta) in the cloaca and colon of chicken (upper panel) and mallard (bottom panel).  Nuclei 
were stained with DAPI (blue). The scale bars are 75 m located at the right bottom of each 
picture. The white arrows indicated staining signals. 
 
Multiple amino acid changes of CK/WX could acquire binding ability to Neu5Gc 
The binding specificity of Neu5Gc with the CK/WX mutants showed that multiple amino 
acid changes (mutated from chicken to waterfowl [S174E, V179I], and from chicken to equine 
[S128T, I130V, A135E, A159G, A160V, R172K, K173R, K193R], H3 numbering) can regain 
binding ability to Neu5Gc but not reduce the binding avidities to Neu5Ac (Figure 21). Of 
interests, results showed that 10 of 11 mutations (except A122N) facilitated the mutant to regain 




Figure 21 Binding specificity to Neu5Gc of CK/WX mutants. 
Rescued viruses of CK/WX mutants were used to perform BLI with glycans analogs (3’SLN is 
present as black bars, 3’GLN is present as white bars, SLex is present as deep grey bars, Glex is 
present as grey bars, and 6’SLN is present as light yellow bars). Y axis is response value of the 
binding while x axis represents different mutants. Mutations include those mutated from chicken 
to waterfowl [S174E, V179I] and those mutated from chicken to equine [S128T, I130V, A135E, 
A159G, A160V, R172K, K173R, K193R].  
Discussion 
In this study, to understand how H7 avian IAVs transmit from wild birds to domestic 
poultry, we investigated the role of Neu5Gc binding with H7 IAVs. We found that chicken 
viruses have greatly lost the hemagglutination ability to Neu5Gc-rich horse RBCs compared to 
other waterfowl species (mallard, mute swan, blue winged teal, American green winged teal, and 
northern shoveler). Our results showed that chicken H7 IAVs have exclusive binding specificity 
to Neu5Ac whereas some waterfowl origin H7 viruses maintain binding to both Neu5Ac and 
Neu5Gc. These results suggested that some viruses from wild birds are more likely to be 
transmitted to chicken or that they can lose binding ability when being adapted to chickens since 
chickens did not have Neu5Gc.  
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We profiled the binding specificity of avian IAVs from different species to Neu5Gc by 
comparing the ability of agglutinating horse RBCs to turkey RBCs which have been reported to 
express a large amount of Neu5Gc (horse) and Neu5Ac (turkey), respectively (Gentsch and 
Pacitti 1987; Ustinov et al. 2017; Jankowski et al. 2019). The results indicated that binding 
specificity to Neu5Gc is species related, as chicken isolates obviously have a most loss of HA 
titer to these two RBCs compared to viruses from other wild bird species. Although horse RBCs 
were used to validate virus binding specificity to Neu5Gc (Broszeit et al. 2019), the detailed 
glycan structures present in the RBCs are not well characterized.  
In order to characterize the receptor binding properties of these viruses in more details, a 
glycan array contains isoform with different types of Sias (i.e. Neu5Ac and Neu5Gc). Glycan 
array results of selected H7 IAVs reveal that the H7 chicken isolates bound exclusively to 
Neu5Ac while wild bird isolates bound both Neu5Ac and Neu5Gc, which has been consistent 
with what we observed in the HA test. To confirm this pattern, we found from the glycan array 
as well as to quantify the binding avidity by a detail BLI binding assay with a rg-CK/WX and a 
rg-MS/5125 as representative viruses from chicken and wild bird isolates, respectively. The BLI 
applied the reverse genetic viruses with the same backbone (except HA) to exclude the possible 
effects of other proteins. The result confirmed that the H7 chicken virus we tested does not bind 
to 3GLN nor GLex but binds by the wild bird virus, as was identified from the glycan array. 
Similar binding results have been reported for duck viruses of H1, H3 and H11 which recognized 
both Sias through α2,3 linkage (Neu5Gcα2,3Gal and Neu5Acα2,3Gal), though prefer to 
NeuAcα2,3Gal in most cases (Ito 2000). A separate study found that duck and gull IAVs from 
different subtypes including H1, H2, H3, H4, H5, H6, H9, H11, H12, H13, H14 bound both 
Neu5Gcα2,3Gal and Neu5Acα2,3Gal, of which the binding avidity of these viruses was stronger 
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to Neu5Gcα2,3Gal (Gambaryan, Yamnikova, et al. 2005). However, studies about the binding 
ability of chicken virus to Neu5Gc are extremely rare (Gambaryan et al. 2012; Gambaryan, 
Yamnikova, et al. 2005), which showed chicken viruses have no/very weak binding avidity to  
3GLN. These finding suggested that viruses from chicken do not favor Neu5Gc receptors. 
Chickens have no detectable Neu5Gc expression whereas the mallard showed fine signals 
in the intestinal tract by immunofluorescent staining. Neu5Gc was detected in duck intestine, 
mainly on the crypt epithelial cells of duck colon (Ito et al. 2000), which is consistent with our 
results. On the other hand, histological immunostaining could not detect Neu5Gc in chicken 
trachea (Suzuki et al. 2000). These studies to some extent agree with our results of Neu5Gc 
expression in chickens and mallards. In addition, directed-mutagenesis from rg-CK/WX to wild 
bird stain suggested that it could gain its binding ability to Neu5Gc by mutation. It is possible 
that these chicken viruses with no binding ability to Neu5Gc are well adapted in chicken because 
there is no Neu5Gc expressed in chicken.  
In addition, we found that viruses from waterfowl bound strongly to SLex from both 
glycan array and BLI results, and SLex is expressed in the chicken trachea as previous described 
in chapter III, which also supported that SLex in chicken trachea may facilitate H7 virus 
infections from waterfowl. Taken together, the results of the receptor binding specificity to 
Neu5Gc and SLex of chicken and waterfowl viruses and the presence of these glycan motifs in 
chickens and mallards,  it is likely that the glycan substructure facilitated the introduction of 
waterfowl origin H7 viruses into the chicken, and that the introduced viruses gradually lost the 
binding ability to Neu5Gc but remain the binding ability to Neu5Ac and SLex, both of which are 
highly expressed in the upper and lower respiratory tracts of domestic poultry such as chickens. 
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Taken together, our results showed that H7 IAVs from wild bird bind to both Neu5Ac and 
Nue5Gc. Thus, we speculate avian IAVs circulating in waterfowl could bind to both Neu5Gc and 
Neu5Ac but lose the binding affinity to Neu5Ac after acquiring adapted mutations in chickens or 
another possible immediate host which could have less Neu5Gc but more Neu5Ac. Further 
studies will be designed to determine glycan binding for those viruses isolated from poultry 
immediately after being introduced to poultry. On the other hand, to identify the potential 







The studies in this dissertation have generated following conclusions: 
First, in the fall of 2015, four H10N7 IAVs were recovered from gulls in Iceland, and 
genomic analyses showed that the viruses were genetically related with the IAVs that caused 
outbreaks among seals in Europe a year earlier. These gull-origin viruses showed high binding 
avidity to human-like glycan receptors. Transmission studies in ferrets demonstrated that the 
gull-origin IAV could infect ferrets, and that the virus could be transmitted between ferrets 
through direct contact and aerosol droplets. This study demonstrated that avian H10 IAV can 
infect mammals and be transmitted among them without adaptation. Thus, avian H10 IAV could 
be a candidate for influenza pandemic preparedness and should be monitored in wildlife and at 
the animal-human interface.  
Second, we determined the glycan binding preference of H7 IAVs from wild birds and 
domestic poultry, and our results showed that these viruses bound stronger to the SLex glycan 
which is present in chicken and other susceptible poultry than to the conventional avian-like 
receptors. These results indicated that SLex is the receptor facilitating the introduction of avian 
H7 IAVs into poultry. The systematic characterization of SLex expression in wild birds’ species 
is needed to further understand the transmission of avian H7 IAVs from wild birds to poultry. 
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The study also shed a light on surveillance tactics of avian H7, which may need to be optimized 
to focus on bird species that express SLex receptors. However, further studies are needed to 
validate the correlations between SLex in host and viral replication.  
Third, we performed the hemagglutination assay, glycan array, and the biolayer 
interference assay to determine H7 avian IAVs binding specificity to Neu5Gc and Neu5Ac, 
which suggested that isolates from North American waterfowl would bind to both Neu5Gc and 
Neu5Ac, whereas the chicken origin IAVs bind exclusively to Neu5Ac. Furthermore, we 
detected Neu5Gc expression in the intestinal tract of the mallard but not in chicken by 
immunofluorescent staining assay. Combined with the results of SLex binding, these results 
suggest that H7 avian IAVs have a diversity of binding to Neu5Gc, and during the transmission 
and adaptation to chickens from waterfowl, these two glycan motifs play an important role. The 
high binding avidity to SLex by the H7 IAVs could easily facilitate transmission of these viruses 
into the chicken since SLex is widely expressed in tracheal epithelial cells. During adaptation in 
the chicken, viruses would gradually lose the binding ability to Neu5Gc because no such glycan 
was detected in chicken trachea and gastrointestinal tract.  
Overall, this dissertation has evaluated the risk assessment, and the receptor binding 
properties of the H7 subtypes of avian IAVs in mammalian and avian animal models. 
Additionally, the inner structures of avian-like receptors, and modification of Sias were 
investigated in affecting the viral receptor binding properties and their distribution among avian 
species, especially chicken and mallard. This study has shed light on understanding the 
correlations between IAV infections and the distribution of glycan receptors in hosts. These 
results will be useful in understanding IAVs host/tissue tropisms.  
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The future direction of this study will be to focus on understanding: 1) The biological 
functions of these glycan motifs in IAVs infection. For instance, growth kinetics of Neu5Gc- or 
Neu5Ac-binding viruses in the Neu5Gc-expressed cell lines; 2) The molecular mechanisms 
behind the binding of H7 IAVs to SLex and Neu5Gc; 3) Explore other subtypes of IAVs and 4) 
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Anti-NP monoclonal antibody was applied to detect the presence of antigens in infection 
birds. The negative control represents the non-infected tissues while infected indicated infected 
bird tissues. The pictures were taken under 100× magnification. Black arrows and blown staining 



















































































































































Table APPENDIX B (continued) 
63 Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-
4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-
4)GlcNAc(b-)Asn 
64 Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB 
65 Gal(b1-4)Gal(b1-4)Glc-AEAB 
66 GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB 
67 Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB 
68 Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB 
69 GlcNAc(b1-2)Man(a-)Thr 
70 Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr 
71 GlcA(a1-6)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr 
72 GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr 
73 Gal(b1-4)GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr 
74 GlcNAc(b1-2)[Gal(b1-4)GlcNAcb1-6)Man(a-)Thr 
75 Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAcb1-6)Man(a-)Thr 
 
 
